Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY1,Aminoacylase-1,29478,0.170619374627943,0.00422726430843078,0.162333936583419,0.178904812672468,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.265059625226859,0.00568723560283048,0.253912643445311,0.276206607008406,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADIPOQ,Adiponectin,24966,-0.232856660593574,0.00453033465939122,-0.24173611652598,-0.223977204661167,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFM,Afamin,24966,0.057117851309762,0.00132601729740725,0.0545188574068438,0.0597168452126802,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRP,Agouti-related protein,29786,0.27003661733876,0.00338044156199763,0.263410951877245,0.276662282800275,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,APCS,Serum amyloid P-component,24726,0.109517851918418,0.00234735861017778,0.104917029042469,0.114118674794366,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCHE,Cholinesterase,24528,0.0902661411725811,0.00189447737544865,0.0865529655167017,0.0939793168284604,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9,Complement component C9,24951,-0.160010318959029,0.0036115173498396,-0.167088892964715,-0.152931744953343,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL23,C-C motif chemokine 23,29581,0.128281616222878,0.00283303246080296,0.122728872599704,0.133834359846052,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL27,C-C motif chemokine 27,29478,0.220408233113583,0.00412170772255236,0.21232968597738,0.228486780249786,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN1,CCN family member 1,29301,0.355143277428108,0.00489450271473598,0.345550052107226,0.364736502748991,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.10161689776586,0.00257914251970177,-0.106672017104475,-0.0965617784272444,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.0915634048066351,0.00203899958506456,0.0875669656199086,0.0955598439933617,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.320551328543833,0.00720806351065131,0.306423524062956,0.334679133024709,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES1,Liver carboxylesterase 1,29489,0.302609673854667,0.00541377344438519,0.291998677903672,0.313220669805662,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFH,Complement factor H,23693,0.0656642825412238,0.00159356427828769,0.06254089655578,0.0687876685266677,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFI,Complement factor I,24966,0.0558770764507362,0.00136030724468331,0.0532108742511569,0.0585432786503154,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFP,Properdin,24966,0.0644990588054807,0.00157368090973252,0.061414644222405,0.0675834733885565,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.15632749744301,0.00386216492870528,0.148757654182748,0.163897340703272,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN3,Contactin-3,29443,0.100216838749188,0.00219749339208188,0.0959097517007075,0.104523925797668,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPM,Carboxypeptidase M,29584,0.108155982396416,0.002331278645944,0.103586676250366,0.112725288542466,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIP2,Cysteine-rich protein 2,29218,0.0998015515417719,0.00249113685608317,0.0949189233038489,0.104684179779695,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.223980436473334,0.00525603483515837,0.213678608196423,0.234282264750244,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.45548140516595,0.0100246110660989,0.435833167476396,0.475129642855504,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.276384408528579,0.00590096389401234,0.264818519296315,0.287950297760843,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG2,Desmoglein-2,29443,-0.0866446398068572,0.0018348494806427,-0.0902409447889169,-0.0830483348247975,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0572134141125533,0.00133325074479987,0.0546002426527456,0.0598265855723611,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,F7,Coagulation factor VII,29544,0.116179199401621,0.00204933992827612,0.1121624931422,0.120195905661042,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,F9,Coagulation factor IX,29545,0.0498907610327202,0.00124724444204783,0.0474461619263064,0.0523353601391339,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,FURIN,Furin,29566,0.124434973924023,0.0022477710023772,0.120029342759364,0.128840605088682,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCG,Pro-glucagon,28797,0.472074334782071,0.00832345254457494,0.455760367794704,0.488388301769438,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHR,Growth hormone receptor,24381,0.109840148946749,0.00190132196462854,0.106113557896077,0.113566739997421,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR37,Prosaposin receptor GPR37,28916,0.196651167574374,0.00452249256615754,0.187787082144705,0.205515253004042,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA1,Glutathione S-transferase A1,29426,0.235933508825198,0.0057679638420927,0.224628299694696,0.2472387179557,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA3,Glutathione S-transferase A3,28797,0.217167649779333,0.0052459814173348,0.206885526201357,0.227449773357309,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUSB,Beta-glucuronidase,29604,0.166378898849269,0.00409751216108911,0.158347775013535,0.174410022685004,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.277572906964171,0.00508624094097916,0.267603874719852,0.287541939208491,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.0974633504596439,0.00234408650930317,0.0928689409014097,0.102057760017878,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.395573717231241,0.00827725749255902,-0.411797141916657,-0.379350292545826,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.189620956242349,0.0042466025305319,-0.197944297202192,-0.181297615282507,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF9,Protein turtle homolog A,24922,0.301515671065931,0.00552777571904673,0.2906812306566,0.312350111475263,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBC,Inhibin beta C chain,29443,0.146868215583098,0.0027818069956092,0.141415873871704,0.152320557294492,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0540897511259246,0.0013448446160848,0.0514538556783984,0.0567256465734508,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0896871786498018,0.00146094981589805,0.0868237170106416,0.092550640288962,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLR,Low-density lipoprotein receptor,29500,0.396862285806396,0.00290875805304121,0.391161120022435,0.402563451590357,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPL,Lipoprotein lipase,29478,-0.17992802990281,0.003141112046183,-0.186084609513329,-0.173771450292292,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFGE8,Lactadherin,29443,0.229483652355603,0.00278584168613991,0.224023402650768,0.234943902060437,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0848286375428627,0.00209115502361173,-0.0889273013891417,-0.0807299736965838,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0935322711408502,0.00234218825165915,-0.0981229601141021,-0.0889415821675983,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPY,Pro-neuropeptide Y,29725,0.357440322067758,0.00414937151109267,0.349307553906017,0.3655730902295,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP1,Neuropilin-1,29628,-0.091560078696513,0.00188496672226008,-0.0952546134721428,-0.0878655439208833,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0791928960749835,0.00188854139470887,0.0754913549413541,0.0828944372086129,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.117095374795914,0.00213772923432572,0.112905425496635,0.121285324095192,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAT,Tissue-type plasminogen activator,29736,0.143404426329307,0.00344219606583702,0.136657722040267,0.150151130618348,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLTP,Phospholipid transfer protein,29702,-0.101623430055305,0.00246111278352577,-0.106447211111015,-0.0967996489995943,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.143296968591958,0.00273711761717107,0.137932218062303,0.148661719121613,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROC,Vitamin K-dependent protein C,29545,0.0906103081965755,0.0017441499219313,0.0871917743495901,0.0940288420435608,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.163272170688943,0.00406119896687143,0.155312220713875,0.171232120664011,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH,Parathyroid hormone,24195,0.277106884372003,0.00543188585651371,0.266460388093236,0.28775338065077,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.16993027099963,0.00317514140503545,0.16370699384576,0.176153548153499,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA4,Kallistatin,24557,0.0715481730158166,0.00162248923688199,0.0683680941115279,0.0747282519201053,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.0967092057489322,0.00216157453382958,0.0924725196626263,0.100945891835238,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPIND1,Heparin cofactor 2,24914,0.0761766694608215,0.00193028126231103,0.0723933181866919,0.0799600207349511,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.0728994975113329,0.00178606504050213,0.0693988100319487,0.0764001849907171,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHBG,Sex hormone-binding globulin,24951,-0.15082806997614,0.0035125515930984,-0.157712671098613,-0.143943468853668,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.182166284141351,0.003607999706866,0.175094604715894,0.189237963566808,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.266169608349697,0.00557700513501935,0.25523867828506,0.277100538414335,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.12084214513883,0.00220487757028211,0.116520585101077,0.125163705176583,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.355734589456245,0.00777390930419339,0.340497727220026,0.370971451692464,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.145077181510086,0.00287401506492653,0.13944411198283,0.150710251037342,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.0917372985764851,0.00216610416227746,0.0874917344184213,0.095982862734549,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS15,Enteropeptidase,29349,0.279384755050828,0.00615046539050995,0.267329842885428,0.291439667216227,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTR,Transthyretin,24707,0.0828412851249758,0.00171061457553602,0.0794884805569252,0.0861940896930264,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.190346464035803,0.00466127690407555,0.181210361303815,0.199482566767791,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.250739571475708,0.00540605735545005,0.240143699059026,0.26133544389239,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPB1,Beta-ureidopropionase,24922,0.243952357630633,0.00626785076019706,0.231667370140647,0.25623734512062,1.11253692925365e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.083821995309786,0.00216007026829013,0.0795882575839373,0.0880557330356347,1.11253692925372e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.0788372308478108,0.00204773343917673,0.0748236733070244,0.0828507883885972,1.11253694087463e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO3,Beta-enolase,24240,0.15882241044562,0.0041268806511055,0.150733724369453,0.166911096521787,1.11253765835659e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.13737962048869,0.00359183599446392,0.130339621939541,0.144419619037839,1.11262533011472e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKB,Creatine kinase B-type,24938,-0.155668954627394,0.0040618486317534,-0.163630177945631,-0.147707731309158,1.11267251959259e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,F10,Coagulation factor X,24951,0.072261040391416,0.00188757489039402,0.0685613936062437,0.0759606871765883,1.11315469602322e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.154613949610529,0.00406281763769833,-0.162577072180418,-0.14665082704064,1.23755100862925e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.192675862833831,0.00506800633552071,0.18274257041621,0.202609155251452,1.60430505885602e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0666563610530114,0.00175028601774888,0.0632258004582236,0.0700869216477992,1.92726279489014e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR3,Anterior gradient protein 3,28764,0.15552797225472,0.0040946271568952,0.147502503027205,0.163553441482235,4.49545257306781e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH1,Somatotropin,29433,-0.46274076530748,0.0122084007853754,-0.486669230846815,-0.438812299768144,5.52009576838734e-307
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.286990503984468,0.00757986187064552,0.272133974718003,0.301847033250933,3.52099877518381e-306
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCA,Alpha-synuclein,24381,0.300043291026606,0.00794464154971926,0.284471793589157,0.315614788464056,2.18655553956412e-303
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0984176836594489,0.00262482250285776,-0.10356233576505,-0.0932730315538477,1.22686738576374e-300
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCS1,Neuronal calcium sensor 1,29725,0.0738113531781893,0.00197012034880112,0.0699499172945392,0.0776727890618395,3.30225811850671e-300
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYNU,Kynureninase,29786,0.116407720469496,0.00312476042012974,0.110283190046042,0.122532250892951,6.22468549868756e-297
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL16,C-C motif chemokine 16,29820,0.134161087837328,0.00360154424431353,0.127102061118473,0.141220114556182,6.64839970269654e-297
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0635092278759373,0.00170888615965919,0.0601598110030053,0.0668586447488693,1.6657159037315e-295
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRP,Gastrin-releasing peptide,24240,0.13754914422013,0.00370789348151817,0.130281672996355,0.144816615443906,5.00157959987906e-293
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.075883178067686,0.00205253661086845,0.0718602063103839,0.0799061498249882,1.57334889449712e-292
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLKB1,Plasma kallikrein,24454,0.0639662173146334,0.00172655806938762,0.0605821634986337,0.0673502711306332,2.29439074929676e-292
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP5,Retinol-binding protein 5,29349,0.141959241635505,0.00386493398123581,0.134383971032283,0.149534512238727,8.51823337562302e-289
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0653218086341254,0.00177981591349063,0.0618333694436837,0.068810247824567,2.38389439371809e-288
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.145891303298878,0.00397839712485458,0.138093644934163,0.153688961663593,9.23619480396993e-287
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.0639181961194151,0.00175010645840728,0.0604879874609368,0.0673484047778934,1.10857883652326e-285
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.174437798637073,0.0047662501532439,0.165095948336715,0.183779648937431,1.20241487996138e-285
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUMB,Protein numb homolog,24229,0.208933934596443,0.00574442408955002,0.197674863380925,0.220193005811961,4.5903437605601e-282
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS1,Protein MTSS 1,24805,0.277388545996168,0.00763128228879309,0.262431232710133,0.292345859282202,6.80215813968675e-282
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.181881587026217,0.00501917899024107,0.172043996205345,0.19171917784709,2.77197230625725e-281
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRN,"Attractin, Isoform 2",24966,0.0412804906351542,0.00114327626949897,0.0390396691469363,0.0435213121233722,2.52306246736095e-278
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.0704483143933488,0.00195592648529032,-0.0742819303045178,-0.0666146984821798,4.53990065567669e-278
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF21,Fibroblast growth factor 21,29674,0.294376972153669,0.00817414227044029,0.278355653303606,0.310398291003732,5.11576785962303e-278
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.308053751136057,0.00855312234619044,0.291289631337524,0.32481787093459,5.29025470326873e-278
NMR metabolomics,X23501.Triglycerides in Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.211058281237485,0.00586337484030947,0.199566066550478,0.222550495924491,1.26456182253722e-276
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.0823991731945738,0.0022961840065557,0.0778986525417247,0.086899693847423,4.47851566968576e-276
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.166865436199591,0.0046793527135655,0.157693904881003,0.17603696751818,1.42362705066642e-272
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.134561652321351,0.00379482282306535,0.127123799588143,0.141999505054559,1.26207278017444e-269
NMR metabolomics,X23501.Triglycerides in Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.207841630953898,0.00587327116840354,0.196330019463827,0.219353242443969,1.70004430094106e-267
NMR metabolomics,X23501.Triglycerides in Large VLDL,P4HB,Protein disulfide-isomerase,29313,0.0943915295128653,0.00267440345101108,0.0891496987488836,0.099633360276847,2.85628325590245e-267
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0535982262969199,0.0015243684048932,0.0506104642233292,0.0565859883705106,2.34755907899584e-265
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLA,Alpha-galactosidase A,24329,0.0910908805869741,0.00258807001657455,0.086018263354488,0.0961634978194602,9.86852181795058e-265
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0971070918793675,0.00278160316779207,-0.10255903408824,-0.0916551496704951,1.13307530864919e-261
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR5,Cadherin-related family member 5,29478,0.0936249480888476,0.0026859998006328,0.0883603884796073,0.0988895076980879,6.79009539998856e-261
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR2,Cadherin-related family member 2,29349,0.174237670825978,0.00500541643763038,0.164427054608223,0.184048287043734,3.43023252656718e-260
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0731399610169769,0.00210328528188598,0.0690175218644804,0.0772624001694734,1.07380588439217e-259
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0492432444182218,0.00141634339159925,0.0464672113706872,0.0520192774657563,1.19597502163702e-259
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTYMK,Thymidylate kinase,24922,0.164185318944578,0.00471713095371166,0.154939742275303,0.173430895613853,3.16339004204759e-259
NMR metabolomics,X23501.Triglycerides in Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.335388608075172,0.00963611614953714,0.316501820422079,0.354275395728265,3.46909267898538e-259
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAB2,Stabilin-2,24938,0.0674967845680023,0.00194262497423903,0.0636892396184938,0.0713043295175108,2.37797966658655e-258
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0325816216253936,0.000939279218971632,0.0307406343562092,0.034422608894578,2.0070018243003e-257
NMR metabolomics,X23501.Triglycerides in Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0945182588542949,0.00273453955371658,0.0891585613290104,0.0998779563795794,1.22162444629822e-256
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.125310529929341,0.00365293309588,0.118150781061416,0.132470278797265,8.5494849783472e-253
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH9,Myosin-9,24938,0.2669112613458,0.00778606466255495,0.251650574607193,0.282171948084408,1.06310684182997e-251
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.093728699567737,0.00273996765173484,-0.0990990361651373,-0.0883583629703367,1.54797269055754e-251
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORT1,Sortilin,29433,0.0879310119034471,0.00257221441291335,0.0828894716541369,0.0929725521527572,3.35797171119525e-251
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.284741115040773,0.00833409857038784,0.268406281842812,0.301075948238733,6.75995078416801e-250
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.215207557292553,0.00631423645631799,0.20283165383817,0.227583460746936,9.14055168454805e-250
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEG1,Protein HEG homolog 1,24381,0.0639693464195092,0.00187928693132116,0.0602859440341197,0.0676527488048987,3.78156591995784e-248
NMR metabolomics,X23501.Triglycerides in Large VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.266458504129905,0.00785761260065493,0.251057583432621,0.281859424827188,2.76542566361991e-247
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0664439212703108,0.00195648665155411,0.0626092074332648,0.0702786351073569,3.64294807262275e-247
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0650751945096077,0.00192101167756881,0.0613100116215729,0.0688403773976426,8.51378028986079e-247
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0510052691330092,0.00150791092281883,0.0480497637242843,0.0539607745417341,3.90971906028771e-245
NMR metabolomics,X23501.Triglycerides in Large VLDL,EEF1D,Elongation factor 1-delta,24922,0.212938487697578,0.00630002970764804,0.200590429470588,0.225286545924568,6.78139617262845e-245
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.133183589622338,0.00395533752671194,0.125431128069983,0.140936051174694,5.90726562163195e-243
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN2,Ficolin-2,29381,0.0950256134266667,0.00283691168907671,0.0894652665160763,0.100585960337257,1.93280934647315e-241
NMR metabolomics,X23501.Triglycerides in Large VLDL,FYB1,FYN-binding protein 1,29400,0.212551395622075,0.00635672321939625,0.200092218112059,0.225010573132092,1.28397742932881e-240
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYAP1,Synapse-associated protein 1,24381,0.132851321303525,0.00396818970317694,0.125073669485298,0.140628973121752,2.68672196711546e-240
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0733363664500366,0.00219772044662055,0.0690288343746603,0.0776438985254129,1.16671241444976e-239
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11R,Junctional adhesion molecule A,29443,0.129595481035324,0.0038848009769934,0.121981271120417,0.137209690950231,1.5420789195584e-239
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.174285475385396,0.00521638902880821,0.164061352888931,0.18450959788186,2.36369569526522e-239
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLN,Promotilin,29434,0.205014666961969,0.00616086630450803,0.192939369005133,0.217089964918805,2.20591798812525e-238
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORD,Sorbitol dehydrogenase,29595,0.156159941450159,0.00471042984624633,0.146927498951516,0.165392383948801,1.14693556372532e-236
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCLY,Selenocysteine lyase,29632,0.111039459033097,0.00335269625785967,0.104468174367692,0.117610743698502,3.20368176177021e-236
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOMO1,Nodal modulator 1,29443,0.053798531143029,0.00162774821922973,0.0506081446333387,0.0569889176527192,3.04309069724857e-235
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0995738643281157,0.00302028863333814,0.093654098606773,0.105493630049458,4.35584241613929e-234
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.0905650085605815,0.00275621583068593,0.0851628255324371,0.0959671915887259,1.36503880345536e-232
NMR metabolomics,X23501.Triglycerides in Large VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.247788469975678,0.00754369013408705,0.233002837312867,0.262574102638489,1.14552187762631e-231
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTD,Biotinidase,24966,0.0468577688247339,0.00143008772366578,0.0440547968863489,0.0496607407631188,1.39438249097729e-230
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBP,Protein AMBP,29683,0.0455191887554015,0.00139286445207789,0.0427891744293289,0.0482492030814742,3.61581250862061e-230
NMR metabolomics,X23501.Triglycerides in Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.149094795178133,0.00455561421216805,0.140165791322283,0.158023799033982,4.68569449075598e-230
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.179628283088951,0.00549640575469106,0.168855327809757,0.190401238368146,2.14446424621166e-229
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.107062389211529,0.00328403227456055,0.100625685953391,0.113499092469668,5.30404608375873e-229
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL16,Pro-interleukin-16,29786,0.0931703427698631,0.00286169749834505,0.0875614156731068,0.0987792698666194,1.66795705281144e-228
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJAP1,Tight junction-associated protein 1,29566,0.186625806210848,0.00573387426579385,0.175387412649892,0.197864199771804,2.4261188470501e-228
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.153490312473576,0.00470686059729356,0.144264865702881,0.162715759244272,2.70312532470344e-228
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.152182038442377,0.00468432329905058,0.143000764776237,0.161363312108516,1.73168936318426e-227
NMR metabolomics,X23501.Triglycerides in Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.200928067061168,0.00619037620403516,0.188794929701259,0.213061204421077,4.60353521842248e-227
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.124592221152574,0.00383841183702698,0.117068933952001,0.132115508353146,2.19664366196457e-226
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHK,Ketohexokinase,24240,0.143651785238069,0.00443061992256456,0.134967770189842,0.152335800286295,8.79943969465978e-226
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.218439111062881,0.00675193276060379,0.205205322852098,0.231672899273665,1.17464385455694e-225
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0655415556872837,0.002042661459306,0.0615379392270439,0.0695451721475234,2.18921712100875e-221
NMR metabolomics,X23501.Triglycerides in Large VLDL,FN1,Fibronectin,24966,0.059168670630427,0.00185093627506771,0.0555408355312943,0.0627965057295597,8.51420952905742e-220
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.13901179104937,0.00436780214015637,-0.147572683244076,-0.130450898854664,1.46694469305521e-218
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELN,Elastin,24922,0.0773778081679303,0.00243030461155566,0.0726144111292812,0.0821412052065794,4.41973297615769e-218
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOST,Sclerostin,29433,0.0850523018316977,0.00268116301364183,0.0797972223249597,0.0903073813384357,3.52521978576319e-217
NMR metabolomics,X23501.Triglycerides in Large VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.18723396761799,0.00590470031456611,0.17566075500144,0.19880718023454,6.03449497066298e-217
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.213145028968625,0.00674244202745322,0.199929842594816,0.226360215342433,1.04258148399985e-215
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXLNA,Alpha-taxilin,29218,0.194033685487785,0.0061417156486244,0.181995922816481,0.206071448159088,1.9748601368164e-215
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLUL1,Clusterin-like protein 1,29435,-0.0986025062506071,0.0031249183111511,-0.104727346140463,-0.0924776663607509,6.14830076737074e-215
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES3,Carboxylesterase 3,29349,0.152480351554743,0.00483278769423622,0.14300808767404,0.161952615435446,6.77568903851623e-215
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPC,C-type natriuretic peptide,29434,0.104566282926071,0.00331849566886692,0.0980620314150921,0.11107053443705,2.31963464436921e-214
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.138425109915689,0.00439381162233589,0.129813239135911,0.147036980695467,3.28475383018103e-214
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2AP,CD2-associated protein,29478,0.137976983855776,0.00440258201408191,0.129347923108175,0.146606044603376,4.0653024221826e-212
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPY30,Protein dpy-30 homolog,29604,0.12979383077843,0.00414450425181147,0.12167060244488,0.137917059111981,7.88340905340839e-212
NMR metabolomics,X23501.Triglycerides in Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.23007506938863,0.00735953239938287,0.21565038588584,0.244499752891421,4.35642907326981e-211
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.183137518470405,0.00585179124128811,0.17166800763748,0.19460702930333,8.30120184505928e-211
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0878150036422482,0.00281749655465414,0.0822927103951261,0.0933372968893703,3.12495502266765e-209
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPY,Pancreatic prohormone,29400,0.219519707374519,0.00705933493965955,0.205683410892787,0.233356003856252,6.58647217904626e-209
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.0705969872201863,0.00227519428392089,0.0661376064237014,0.0750563680166712,4.53943973322065e-208
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.107884965510391,0.00348774289313638,0.101048989439844,0.114720941580938,9.07689385206303e-207
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.112420608014546,0.00362961684358909,0.105306559001111,0.11953465702798,1.07946304200691e-206
NMR metabolomics,X23501.Triglycerides in Large VLDL,MME,Neprilysin,29349,0.171985030942648,0.00556320955358815,0.161081140217615,0.182888921667681,1.56814136868692e-206
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.0898496368506582,0.00291264031190856,0.0841408618393174,0.0955584118619989,1.03117711221551e-205
NMR metabolomics,X23501.Triglycerides in Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.114281965864194,0.0037109277220857,0.107008547528906,0.121555384199482,5.64043696853569e-205
NMR metabolomics,X23501.Triglycerides in Large VLDL,HJV,Hemojuvelin,24867,0.0942174008258239,0.00306550632332517,0.0882090084321066,0.100225793219541,1.26513294647004e-203
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.239220973059575,0.00780000340828448,0.223932966379337,0.254508979739812,1.01441721188137e-202
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.172612085834364,0.00563667032129007,0.161564212004636,0.183659959664093,3.51517390625575e-202
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXIN1,Axin-1,29434,0.20118962565318,0.00660161285858081,0.188250464450362,0.214128786855999,7.2630832885896e-201
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHBP1,EH domain-binding protein 1,24922,0.157334851288868,0.00517660188610427,0.147188711592103,0.167480990985632,2.91282268756896e-199
NMR metabolomics,X23501.Triglycerides in Large VLDL,MVK,Mevalonate kinase,28931,0.167799922369566,0.00552864036860015,0.15696378724711,0.178636057492022,3.26124999040429e-199
NMR metabolomics,X23501.Triglycerides in Large VLDL,BECN1,Beclin-1,24240,0.126618821656484,0.00417767277058054,0.118430583026147,0.134807060286822,4.41351735997363e-198
NMR metabolomics,X23501.Triglycerides in Large VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.130961034712356,0.00432173350267765,0.122490437047107,0.139431632377604,5.42882926995921e-198
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.171765905306189,0.00567940706342671,0.160634267461873,0.182897543150506,6.39482383193723e-198
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS2,Protein MTSS 2,24793,0.207970985667707,0.00687633064569742,0.19449337760214,0.221448593733274,2.37949411280996e-197
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN1,Dynactin subunit 1,29725,0.135979689669924,0.0045048215992233,0.127150239335447,0.144809140004402,3.51841719065677e-197
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.173836245132327,0.00574959170698639,0.162567045386633,0.18510544487802,3.64362015150522e-197
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4R,Reticulon-4 receptor,29725,0.0706465776299842,0.00234798597357164,0.0660445251217838,0.0752486301381846,6.05652021751869e-196
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL22,C-C motif chemokine 22,29169,0.107884756721954,0.00358675071554564,0.100854725319485,0.114914788124424,9.06466480761744e-196
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.203196034202933,0.00676254526973414,0.189941445474254,0.216450622931612,7.2359600879007e-195
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0624013798076474,0.00207754236251521,0.0583293967771176,0.0664733628381772,1.01889946358245e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.0492009077648531,0.00164028925552034,0.0459859408240333,0.052415874705673,1.03448094725605e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB2,Carboxypeptidase B2,24914,0.046989675487384,0.00156663442991599,0.0439190720047487,0.0500602789700193,3.34008572898665e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.102834980578534,0.00342784796299846,0.0961163985710568,0.109553562586011,3.34244594639627e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.13875924220387,0.00463194078773359,0.129680638259912,0.147837846147827,3.42508005805034e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.150940414339864,0.00504273264342527,0.141056658358751,0.160824170320978,5.82521654755723e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.14852129636197,0.00496184033553449,0.138796089304322,0.158246503419617,6.94960584554247e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.0982076912895369,0.00328013813986597,0.0917786205353996,0.104636762043674,1.62598858180881e-193
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.163853487909285,0.00548572633107919,0.15310146430037,0.174605511518201,4.43335068281285e-193
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3F,Semaphorin-3F,29478,0.0545192034635121,0.00182916175903051,0.0509340464158123,0.0581043605112119,2.38303696482401e-192
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A4,Protein S100-A4,29566,0.117699146276226,0.00395765854797011,0.109942135522205,0.125456157030248,1.57744135082905e-191
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.131896018993556,0.00444096414847557,0.123191729262544,0.140600308724568,5.88833863389814e-191
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYY,Peptide YY,24111,0.200294339903068,0.00673626566295821,0.18709125920367,0.213497420602466,7.85500359380146e-191
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.113475757624432,0.00382246172345029,0.10598373264647,0.120967782602395,8.94789938936009e-191
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK1,Dickkopf-related protein 1,29694,0.122263538619261,0.00412005860357003,0.114188223756264,0.130338853482258,9.85740708823068e-191
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZN,Kazrin,24805,0.214566341176132,0.00722398309072429,0.200407334318312,0.228725348033952,1.57598914067096e-190
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARF6,ADP-ribosylation factor 6,24805,0.219815444945533,0.00740980471734111,0.205292227699545,0.234338662191522,4.48699078628121e-190
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCXR,L-xylulose reductase,29566,0.110372526809361,0.00372591057210524,0.103069742088035,0.117675311530687,4.56473555623187e-190
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNA4,Plexin-A4,29434,0.167766047588227,0.00566874526451815,0.156655306869772,0.178876788306683,1.05270011247914e-189
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.113403170951692,0.00383633000916277,0.105883964133733,0.120922377769651,3.1733526340051e-189
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.0968264935755416,0.00327600475972388,0.0904055242464828,0.1032474629046,1.16875474428856e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,THOP1,Thimet oligopeptidase,29343,0.0631493564944758,0.00214264460197678,0.0589497730746013,0.0673489399143503,3.59584481980462e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.105740158936726,0.00358992600843254,0.0987039039601983,0.112776413913254,6.79283404170033e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFC,Platelet-derived growth factor C,28797,0.0592025589824008,0.00201026515589576,0.0552624392768451,0.0631426786879564,7.70234294344877e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP20,Centrosomal protein 20,28797,0.152041751602996,0.00516402486692217,0.141920262863829,0.162163240342164,9.5831005222641e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.0877406363184245,0.00298316201464504,0.0818936387697202,0.0935876338671288,2.00371262742488e-187
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.110139520058275,0.00374933700595351,0.102790819526607,0.117488220589944,5.70911738191334e-187
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS8,Prostasin,29347,0.0836845065958559,0.00285151976885497,0.0780955278489002,0.0892734853428117,1.29312379074989e-186
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.195347035759303,0.00666372279487209,0.182286139081354,0.208407932437253,3.02992847344508e-186
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD63,CD63 antigen,29169,0.104544855637081,0.00356629053202132,0.0975549261943191,0.111534785079843,3.40143581013092e-186
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.209936740339718,0.00721316497041997,0.195798936997694,0.224074543681741,1.26053715487611e-183
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.184479704507682,0.00636916942656341,0.171996132431618,0.196963276583746,6.62149878610748e-182
NMR metabolomics,X23501.Triglycerides in Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0405062811421037,0.001405830107091,0.0377508541322053,0.043261708152002,4.74015190409743e-180
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTBS,Di-N-acetylchitobiase,24653,0.0545623726932462,0.00189182546886662,0.0508543947742676,0.0582703506122248,6.38692403158217e-180
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.145181133248574,0.00503570712795275,0.135311147277786,0.155051119219361,9.68007736724202e-180
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.216033983694352,0.00749802199817335,0.201337860577932,0.230730106810772,1.36248163462762e-179
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.121628710166177,0.00422822032415428,0.113341398330835,0.129916022001519,1.67080951257777e-179
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCR,Breakpoint cluster region protein,29434,0.183004488785661,0.00636711769254161,0.170524938108279,0.195484039463043,3.41879280079311e-179
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.172178273132101,0.00603981556683738,0.1603402346211,0.184016311643102,2.37172026817468e-176
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN1,Perilipin-1,28774,0.0690529419695364,0.00242542591697395,0.0642991071722675,0.0738067767668053,7.50919332515566e-176
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBIN,Erbin,29349,0.202245754613028,0.00711467018969309,0.18830100104123,0.216190508184827,2.27288753824556e-175
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.174772055240214,0.00614173967948636,0.162734245468421,0.186809865012008,2.63868388230191e-175
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEP,Leptin,29478,0.132719484655652,0.00467023101150043,0.123565831873112,0.141873137438193,2.80133589793353e-175
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0513125957389471,0.00180943397692671,0.0477661051441708,0.0548590863337235,1.38748630214831e-174
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.146609324023963,0.00516310224771135,0.136489643618448,0.156729004429477,1.70996993377434e-174
NMR metabolomics,X23501.Triglycerides in Large VLDL,EZR,Ezrin,29694,0.0473405044599018,0.00167127952546421,0.0440647965899919,0.0506162123298116,3.45818719420982e-174
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.05419359899577,0.00191171817916767,0.0504466313646014,0.0579405666269387,5.26709008648133e-174
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.204865361881835,0.00726531380354301,-0.219105376936779,-0.190625346826891,1.22783699094415e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0703715645575205,0.00249655443385726,0.0654783178671602,0.0752648112478807,1.60275742522283e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.132643311463608,0.004698822742152,0.12343361888899,0.141853004038226,1.64906184120743e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.167155566578547,0.00592480143534929,0.155542955765262,0.178768177391831,2.15216225667301e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.213370022139445,0.00757282800306005,0.198527279253447,0.228212765025443,6.03620646459884e-172
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.158280859136971,0.00564892421500661,0.147208967675558,0.169352750598384,1.65447893325733e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R9B,Neurabin-2,29786,0.18366161092167,0.00655553749651751,0.170812757428496,0.196510464414845,1.68461407348798e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0963070849031818,0.00344193466220649,0.0895608929652571,0.103053276841107,5.30736915963119e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAXX,Protein PAXX,24381,0.0890476883921172,0.00318061505695152,0.0828136828804923,0.0952816939037422,8.59841901088197e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM1,Isthmin-1,29434,0.0763859369171128,0.00273551267088401,0.0710243320821801,0.0817475417520454,2.22731309877471e-169
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.243027551069326,0.0087049507814666,0.225965847537652,0.260089254601001,2.52345901438527e-169
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.14444925418051,0.00517613148379763,0.134304036472267,0.154594471888754,1.02778574493338e-168
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD6,T-cell differentiation antigen CD6,29760,0.102061965399528,0.00366277139222929,0.094882933470759,0.109240997328298,1.05411032491528e-168
NMR metabolomics,X23501.Triglycerides in Large VLDL,BACH1,Transcription regulator protein BACH1,29434,0.142778644307861,0.00512539769940016,0.132732864817037,0.152824423798685,1.3683011576873e-168
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.207631041226466,0.00745597110793672,0.19301733785491,0.222244744598022,4.32530269737893e-168
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0392951020104151,0.00141385797082439,0.0365239403875993,0.0420662636332309,7.9434749575655e-168
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSO,Cathepsin O,29786,0.0584654802479093,0.00211133466333748,0.0543272643077679,0.0626036961880508,1.15654023031254e-166
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAB2,Disabled homolog 2,29725,0.212736316453115,0.00768762865186893,0.197668564295452,0.227804068610778,1.93527526146298e-166
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.111411605474894,0.00402613872440188,0.103520373575067,0.119302837374722,2.13020251060042e-166
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELP,P-selectin,29594,0.109191072216399,0.00395100325351987,0.1014471058395,0.116935038593298,5.26075008976574e-166
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSD,Cathepsin D,27442,0.0779311296812152,0.00282732283689259,0.0723895769209057,0.0834726824415246,5.40472839009507e-165
NMR metabolomics,X23501.Triglycerides in Large VLDL,F13B,Coagulation factor XIII B chain,24833,0.0495119161069505,0.00179662754880263,0.0459905261112974,0.0530333061026037,1.06280826023843e-164
NMR metabolomics,X23501.Triglycerides in Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.134149317710956,0.00488990772887222,0.124565098562367,0.143733536859546,1.348756897419e-163
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.217641588353682,0.00792682934600767,0.202105002835507,0.233178173871857,1.63505090135538e-163
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0530899008420399,0.00193691313836356,0.0492935510908473,0.0568862505932325,2.3809028824632e-163
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.216805768633932,0.00791612224223335,0.201290169039154,0.232321368228709,4.29801235079349e-163
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.131831581329495,0.00483520972174825,0.122354570274869,0.141308592384122,1.22820916952388e-161
NMR metabolomics,X23501.Triglycerides in Large VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.0608319126712712,0.00223043672519713,0.0564602566898848,0.0652035686526576,2.62894121392155e-161
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.116073466990619,0.00426314726516178,0.107717698350902,0.124429235630336,3.43667691760645e-161
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.259252586807464,0.00955589329203187,0.240523035955081,0.277982137659846,4.12700925000831e-160
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMIP,C-Maf-inducing protein,24793,0.156353613059787,0.00576488275968017,0.145054442850814,0.16765278326876,1.17049478053586e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLA2,Src-like-adapter 2,24867,0.197306010800993,0.00727964518626757,0.183037906235909,0.211574115366077,1.84924551376478e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0421960025669152,0.00156034311393768,0.0391377300635973,0.0452542750702331,4.37887892358819e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,FETUB,Fetuin-B,29545,0.0621218571628422,0.00229826697643381,0.0576172538890319,0.0666264604366524,5.68587771980401e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.104522844515233,0.00387460759264316,0.0969286136336521,0.112117075396813,2.32590699249126e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLK1,Protein delta homolog 1,29820,0.104346760614892,0.0038807067822427,0.0967405753216964,0.111952945908088,2.26005942838272e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREG1,Protein CREG1,29079,0.0712826828555704,0.0026524761821942,0.0660838295384698,0.076481536172671,3.69480464821832e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0437807310787916,0.0016308941759819,0.0405841784938671,0.0469772836637161,7.4482895438805e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.135553802800594,0.00504483984241733,0.125665916709456,0.145441688891732,8.51650800103111e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.195617365371482,0.00729206145012003,0.181324924929247,0.209909805813718,1.25674034780896e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPL,N-acetylneuraminate lyase,24922,0.083782033076134,0.00312147829846449,0.0776639356111436,0.0899001305411244,1.83135421798842e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.202498630015222,0.00754655568201628,0.18770738087847,0.217289879151974,2.26602587406854e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.129361706165081,0.00482117690353486,0.119912199434153,0.13881121289601,2.3237908887904e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.0964884871005459,0.00360007358262799,0.089432342878595,0.103544631322497,2.51485424256574e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRN,Agrin,29581,0.0641466408250765,0.00239786517271937,0.0594468250865466,0.0688464565636065,8.50090232106313e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,AAMDC,Mth938 domain-containing protein,24240,0.0995220372069125,0.00371569798728302,0.0922392691518378,0.106804805261987,9.1549131068867e-156
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL17,C-C motif chemokine 17,29414,0.169250274821696,0.00633506916041173,0.156833539267289,0.181667010376103,2.18224430995327e-155
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP10,Stromelysin-2,29439,-0.109929999292673,0.00411573997187072,-0.11799684963754,-0.101863148947806,2.59359673093728e-155
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC1,Stanniocalcin-1,29694,0.0806934720898378,0.00302751244913968,0.0747595476895241,0.0866273964901516,1.08600666881545e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.176429029530094,0.00662530865134594,0.163443424573456,0.189414634486732,2.0572265506002e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUOM,Fucose mutarotase,24381,0.118002098954087,0.00443117863986918,0.109316988819943,0.12668720908823,4.89179223383021e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.19032071317284,0.00714899245180137,0.176308687967309,0.204332738378371,6.18314152944019e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCTN3,Tectonic-3,24922,0.0550095519124528,0.00207371567212135,0.050945069195095,0.0590740346298107,6.2984792731424e-153
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO1,Forkhead box protein O1,29434,0.157528141883886,0.00595561717641553,0.145855132218112,0.169201151549661,2.19525449426931e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.194451504234515,0.00735230473472166,0.180040986954461,0.208862021514569,2.30447540267163e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPK2,SRSF protein kinase 2,29434,0.154340373452782,0.00583962826490549,0.142894702053567,0.165786044851996,3.73212366976754e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.116331469020232,0.00439680682489086,0.107713727643446,0.124949210397018,3.76381629422826e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0736110454762865,0.00278814607123035,0.068146279176675,0.079075811775898,1.6411414802988e-151
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUCB2,Nucleobindin-2,29652,0.0684498817410607,0.00259622219633844,0.0633612862362373,0.073538477245884,1.92384702903135e-151
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.189015632700203,0.00717707971314118,0.174948556462447,0.20308270893796,4.10629706580559e-151
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK2,Docking protein 2,29478,0.223060279658037,0.00847224058716585,0.206454688107192,0.239665871208882,5.08741111348752e-151
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0365280716310785,0.00138755838959948,0.0338084571874636,0.0392476860746935,5.54254051570232e-151
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.107845826795994,0.0040962481507155,0.0998171804205921,0.115874473171397,1.08339013330514e-150
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.154129273397308,0.0058563562181882,0.142650815209659,0.165607731584956,1.37171340515052e-150
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.18100412732305,0.00689023767612531,0.167499261477845,0.194508993168256,2.21347628176667e-150
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEXIM1,Protein HEXIM1,29434,0.148427067342896,0.00565906747368481,0.137335295094474,0.159518839591318,6.72698965684877e-150
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.204283375910034,0.00782502959603956,0.188946317901797,0.219620433918272,1.52152172832999e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.121826063429739,0.00466890841843779,0.112675002929601,0.130977123929877,2.03639762608337e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.144672893730345,0.00553951065258345,0.133815452851281,0.155530334609408,2.67609389121989e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.0730436757006065,0.00280079189263584,0.0675541235910402,0.0785332278101727,3.01305803397546e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.121412377243833,0.00465622582310001,0.112286174630557,0.130538579857109,3.30558449976904e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.152966781416922,0.00588607412502497,0.141430076131873,0.164503486701971,3.15581857748635e-147
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPD52L2,Tumor protein D54,24381,0.196108542060115,0.00753962933615388,0.181330868561253,0.210886215558976,3.85390596781488e-147
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINK1,Misshapen-like kinase 1,24845,0.168075931084466,0.00646370874325074,0.155407061947695,0.180744800221238,4.26569065730116e-147
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.163150115021592,0.00629404307000715,0.150813790604378,0.175486439438806,3.37102338372294e-146
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELE,E-selectin,29820,0.0907952465138072,0.003509975175986,0.0839156951688746,0.0976747978587397,6.28157993061657e-146
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.115472684503651,0.00446473068627906,0.106721812358544,0.124223556648758,8.01019150216457e-146
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXT,Oxytocin-neurophysin 1,29694,0.249997960042298,0.00969483342909361,0.230996086521274,0.268999833563321,4.95802827169441e-145
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.135879064072022,0.00527168157127792,0.125546568192317,0.146211559951727,6.54539182844787e-145
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.114475905294926,0.00444865761182309,0.105756536375753,0.123195274214099,2.00120828970301e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD5,Programmed cell death protein 5,29694,0.103807317978498,0.00403442587797129,0.0958998432576743,0.111714792699322,2.05449094861e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNST,Consortin,29478,0.193870268626782,0.00754625705115743,0.179079604806514,0.208660932447051,5.69885381736858e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.139711056824768,0.00543410933688203,0.12906020252448,0.150361911125057,7.4799222123288e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.183508863183951,0.00713973164436718,0.169514989160991,0.197502737206911,8.3885940156638e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP43,Centrosomal protein 43,28705,0.124327683246209,0.00485211394248728,0.114817539918934,0.133837826573484,3.42295566236504e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN2,CCN family member 2,29478,0.101888001147031,0.00397887577520711,0.0940894046276256,0.109686597666437,4.66647326698807e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL5,C-C motif chemokine 5,29594,0.179130150300193,0.00699554135690387,0.165418889240661,0.192841411359725,4.70723620353837e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGF,Hepatocyte growth factor,29786,0.0613873667704738,0.00239773571583171,0.0566878047674436,0.0660869287735039,5.10045953352044e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.171099669200937,0.00668282054806774,0.158001340926724,0.18419799747515,5.57246326542883e-143
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINH1,Serpin H1,24445,0.229051467545091,0.00895445296261213,0.211500739738372,0.246602195351811,1.92925740412766e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.152852896161219,0.0059869679854064,0.141118438909823,0.164587353412616,3.17241244834826e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.198745227759055,0.00778535960661818,0.183485922930083,0.214004532588027,3.52115973965122e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.11915817381111,0.00467667405263506,0.109991892667945,0.128324454954275,1.25048030979125e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.128470735078215,0.00503798998160403,0.118596274714271,0.138345195442159,1.2931286647567e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL13,C-C motif chemokine 13,29732,0.122420436089635,0.00481145391880447,0.112989986408779,0.131850885770492,2.71754359625175e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.167945524820765,0.0066025794095092,0.155004469178127,0.180886580463403,3.45382721504806e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.135834332966854,0.00534555344086194,0.125357048222764,0.146311617710943,6.44034354732955e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0677882641188031,0.00267159672973176,0.0625519345285288,0.0730245937090773,1.5430984656537e-140
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.201565190814464,0.0079435399263377,0.185995852558842,0.217134529070086,2.92925162381598e-140
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.135916249584122,0.00536579863428137,0.125399284260931,0.146433214907314,8.76197495723332e-140
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINC1,Antithrombin-III,24914,0.0260817815218789,0.00103015590672831,0.0240626759446914,0.0281008870990664,1.17516433141023e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2B3,SH2B adapter protein 3,28797,0.172644917147612,0.00683649893163375,0.159245379241609,0.186044455053614,3.41360225778543e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.112123427447223,0.00443850021369699,0.103423967028377,0.120822887866069,4.763785475543e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.10708344872345,0.00424315001127602,0.0987668747013486,0.115400022745551,5.15071105109524e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.0652494307150484,0.00258710808675025,0.0601786988650179,0.0703201625650789,7.26540531613858e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.17114378846351,0.00677879649579652,0.157857347331749,0.184430229595271,7.65198041706406e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.0757348550152175,0.00300078633852672,0.0698533137917051,0.0816163962387298,9.64548130052559e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0694224831028945,0.00275414533713887,0.0640243582421023,0.0748206079636866,9.67120323955073e-139
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.121951078679726,0.00483425071575379,0.112475947276849,0.131426210082604,1.26415434408083e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.117125452143147,0.00465322415127029,0.108005132806657,0.126245771479636,2.37034857640637e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH2,Neutral ceramidase,29218,0.0926966235177862,0.00369309163403361,0.0854581639150803,0.099935083120492,1.43203176547361e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,USO1,General vesicular transport factor p115,29349,0.156898797437141,0.00626038490799573,0.144628443017469,0.169169151856812,3.57854668924507e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.040972210328939,0.00163615881492519,0.0377653390516856,0.0441790816061923,5.85369055446084e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0654965609822481,0.00261382248341419,0.0603734689147563,0.0706196530497399,7.76115605007637e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH2,Cadherin-2,29478,0.061449462648543,0.00246911709950438,0.0566099931335144,0.0662889321635715,2.56217838160665e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.0442298956416289,0.00177760276234939,-0.0477139970558337,-0.0407457942274241,2.87708214674151e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP5,Fatty acid-binding protein 5,29624,0.118068828568834,0.00474573198776819,0.108767193872808,0.12737046326486,3.08672729035526e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.125196429683124,0.00502963187993812,0.115338351198445,0.135054508167803,4.17550996468884e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.180671217530766,0.00726623443538377,0.166429398037414,0.194913037024119,4.41288930569812e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5E,5'-nucleotidase,29566,0.0972443958604144,0.00391741046875726,0.0895662713416502,0.104922520379179,1.19629282470226e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR,GMP reductase 1,29786,0.0859236059793998,0.00346176704807533,0.0791385425651722,0.0927086693936274,1.25463857517416e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGFR,Opioid growth factor receptor,29349,0.0565332830564304,0.0022788446447118,0.0520667475527952,0.0609998185600655,1.79746088358178e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.126253203875336,0.00508895808231954,0.11627884603399,0.136227561716682,1.8223648789325e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0920691698728131,0.00371100215464803,0.084795605649703,0.0993427340959232,3.22355525147217e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNMBP,Dynamin-binding protein,29218,0.105635220187468,0.00426444698761278,0.097276904091747,0.113993536283189,4.45345197524219e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE4,Ribonuclease 4,24194,0.0475287139420763,0.00191858099545009,0.0437682951909941,0.0512891326931585,8.19929332539547e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANG,Angiogenin,29435,0.058176388218102,0.00235204759295752,0.0535663749359053,0.0627864015002988,1.06317008079507e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.132146114628847,0.00534045591261833,0.121678821040115,0.142613408217579,1.48874697380443e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEC31A,Protein transport protein Sec31A,24240,0.13269557853703,0.0053622388091805,0.122185590471036,0.143205566603023,1.54708088314169e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.133351616597443,0.00539800329513287,0.122771530138983,0.143931703055903,3.92353633119312e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.108601009410347,0.00440118134335689,0.0999746939773672,0.117227324843326,7.82299539769389e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRAP,BRCA1-associated protein,24565,0.188565161288814,0.00764425063012619,0.173582430053767,0.203547892523861,9.85062849513561e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0463707572687929,0.00188403527770101,0.042678048124499,0.0500634664130869,2.04964004013171e-132
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.125187523395938,0.00508432127404011,0.11522225369882,0.135152793093057,2.78531432394443e-132
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1A,Meprin A subunit alpha,24805,0.123425199385331,0.00502195961937534,0.113582158531356,0.133268240239307,8.39584516948613e-132
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.160093452877453,0.00652170827414204,0.147310904660135,0.172876001094772,1.02237514913378e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP2,Methionine aminopeptidase 2,29674,0.0981880718256491,0.00400848802312924,0.0903314353003157,0.106044708350982,3.36491302724086e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN1,Pantetheinase,24951,0.124277429820538,0.00507169073587239,0.114336915978229,0.134217943662848,4.73654019587494e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.0943439478840399,0.0038531975143001,0.0867916807560117,0.101896215012068,7.65734583619886e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.156512195343714,0.00640746981774704,0.14395355450093,0.169070836186499,1.88380033070704e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0644792165576615,0.00264088803071554,0.059303076017459,0.0696553570978639,2.31403941574863e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMN,Protein amnionless,28931,0.0808324973170061,0.00331398491987615,0.0743370868740489,0.0873279077599634,4.37011087159526e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.144212833876936,0.00591261133574804,0.13262411565887,0.155801552095003,7.97846938032525e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.0913250625087875,0.00375031312750563,-0.0986756762386985,-0.0839744487788764,1.12614697836285e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAMBP,STAM-binding protein,29163,0.108547384612155,0.00446063017801444,0.0998045494632468,0.117290219761063,1.65969043923934e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0582120881090749,0.00239276638714114,-0.0629019102278715,-0.0535222659902782,1.86859390529826e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.153642856549252,0.0063229029339475,0.141249966798715,0.166035746299789,6.40745421665265e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0941486999047126,0.00387935065383626,0.0865451726231935,0.101752227186232,7.42607025950379e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0555471659644921,0.00228932060409496,0.051060097580466,0.0600342343485182,8.63376429765856e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.103442801561913,0.00426522243736132,0.0950829655846852,0.111802637539142,1.14039090241483e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.178961664452541,0.00737527111019073,0.164506133076567,0.193417195828515,1.52251739650683e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.075897360645639,0.00313338438973064,-0.0820387940495111,-0.069755927241767,3.97584122565445e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT2,Omega-amidase NIT2,24813,0.125797756206116,0.00519364242521958,0.115618217052686,0.135977295359547,4.06994746199595e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB3,Plexin-B3,29383,0.0797641604397146,0.00330298089001541,0.0732903178952844,0.0862380029841448,1.34058700289155e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPHN1,Oligophrenin-1,24845,0.181188236147702,0.0074992733648076,0.166489660352679,0.195886811942725,1.70598196893732e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0875814714002317,0.00363052519880133,0.0804656420105811,0.0946973007898823,2.41864109271172e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.169616704590365,0.00705400309765268,0.155790858518966,0.183442550661765,1.55287935547308e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0556167612083934,0.00231236437767953,0.0510845270281415,0.0601489953886453,2.55277862712618e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.143436408614175,0.00597767959319598,0.131720156611511,0.155152660616839,4.99895645045576e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.10602290045095,0.0044187552042872,0.0973621402505476,0.114683660651353,5.57932968855735e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.126563287081227,0.00527368382131627,0.116226866791448,0.136899707371007,7.69926353047937e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.133908115995503,0.00558062101664373,0.122970098802882,0.144846133188125,8.4238999031598e-126
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0736672406403963,0.00307419590256004,0.0676418166713787,0.079692664609414,1.09183784990556e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,QDPR,Dihydropteridine reductase,29345,0.0720211772464224,0.00300965002413989,0.0661222631991082,0.0779200912937366,2.37470211469052e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBPL,FK506-binding protein-like,24805,0.0987861679008359,0.00412726906670856,0.0906967205300871,0.106875615271585,3.48746755399056e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,BID,BH3-interacting domain death agonist,29434,0.111172231420057,0.0046541531394292,0.102050091266776,0.120294371573338,6.53055317474339e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,EREG,Proepiregulin,29163,0.133778436189095,0.00560123453907639,0.122800016492505,0.144756855885685,7.17379142810049e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDUA,Alpha-L-iduronidase,29725,0.0768382159371138,0.00321880902798804,0.0705293502422573,0.0831470816319704,9.05261617906612e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA5,Integrin alpha-5,29443,0.0417208998856002,0.00174777225374439,0.0382952662682612,0.0451465335029392,9.44735247696979e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.150960992368929,0.00631933103685619,0.138575103536691,0.163346881201167,1.01417945497181e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.109625899557275,0.00459141826687787,0.100626719754194,0.118625079360355,1.36818671850214e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.105040516415127,0.00440617615321318,0.096404411154829,0.113676621675425,3.24768142074072e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.108021821758731,0.00453823901567449,0.099126873288009,0.116916770229453,4.57672506495989e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.137168375615629,0.00576572954000717,0.125867545717215,0.148469205514043,6.62506804273392e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.139866531176959,0.00588540661367383,0.128331134214158,0.15140192813976,1.13733763017938e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.212366243957625,0.00893833236648078,0.194847112519323,0.229885375395928,1.26302066713839e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXN,Paxillin,28774,0.0854235105179739,0.00359724515479919,0.0783729100145675,0.0924741110213803,1.82776942448492e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDHD2,Phospholipase DDHD2,24867,0.10985315469411,0.00462363614320817,0.100790827853422,0.118915481534798,2.10711452773662e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0543817579629953,0.00229089035226592,0.0498916128725541,0.0588719030534365,2.11694796562286e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,MITD1,MIT domain-containing protein 1,29218,0.160058886053551,0.00674313727889172,0.146842336986923,0.173275435120178,2.23407378386015e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC13,Mucin-13,28774,0.0850767270577767,0.00359682418351337,0.0780269516580906,0.0921265024574629,1.61770485153324e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.12694775910851,0.00536776726657021,0.116426935266032,0.137468582950987,1.6446380263137e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0463018051196307,0.00196045592956662,0.0424593114976802,0.0501442987415813,3.45674962960316e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.124359998812605,0.00527856555458038,0.114014010325628,0.134705987299583,1.36169060148034e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0442373265496477,0.00187637278694489,0.0405596358872357,0.0479150172120597,1.45435527419031e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.176132540861758,0.00747102046586825,0.161489340748657,0.19077574097486,1.48794485657166e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.0875311145557492,0.00371654262956653,0.0802466910017988,0.0948155381096996,1.60640769788455e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.135855436644022,0.00576385378718691,0.124558283221135,0.147152590066908,1.78173376488231e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAG1,Dystroglycan,29581,0.077967140332302,0.00331178486438316,0.071476041998111,0.084458238666493,1.97450815732581e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES2,Cocaine esterase,29349,0.089811277868521,0.00381543270200727,0.0823330297725868,0.0972895259644553,2.17870122817673e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.115694414115334,0.00491594436863836,0.106059163152803,0.125329665077865,2.39584209663799e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT1,Deaminated glutathione amidase,24240,0.0778024921365355,0.00330389695327433,0.0713268541081178,0.0842781301649532,2.98174960704691e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0823803422012887,0.00350007291655967,0.0755201992848317,0.0892404851177456,3.97958426054625e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.043839207137118,0.00186710425620815,0.04017968279495,0.047498731479286,8.44565147685244e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX15,Sorting nexin-15,24381,0.0886754638429587,0.00377403412710332,0.0812783569538361,0.0960725707320812,9.81968645284266e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0458186467773059,0.00195404791435189,0.0419887128651762,0.0496485806894356,1.87022390952577e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.117176834878305,0.00500155991481157,0.107373777445275,0.126979892311336,4.70250009178403e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0541834315531671,0.00232338814937033,-0.058737272325933,-0.0496295907804013,3.2476971406368e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.123789121578245,0.00530518881563035,0.11339095149961,0.134187291656881,3.86380284111306e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCC,Tubulin-specific chaperone C,29218,0.131617350519857,0.00564608083508172,0.120551032083096,0.142683668956617,4.17643256799846e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRKL,Crk-like protein,29491,0.172590739602317,0.00740522665830539,0.158076495352038,0.187104983852595,4.54256112782127e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM13A,Protein FAM13A,24805,0.109975069051928,0.00471507336230944,0.100733525261801,0.119216612842054,4.83048401169964e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.126785115070927,0.00544237203808362,0.116118065876283,0.137452164265571,9.13917350645806e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0796033087426905,0.00342083440334702,0.0728984733121304,0.0863081441732507,1.09945940543005e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1S,Complement C1s subcomponent,24966,0.0339398836440463,0.00146031884325416,0.0310776587112681,0.0368021085768245,3.13374729629211e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0922730394109191,0.00397253469603675,0.0844868714066871,0.100059207415151,4.67714401623356e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.133141092376345,0.00573468773583091,0.121901104414116,0.144381080338573,5.51845921861478e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.146064306222598,0.00629340661791109,0.133729229251492,0.158399383193704,7.13215515697353e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0825503441174143,0.00356088629912442,0.0755710069711305,0.0895296812636982,8.23431541349628e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.0924853191982831,0.00399211454412954,0.0846607746917892,0.100309863704777,1.11025895208725e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD1,COMM domain-containing protein 1,24240,0.0990936224181891,0.0042799466632262,0.0907049269582657,0.107482317878112,2.5477642997697e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTDH,Protein LYRIC,24229,0.150415385561263,0.00649742660370289,0.137680429418005,0.163150341704521,2.73146699713937e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0807006809289024,0.00349032934514721,0.0738596354124138,0.0875417264453909,3.05338605495582e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,THPO,Thrombopoietin,28916,0.0622827912754454,0.00269683114078862,0.0569970022394997,0.0675685803113911,5.99064052875694e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.190999203522121,0.0082648919550194,0.174800015290283,0.207198391753959,6.32538976817516e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC5,Glypican-5,29218,0.0907480628247697,0.00393045660628733,0.0830443678764465,0.0984517577730928,6.75429459047867e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.18732438615085,0.00812002606288911,0.171409135067587,0.203239637234112,1.02874798594944e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD36,Platelet glycoprotein 4,24229,0.0730203906423919,0.0031628367043392,0.066821230701887,0.0792195505828967,1.13874611522799e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0420753325205826,0.00182334973243312,0.0385015670450137,0.0456490979961515,1.46364292024156e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0984685401008401,0.00427706341069625,0.0900854958158754,0.106851584385805,2.9664002059566e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.143103126640836,0.00621294885325695,0.130925746888452,0.155280506393219,3.60991921181011e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0557614567285169,0.00242554139181811,0.0510073956005534,0.0605155178564803,6.55153013412086e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0736332452357867,0.00320397147797402,-0.0799130293326158,-0.0673534611389577,7.28210944119975e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GLB2,Endophilin-B2,24845,0.106705847290928,0.0046441499953243,0.0976033133000926,0.115808381281764,1.2903825796655e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0274180183845065,0.00119364214530462,0.0250784797797094,0.0297575569893035,1.46933235285737e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA2,Apolipoprotein A-II,24951,-0.0775038004377975,0.00337666465893466,-0.0841220631693095,-0.0708855377062856,2.17223777422814e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBNL,Drebrin-like protein,29581,0.148038175215511,0.00645963998952037,0.135377280836051,0.160699069594971,3.15158595970085e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.0951497842420734,0.00415540806944574,0.0870051844259598,0.103294384058187,4.99062361066182e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.13781342862428,0.0060254132399586,0.126003618673961,0.149623238574599,8.79367979247768e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGLN1,Egl nine homolog 1,29434,0.0868267930248447,0.00379720765725108,0.0793842660166326,0.0942693200330569,1.01612302564265e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL11,Eotaxin,29786,0.0601210442413729,0.00263155506441184,0.0549631963151257,0.0652788921676201,1.54284656675045e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D23,TBC1 domain family member 23,29349,0.143111508500021,0.00626814043392898,0.13082595324952,0.155397063750521,2.21663019882068e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGA,Protein O-GlcNAcase,24805,0.112668677480878,0.00493662968888928,0.102992883290655,0.122344471671101,4.0692152608464e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0992274714700707,0.00434764387894228,0.0907060894673438,0.107748853472798,4.36713764686217e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0625655301226965,0.00275067319921702,0.0571742106522311,0.0679568495931619,1.57781895821802e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.152309680907806,0.00669159119073273,0.13919416217397,0.165425199641642,1.61542261415343e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.0812569035851253,0.0035759703940456,0.0742480016127959,0.0882658055574547,2.5097396286595e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTPBP2,GTP-binding protein 2,24195,0.128433070345951,0.0056484859276014,0.117362037927853,0.13950410276405,2.93330986063899e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS8,Galectin-8,29694,0.0962377669946976,0.00423781754002105,0.0879316446162564,0.104543889373139,3.35086951527526e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0317352184348382,0.00139789287027006,0.0289953484091089,0.0344750884605676,6.02219824548037e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.056805200515935,0.00250722497003319,0.05189103957467,0.0617193614572001,1.11508751144782e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0762925710736171,0.00336649118666093,0.0696942483477617,0.0828908937994726,1.47030949754995e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0747662748120796,0.00330031693580144,0.0682976536179088,0.0812348960062505,1.75716187124201e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASHC3,WASH complex subunit 3,24845,0.119272666940842,0.00526681072159883,0.108949717926508,0.129595615955175,2.0989514867303e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0808258183775522,0.00357066035942267,0.0738273240730837,0.0878243126820206,2.63181651497845e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0941248016808758,0.00416193003000735,0.0859674188220614,0.10228218453969,4.14371550493681e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.100496736307495,0.00445609729445517,-0.109230687004627,-0.0917627856103632,1.65121946039449e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0859540267215409,0.00382327279011345,0.0784604120529185,0.0934476413901632,8.5213886531407e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0549295711338457,0.00244632074979401,-0.0597243598034419,-0.0501347824642494,9.99321893954437e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.147676922978347,0.00657797227354223,0.134784097322204,0.16056974863449,1.08385542447711e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSB,Arylsulfatase B,29349,0.0863183588556641,0.00385205961795459,0.0787683220044731,0.0938683957068551,2.75329121751705e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST13,Hsc70-interacting protein,24381,0.0874740056832344,0.00390062838321386,0.0798287740521353,0.0951192373143336,2.89246532233859e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.130129342072482,0.00580337778526972,0.118754721613353,0.141503962531611,2.93543089913911e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTBDN,Retbindin,29349,0.0463989339447088,0.0020715033981047,0.0423387872844236,0.050459080604994,3.4097423881431e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0557425416217722,0.00248928196787449,0.0508635489647382,0.0606215342788062,3.81665850373457e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.105712220242704,0.00471712374120704,0.0964666577099379,0.11495778277547,3.85553693352788e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2,Prothrombin,24966,0.023175384157428,0.00103491353452056,0.0211469536297677,0.0252038146850883,5.52124947860424e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYDGF,Myeloid-derived growth factor,24922,0.156022784552532,0.00697969165525853,0.142342588908226,0.169702980196839,1.32760164615932e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.132599622710492,0.00594340423732872,0.120950550405328,0.144248695015657,2.48446154977607e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.117986338463298,0.00529238231425065,0.107613269127367,0.12835940779923,3.55378670015622e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.133396636186421,0.00598827769033063,0.121659611913373,0.145133660459469,7.7046324294263e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK1,Docking protein 1,24845,0.212597391304091,0.00954807114213382,0.193883171865509,0.231311610742673,9.16620877752687e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.0896969617229092,0.00403465146763627,0.0817890448463421,0.0976048785994763,1.31097498511345e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLB1,Beta-galactosidase,29218,0.0649347455804472,0.00292682210121598,0.0591981742620639,0.0706713168988305,3.66913597366285e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0766902811306485,0.0034593565650046,0.0699099422632395,0.0834706199980575,8.10190746085348e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLM2,Protein GOLM2,29694,0.0349877429346451,0.00158027564769033,0.031890402665172,0.0380850832041181,9.66164797227056e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0896482768992892,0.00405066780003123,0.081708968011228,0.0975875857873504,1.1714019473639e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGF,Placenta growth factor,29786,0.0405703762555127,0.00183422693273815,0.0369752914673459,0.0441654610436795,1.54374847491557e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON2,Spondin-2,29311,-0.053904071590622,0.00243767469689987,-0.0586819139965458,-0.0491262291846983,1.80125664153235e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.139326870753477,0.00630820587762393,0.126962787233334,0.15169095427362,4.8445389587756e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.169606501358294,0.007688052678809,0.154537918107829,0.18467508460876,5.46997238466504e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0481780117611575,0.00218878038860438,-0.0524680213228221,-0.043888002199493,1.61232663940771e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.119303487160602,0.00541814218283297,0.108683928482249,0.129923045838955,2.08610069441669e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,IST1,IST1 homolog,24636,0.152843832121029,0.00694438352078776,0.139232840420285,0.166454823821773,2.46648025462063e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.0569957737573083,0.00259250968210163,0.0519144547803891,0.0620770927342275,2.892625930606e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.11961314576128,0.00544395241878955,0.108942999020453,0.130283292502108,4.00591228843285e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.140717243716914,0.00641576613995366,0.128142342082605,0.153292145351223,9.25587728541322e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0706129974683697,0.00322059111898402,0.064300638875161,0.0769253560615784,1.04373175702468e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0888873074733278,0.00405925284357029,0.08093117189993,0.0968434430467256,2.84646646395416e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.134831398916191,0.00616753481026201,0.122743030688078,0.146919767144305,6.25993510495837e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.0988116542571452,0.00452789277132756,0.0899369844253432,0.107686324088947,9.57763260589712e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0339872042357598,0.00155799759068297,0.0309335289580212,0.0370408795134985,1.11166055180058e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.110369432692564,0.00506013403877073,0.100451569976574,0.120287295408555,1.20774622828077e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.11036019486459,0.00505587995031471,0.100450670161973,0.120269719567207,1.28594836985144e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.129406706136886,0.00593370041098375,0.117776653331357,0.141036758942414,1.34862729235232e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,TALDO1,Transaldolase,24888,0.0679197170642687,0.00311251722992473,0.0618191832936162,0.0740202508349212,1.39015488825179e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,COCH,Cochlin,24922,0.0704621440544309,0.00323461435934975,0.0641222999101053,0.0768019881987564,3.10933779295299e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.223255059191398,0.0102520290746596,0.203161082205065,0.243349036177731,3.65911575961303e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0311428456186073,0.00143324618973551,-0.0339520081504889,-0.0283336830867257,7.1205630111779e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIP,Gastric inhibitory polypeptide,24240,0.0776767528113844,0.00357829475540971,0.0706632950907814,0.0846902105319875,1.68061803476513e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADD1,Alpha-adducin,24381,0.106229884561738,0.00489384933968963,0.0966379398559459,0.115821829267529,1.69261331270193e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0441994118313075,0.00203840349813804,0.0402041409749569,0.0481946826876581,1.86025183432495e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,TWF2,Twinfilin-2,24938,0.127144548941351,0.00586361906495936,0.115651855574031,0.138637242308672,2.64098724572256e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0674565091444985,0.00311745459566201,0.061346298137001,0.0735667201519961,5.19155425033366e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.0917450842902588,0.00424198297761427,0.0834307976541348,0.100059370926383,8.71377070439044e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPART,Spartin,24381,0.116952239286,0.00541054470190622,0.106347571670264,0.127556906901736,1.18062003225318e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0674387696455832,0.00312709565888498,0.0613096621541687,0.0735678771369978,2.34363033396075e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPP,Lipoma-preferred partner,24111,0.100379602137818,0.00465354781400708,0.0912586484223639,0.109500555853272,3.1491984446254e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEFTY2,Left-right determination factor 2,29674,0.0782366718805458,0.00363076941492516,0.0711203638272925,0.0853529799337992,3.34848155037854e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0477480520287895,0.00221417031233993,0.0434082782166032,0.0520878258409757,3.51940825909537e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASC3,Protein CASC3,24195,0.0632645342716714,0.00293497264283601,0.0575119878917129,0.06901708065163,4.30856781383334e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,RWDD1,RWD domain-containing protein 1,29694,0.0954492067268174,0.00443937719863555,0.0867480274174917,0.104150386036143,9.20128381233515e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0478902949384714,0.00222790489968177,-0.0522569885418477,-0.0435236013350951,1.01376810195722e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.195247605147858,0.00908640232682407,0.177438256587282,0.213056953708433,1.21263498586496e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0750388039438447,0.003492901653602,0.0681927167027848,0.0818848911849046,1.34892776270333e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOT,Angiomotin,24381,0.0605587668782718,0.00281800539561732,0.0550354763028618,0.0660820574536817,1.69397741221285e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.183258685309711,0.00853415748255189,0.166531736643909,0.199985633975512,1.75297241724163e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0553111331673996,0.00257925258128681,0.0502557981080775,0.0603664682267217,4.23723952661626e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,C19orf12,Protein C19orf12,28774,0.0966796262736398,0.00451314065419347,0.0878338705914205,0.105525381955859,5.16041050145625e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR2,GMP reductase 2,24381,0.100624510739088,0.00469829757664134,0.0914158474888706,0.109833173989305,7.85699373339263e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.108270295226945,0.00506369039515627,0.0983454620524391,0.118195128401452,1.1561847214079e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICA1,Islet cell autoantigen 1,28931,0.118907793891247,0.00556935268110159,0.107991862636288,0.129823725146207,2.30640662909975e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.128947222224617,0.00604240492425545,0.117104108573077,0.140790335876158,3.82022381328967e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0893243910960909,0.00418961808699158,0.0811127396455874,0.0975360425465944,4.3340068601428e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIAE,Sialate O-acetylesterase,29495,0.0694864309150666,0.00326082012614105,0.0630952234678302,0.0758776383623031,5.272818662779e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.0549258890902863,0.00258469172367405,0.0498598933118851,0.0599918848686874,1.79818522135294e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN3,Ataxin-3,24845,0.0918259944205195,0.00432098144189554,0.0833568707944043,0.100295118046635,2.46664526775681e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.0487407625602472,0.00229533944699784,0.0442418972441314,0.0532396278763629,2.52716558749153e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCG,Gamma-synuclein,29218,0.0992898634487762,0.00467623286692025,0.0901244470296125,0.10845527986794,2.67724893319159e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.123590568301811,0.0058224940814091,0.112178479902249,0.135002656701373,3.02049384457869e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,YJU2,Splicing factor YJU2,24793,0.0482033543471984,0.00227092236354106,0.0437523465146579,0.0526543621797388,4.16495734206086e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0625145313950485,0.00294847084256156,0.0567355285436279,0.0682935342464692,4.94159604949517e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.154787814554143,0.00730361039523416,0.140472738179484,0.169102890928802,6.05140203920809e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11,Coagulation factor XI,24606,0.0459827362291978,0.0021684726015913,0.0417325299300789,0.0502329425283168,6.58487263356049e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST3,Cystatin-C,29530,0.0420003254934595,0.00198297201363373,0.0381137003467374,0.0458869506401816,7.87158829954907e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0754472186135552,0.00356852068706473,0.0684529180669084,0.0824415191602021,1.8188115732757e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOC1,Apolipoprotein C-I,24914,0.0553926366640383,0.00261943997125392,0.0502585343203806,0.060526739007696,2.16909536254613e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.116882673669279,0.00553762013198454,0.106028938210589,0.127736409127969,4.97455789639192e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC4,Syndecan-4,29478,0.0683515972825168,0.00324124453710406,0.0619987579897928,0.0747044365752407,5.43044209457373e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.117720668726619,0.00558528039403431,0.106773519154312,0.128667818298926,6.84523573391568e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.137004740223523,0.00650170096401225,0.124261406334059,0.149748074112987,7.81215515844331e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.144765809870827,0.00687642404010016,0.13128801875223,0.158243600989423,1.1836684190094e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUS,RNA-binding protein FUS,28765,0.0582287387188088,0.00276705147571255,0.0528053178264122,0.0636521596112054,1.4261174676157e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL32,Interleukin-32,29434,-0.0640717372520385,0.00305047538689747,-0.0700506690103575,-0.0580928054937194,3.13303148562679e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0827661905103861,0.00394531628077129,0.0750333706000743,0.0904990104206978,5.31651966630629e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBKS,Ribokinase,28795,0.0729976153882987,0.00348224017848253,0.0661724246384729,0.0798228061381245,7.59785182169892e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0643043090770932,0.00307316601703591,0.0582809036837028,0.0703277144704836,1.66721179717671e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.101054703999921,0.00482818930946988,0.0915914529533599,0.110517955046482,2.03971505260763e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0984356105487836,0.00470446302468499,0.0892148630204011,0.107656358077166,2.28665004008487e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0503121925552534,0.0024070377034961,0.0455943986564011,0.0550299864541058,2.53711152529488e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLG4,Disks large homolog 4,24845,0.103778287284673,0.00496535897812416,0.0940461836875492,0.113510390881796,3.57287169739136e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.116509177143489,0.00558559121178247,0.105561418368395,0.127456935918583,8.8258036148175e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPACT,Protein IMPACT,24845,0.0812914635064643,0.0038987222779344,0.0736499678417128,0.0889329591712157,9.92028222445408e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0406563904539428,0.00195440193193639,0.0368257626673475,0.0444870182405381,2.01120204329741e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0701005323645401,0.00336767538088634,0.0634998886180028,0.0767011761110773,2.03508047020837e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY4,Protein canopy homolog 4,29349,0.108985205611435,0.00524076347546597,0.0987133091995215,0.119257102023348,2.31264553609732e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.115435012263753,0.00555266158708374,0.104551795553068,0.126318228974437,2.66387150235949e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD207,C-type lectin domain family 4 member K,28835,0.0562153863257065,0.00270411512435726,0.0509153206819663,0.0615154519694468,2.73717601780827e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.119226304165039,0.0057369420152554,-0.13047071051494,-0.107981897815138,3.0193380620211e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD69,Early activation antigen CD69,29344,0.127537029570185,0.00613720693193697,0.115508103983588,0.139565955156781,3.12943942816983e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53,Cellular tumor antigen p53,28797,0.0635358239738131,0.00305793353336239,0.0575422742484228,0.0695293736992034,3.46998958483507e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAX,Protein max,28774,0.1529979230009,0.00736637579488862,0.138559826442918,0.167436019558881,4.06089410587859e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0593875392288288,0.00286624375873212,0.0537697014617138,0.0650053769959437,1.11222145502117e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.064257969657287,0.00310168993163718,0.0581786573912781,0.0703372819232958,1.5462091303959e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0707075779650979,0.00341355145616106,0.0640170171110223,0.0773981388191736,1.72194325118885e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA11,Annexin A11,29373,0.0967442503896125,0.00467507820957394,0.0875810970988476,0.105907403680377,1.87013227118575e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.113489874045166,0.00548610142811488,0.10273711524606,0.124242632844271,2.16716480872178e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGLL,Monoglyceride lipase,29536,0.125562955746366,0.00607075260375739,0.113664280643002,0.137461630849731,2.2912261465815e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOA,Elongin-A,29349,0.0755907710723523,0.0036557467705613,0.0684255074020522,0.0827560347426525,2.61619353280627e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.0409226400741602,0.00198079574659825,0.0370402804108276,0.0448049997374927,3.68129866548136e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,PENK,Proenkephalin-A,24381,0.0446436994898507,0.00216270181764741,0.0404048039272618,0.0488825950524396,7.24298500307564e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.127359911179755,0.00617674125264878,0.115253498324563,0.139466324034947,8.5365260504072e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDC,Nuclear migration protein nudC,29786,0.0912666070507397,0.00443217465168217,0.0825795447334427,0.0999536693680368,1.45967239245166e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0412752533598474,0.00200490057507957,0.0373456482326914,0.0452048584870034,1.60460710961884e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0833544533759329,0.0040461343060293,0.0754240301361155,0.0912848766157503,1.70390284887009e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,RFC4,Replication factor C subunit 4,24793,0.0306250896184155,0.00148834343530872,0.0277079364852105,0.0335422427516206,2.68066722163986e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILPL2,RILP-like protein 2,24922,0.140864909432888,0.00685102195012448,0.127436906410644,0.154292912455132,3.63495399655146e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD226,CD226 antigen,24229,0.0606115091957965,0.00294865281270183,0.0548321496829009,0.0663908687086921,4.2726498578278e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.121943935761963,0.00594445925094867,0.110292795630103,0.133595075893822,7.47854025655433e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.160773565031581,0.00784469503736728,0.145397962758341,0.176149167304821,1.45367413188598e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.109365870917321,0.00534301610667424,0.098893559348239,0.119838182486402,1.85764082514472e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0812071899681395,0.00397049730165397,0.0734250152568977,0.0889893646793813,2.49843589918488e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS9,Galectin-9,29453,0.0456705882487221,0.00223329389815125,0.0412933322083456,0.0500478442890985,2.64120062247352e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBXN1,UBX domain-containing protein 1,24381,0.0987342140151584,0.00482699522425071,0.089273303375627,0.10819512465469,3.25595936144371e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRADD,Death domain-containing protein CRADD,29163,0.108349779040666,0.00530383658396867,0.097954259336087,0.118745298745244,4.12168888527954e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0833645235915989,0.00408446601368581,0.0753589702047747,0.0913700769784231,6.10928331099254e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.182522406802698,0.00894612820542671,0.164987995520062,0.200056818085335,6.88060265551317e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.133213182828275,0.00653808561443266,0.120398535023987,0.146027830632563,1.56238139081593e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.101029189632764,0.00496197021151685,0.0913037280181905,0.110754651247337,1.58916373845756e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM17,Splicing factor 45,24867,0.109047626694954,0.00535256391255728,0.0985566014263415,0.119538651963566,1.62583432794497e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOD,Apolipoprotein D,23787,-0.0620537219833962,0.00304804454816775,-0.068027889297805,-0.0560795546689874,2.34667666081376e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.111832003495583,0.00549846530387621,0.101055011499986,0.122608995491181,2.56417326870688e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0539899206564309,0.00265659564564599,0.0487829931909648,0.059196848121897,4.45553620018358e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXJ3,Forkhead box protein J3,24229,0.0628207400765161,0.00310424098845842,0.0567364277391375,0.0689050524138946,2.58086931095551e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.135981302742058,0.00672574947202074,0.122798833776898,0.149163771707219,2.79421896098446e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.091940541428879,0.00455053026037641,0.0830215021185413,0.100859580739217,4.89686651149591e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRL,Appetite-regulating hormone,29478,0.114086488238837,0.00565408302682366,0.103004485506263,0.125168490971411,6.23532264532979e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGF,Pro-epidermal growth factor,29379,0.145421203947885,0.00722998184800435,0.131250439525796,0.159591968369973,2.24534366173411e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRY2,Protein sprouty homolog 2,28931,0.130167436995538,0.00647291670808404,0.117480520247693,0.142854353743382,2.48770924311042e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.04729551172011,0.00235235607905168,0.0426848938051687,0.0519061296350513,2.61188968456693e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0696678088932319,0.00346536077454188,0.0628757017751298,0.076459916011334,3.58208535158022e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,F12,Coagulation factor XII,24966,0.0584705798139627,0.00290943149774202,0.0527680940783883,0.064173065549537,3.98823783786945e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLG,Plasminogen,24421,0.031179696829121,0.00155155833725221,0.0281386424881067,0.0342207511701354,4.23173213015263e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN3,Centrin-3,24805,0.108954751781358,0.00542974031827828,0.0983124607575324,0.119597042805183,7.39118711406274e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.103121463241828,0.00514331416436114,0.0930405674796805,0.113202359003976,1.06723056374981e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.0971183134074807,0.00484417735400929,0.0876237257936224,0.106612901021339,1.08147283794703e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEXN,Nexilin,24951,0.0965283529281695,0.00482106224712262,0.0870790709238092,0.10597763493253,1.75045974636306e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMA,Granzyme A,29786,0.0485476517442996,0.0024273212838783,0.0437901020278982,0.0533052014607011,2.07878110019331e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0789735226020018,0.00394842182613657,0.0712346158227741,0.0867124293812295,2.08767774138416e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0930817190486626,0.0046572981576101,0.0839534146597468,0.102210023437578,3.68115362173535e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRAS,Ras-related protein R-Ras,24195,0.182948339440622,0.00915813828258728,0.164998388406751,0.200898290474493,4.52395102253869e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0800152896911215,0.00400938861013338,0.07215688801526,0.0878736913669829,5.14057190235915e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSNL1,Visinin-like protein 1,24845,0.0533849035300654,0.00267485882895789,0.048142180225308,0.0586276268348229,6.25033318805244e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS2,Trypsin-2,29594,0.0747034212873541,0.0037472172277198,0.0673588755210233,0.0820479670536849,7.54045232831173e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.10689301911411,0.00536476610829907,0.096378077541844,0.117407960686376,1.24442760576658e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESYT2,Extended synaptotagmin-2,24845,0.114728532307012,0.00576347802807268,0.10343211537199,0.126024949242035,1.73455693119801e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.0943962682434975,0.00474798146537592,0.0850902245713607,0.103702311915634,2.18995263665603e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.107389418765129,0.00540151841390837,0.0968024426738691,0.11797639485639,2.21471772039258e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG2,Secretogranin-2,29559,0.0454062214131458,0.00228480781627167,0.0409279980932533,0.0498844447330382,2.5907105997132e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.116513978349619,0.00586476925156612,0.105019030616549,0.128008926082688,2.95087209435408e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHD3,EH domain-containing protein 3,24240,0.163424194899161,0.00822686486673222,0.147299539760366,0.179548850037956,4.06427199871871e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.0336567146401981,0.00169585421998232,0.0303328403690327,0.0369805889113634,4.39461620348411e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIN2,Bridging integrator 2,29443,0.124807558728,0.00630279141598593,0.112454087552668,0.137161029903333,1.05220463227876e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMNL1,Formin-like protein 1,28774,0.085147332480723,0.00430335545334368,0.0767127557921694,0.0935819091692766,1.47395723367772e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.14413299083768,0.00729207542386187,0.129840523006911,0.15842545866845,2.78968903362316e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.074778599037003,0.00378663741044969,0.0673567897125216,0.0822004083614844,3.03462653708009e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.173749501286632,0.00879329143369466,0.156514650076591,0.190984352496674,3.15911122120002e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB1,Carboxypeptidase B,29820,0.0816277914825292,0.00413499229431211,0.0735232065856775,0.089732376379381,3.42883437731804e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.135050369795578,0.00683746474448305,0.121648938896391,0.148451800694764,3.57361228709161e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED8,Protein TMED8,24805,0.142155203711879,0.00720185634820318,0.128039565269401,0.156270842154357,4.60070101380708e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.105395548356497,0.00534678085494406,0.0949158578808066,0.115875238832187,6.08576722173242e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0489217878668112,0.00248280337616409,0.0440554932495296,0.0537880824840928,7.11208639369214e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEPR,Leptin receptor,29478,-0.0428737910899822,0.00217608523872238,-0.047138918157878,-0.0386086640220863,7.37218567443874e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,POSTN,Periostin,24938,-0.0523458262329089,0.0026566658704218,-0.0575528913389356,-0.0471387611268822,9.0401961547722e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIFBP,KIF-binding protein,29349,0.11355283324876,0.00576696965073209,0.102249572733325,0.124856093764195,9.37541096180617e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARC,SPARC,29566,0.0969103437412919,0.00492635710433206,0.087254683816801,0.106566003665783,1.32924441899502e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0535608222974324,0.00272211959950091,0.0482254678824106,0.0588961767124542,1.59389130439723e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN2,Centrin-2,28774,0.0929807947894337,0.00473340489273649,0.0837033211996702,0.102258268379197,2.38429474574591e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0457616384832619,0.0023302977899942,0.0411942548148733,0.0503290221516506,2.59611710573355e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0841536492868093,0.00428601033574064,0.0757530690287576,0.0925542295448609,2.74642380622376e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK13,Kallikrein-13,28845,0.0606294609251021,0.00308861103578416,0.0545757832949651,0.066683138555239,3.09102386795511e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.084967384633335,0.0043385652167987,0.0764637968084096,0.0934709724582605,7.53840541827557e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,PF4,Platelet factor 4,24822,0.133381123256973,0.00680917765744044,0.12003513504839,0.146727111465557,8.49344651604159e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.0923315224556549,0.00471690399305966,0.083086390629258,0.101576654282052,8.69995332526819e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.116941260120412,0.00597471235548472,0.105230823903662,0.128651696337163,1.18200289305865e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL4,C-C motif chemokine 4,29498,0.0893483940247326,0.00457195632160183,0.0803873596343931,0.0983094284150722,1.63251347622241e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4D,Semaphorin-4D,29694,0.0410152712019166,0.00209902736312911,0.0369011775701836,0.0451293648336497,1.7020392136999e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE2,Glia-derived nexin,24922,0.0881911401317023,0.00451109422758744,0.0793493954456309,0.0970328848177737,1.78017013858807e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.105466568611948,0.00539948243402497,0.0948835830412596,0.116049554182637,1.98399936568137e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSZ,Cathepsin Z,29487,0.0431952676690071,0.00221185622849038,0.0388600294611659,0.0475305058768482,2.13020499412684e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0702165405656583,0.00359386198318166,0.0631725710786223,0.0772605100526944,2.2577659644999e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,TADA3,Transcriptional adapter 3,24793,0.0541547351352656,0.00277207556533988,0.0487214670271994,0.0595880032433318,2.35106754964817e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP7,Caspase-7,24845,0.11472504243651,0.00588630402223351,0.103187886552932,0.126262198320087,5.6479094952323e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.077699366402281,0.00399193905021463,0.0698751658638603,0.0855235669407016,9.35847865375825e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH9,Protocadherin-9,24805,0.0461352068890818,0.00237188153818219,0.0414863190742447,0.0507840947039188,1.20465368687806e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.052709730119908,0.00271165932862319,0.0473948778358065,0.0580245824040095,1.22227349661077e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX2,Heme oxygenase 2,28774,0.0636003162005069,0.00327248489412007,0.0571862458080315,0.0700143865929822,1.34705762887828e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.0795039913093572,0.00409111380005456,0.0714854082612503,0.0875225743574641,1.68746534170886e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0906406965444407,0.00466852256540969,0.0814903923162377,0.0997910007726437,2.37737414030752e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD22,B-cell receptor CD22,29786,0.0568205533759759,0.00293118379504146,0.0510754331376947,0.0625656736142572,3.37893654475271e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATOX1,Copper transport protein ATOX1,29566,0.0969514908738558,0.0050020082636546,0.0871475546770927,0.106755427070619,3.56478126263477e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0645679507139381,0.00333208260159419,0.0580370688148135,0.0710988326130627,4.87342529830471e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,YWHAQ,14-3-3 protein theta,24381,0.1003166271589,0.00517667289718922,0.0901703482804094,0.110462906037391,4.93751975522779e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP10,Caspase-10,28774,0.0970767244683824,0.00501249323894475,0.0872522377200507,0.106901211216714,4.9627631649412e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.0973201109943936,0.00502937437961894,0.0874625372103404,0.107177684778447,6.54031727285909e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA1,Carboxypeptidase A1,29820,0.0822923718759628,0.00426008645471699,0.0739426024247175,0.0906421413272081,1.23671157911921e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,C3,Complement C3,23779,0.0630250081929358,0.00326070045720197,0.05663403529682,0.0694159810890517,1.32847272365901e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMT,Catechol O-methyltransferase,28591,0.114018882944988,0.00590391775082344,0.102447204153374,0.125590561736602,1.4206369591375e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.115370656433244,0.0059733485161556,0.103662893341579,0.127078419524909,1.64255101509938e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCB,Tubulin-folding cofactor B,29218,0.13578171283013,0.00704377718121026,0.121975909554958,0.149587516105302,2.73168060285935e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0719585712277944,0.00374104616158795,0.0646261207510821,0.0792910217045068,7.86072946942371e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.071349325175041,0.00371152674276686,0.0640747327592179,0.078623917590864,9.23341362371203e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPBP,Platelet basic protein,24816,0.113763917547649,0.00592506348762603,0.102150793111902,0.125377041983396,1.43491150385695e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT1,Angiopoietin-1,29322,0.113008026748443,0.00589753058626011,0.101448866799373,0.124567186697512,2.42312674856762e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0719344078676203,0.00375346714612261,0.06457761226122,0.0792912034740206,2.88931185102693e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0645060925580341,0.00336722284221935,0.0579063357872842,0.0711058493287841,3.25654847304529e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL7,C-C motif chemokine 7,29434,0.0787599336349901,0.00411364936431049,0.0706971808809415,0.0868226863890386,3.26338062639874e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0877591966025264,0.00458401274618059,0.0787745316200125,0.0967438615850404,3.31677423562173e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREH,Trehalase,24938,0.100596062972527,0.00525176522119964,0.0903026031389758,0.110889522806078,3.39151461907988e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2,Microtubule-associated protein 2,24845,0.0620014672955278,0.00323998612962924,0.0556510944814545,0.0683518401096011,4.82555560131276e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.10751594009845,0.00562059226221756,0.0964995792645032,0.118532300932396,5.7523444262098e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0916419686342335,0.00479084631129458,0.0822519098640961,0.101032027404371,5.82130034917444e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.122891732148549,0.00642966473518216,0.110289589267592,0.135493875029506,6.07040849517858e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.132964671841978,0.00695403927146219,0.119334754869913,0.146594588814044,6.78254357977288e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0732352480596854,0.00383601929077098,0.0657166502497742,0.0807538458695965,9.34410411619798e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.0545378535043582,0.00286193822584475,0.0489284545817025,0.0601472524270139,1.75679638158395e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.0747059652228528,0.00392544873543265,0.0670120857014048,0.0823998447443008,2.86002149112635e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF19,Fibroblast growth factor 19,29581,0.102733351880727,0.00539979139560299,0.0921497607453455,0.113316943016109,3.17068347310376e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSTN,Growth/differentiation factor 8,28916,0.0701506919309072,0.00368869520334403,0.0629208493323529,0.0773805345294615,3.75762704689349e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACYBP,Calcyclin-binding protein,24329,0.137169661771687,0.00721110030912797,0.123035905165796,0.151303418377578,4.28213119607439e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0832925424417485,0.00438162740968103,0.0747045527187736,0.0918805321647233,5.26433313339711e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0818256678756205,0.00430851951464788,0.0733809696269106,0.0902703661243303,7.61828399548281e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0797688737782184,0.00420297364308643,0.071531045437769,0.0880067021186678,7.80436073884128e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.14884699362961,0.0078466088501363,0.133467640283343,0.164226346975877,9.34790891074536e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0468428375606646,0.0024684801495336,0.0420046164675787,0.0516810586537504,9.83928370088098e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0896495734847351,0.00473441158275926,0.0803701267825269,0.0989290201869432,1.71890709516582e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0402062830433448,0.00212776239264999,0.0360358687537508,0.0443766973329388,4.44809183467483e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.061811190052819,0.00327852887097913,0.0553852734657,0.0682371066399381,7.97760509595487e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6AP2,Renin receptor,28797,0.0536109015735889,0.00284561274082867,0.0480335006015647,0.0591883025456131,1.06040532498914e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.131845593320264,0.00700740866260588,0.118111072341557,0.145580114298972,1.64132220379497e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0974361854884865,0.00518206950953345,0.0872793292498009,0.107593041727172,2.1268002499e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.0597119323140676,0.00317656933591945,0.0534858564156655,0.0659380082124697,2.33001147948052e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D5,TBC1 domain family member 5,29434,0.102898186130506,0.00547590447268489,0.0921654133640435,0.113630958896968,2.57095797651168e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,THTPA,Thiamine-triphosphatase,24755,0.116129788337711,0.00617785314100719,0.104021196181337,0.128238380494085,2.76852158715302e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB9,Serpin B9,29218,0.0436933866436201,0.00232731389083169,0.03913185141759,0.0482549218696502,3.54959799934581e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL3,C-C motif chemokine 3,29434,0.0796063958628536,0.0042417383049054,0.071292588785239,0.0879202029404682,3.99502773294189e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP2,Caspase-2,29434,0.0892280963380941,0.00475868719529285,0.0799010694353201,0.0985551232408681,5.46247674211896e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK10,Kallikrein-10,29466,0.0525471077057883,0.0028036144019869,0.047052023477894,0.0580421919336827,6.32351684124935e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0378550781082866,0.00201947728100922,0.0338969026375086,0.0418132535790647,7.51284967146553e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.0816373039154771,0.00435639921009968,0.0730987614636818,0.0901758463672725,8.09706085891826e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.109113939792096,0.00583171063161794,0.0976837869541247,0.120544092630067,1.39407231630829e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG4A,Cysteine protease ATG4A,28797,0.0771623552303505,0.00412865938709062,0.0690701828316529,0.0852545276290481,1.73674498757825e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM3,Dynamin-3,24867,0.0718708799829841,0.00384671816016732,0.0643313123890562,0.0794104475769121,2.27973543476403e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0963065592764821,0.00515749182627763,0.086197875296978,0.106415243255986,2.82858277372838e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMVK,Phosphomevalonate kinase,28757,0.143538454273679,0.00769594169935835,0.128454408542936,0.158622500004421,3.52969633838058e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.143090991998374,0.007672590828405,0.1280527139747,0.158129270022047,3.55144534749423e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.11291647373691,0.00606336373901819,0.101032280808434,0.124800666665385,6.00353401492013e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.155218942159902,0.008333607142649,0.13888507216031,0.171552812159494,6.81047492842762e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOM,Apolipoprotein M,29545,0.0361775451615222,0.00194380630234692,0.0323676848089222,0.0399874055141221,7.11786314292377e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0392463111903495,0.00210949798534263,0.035111695139078,0.0433809272416211,8.23460829891886e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0615776011035516,0.00331402089060576,0.0550821201579643,0.0680730820491388,1.51445340579706e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0547621136012907,0.00294867207592979,0.0489827163324683,0.0605415108701131,1.79790168806968e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS1,Galectin-1,29478,0.0445576569782917,0.00240132651730565,0.0398510570043726,0.0492642569522108,2.01140977686455e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0865315543825416,0.00466144255732695,0.0773951269701808,0.0956679817949024,2.17446596077923e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0745175975851879,0.00401736220807134,0.0666435676573681,0.0823916275130077,2.27148599382647e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOF,Apolipoprotein F,24951,-0.0325163083206805,0.00175271720368915,-0.0359516340399112,-0.0290809826014497,2.56900572641254e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.115009363696866,0.00620509881159601,0.102847370026138,0.127171357367594,3.53248621433275e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0771755085212891,0.00416744772041519,0.0690073109892754,0.0853437060533029,3.93397434812928e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.115719769097348,0.00625118226044201,0.103467451866881,0.127972086327814,4.51430372098108e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM3,Junctional adhesion molecule C,24381,0.0656839847382798,0.00355152380102633,0.0587229980882682,0.0726449713882914,7.54995220908952e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0822750767758824,0.0044497911683365,0.0735534860859428,0.0909966674658219,8.26434514342684e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTF1,Cardiotrophin-1,28916,0.109268061445492,0.00592252502559033,0.0976599123953345,0.120876210495649,1.4290392130508e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0862824536165436,0.00467517252255065,0.0771191154723443,0.0954457917607429,1.56393653495354e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0603747060181058,0.00327274200278991,0.0539601316926376,0.0667892803435741,1.73830508032304e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD2,Polycystin-2,24111,0.0763073765031283,0.0041397277094632,0.0681935101925804,0.0844212428136762,2.35809817666228e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0747751995291968,0.00406430312552315,0.0668091654031714,0.0827412336552222,3.67769609577984e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.118837254754052,0.00645608309490845,0.106183331888032,0.131491177620073,3.75798778107168e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.0609431197998961,0.00331170764420149,0.0544521728172611,0.067434066782531,3.95918725191151e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIAPIN1,Anamorsin,29566,0.0807673946812274,0.0043926990966307,0.0721577044518312,0.0893770849106235,4.40507205367907e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO3,Forkhead box protein O3,28797,0.124307725644125,0.00676297447420885,0.111052295674675,0.137563155613574,5.05116762399036e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.0934961838981121,0.00508679817840616,0.083526059468436,0.103466308327788,5.92591267117414e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIF,Macrophage migration inhibitory factor,29386,0.0874265561689922,0.00476730808769891,0.0780826323171024,0.0967704800208821,1.06122455704814e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0722812891477598,0.00394189321988704,0.0645551784367812,0.0800073998587384,1.10807089301787e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0566627400154198,0.00309035215285269,0.0506056497958285,0.062719830235011,1.13513203498604e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB6,Serpin B6,29623,0.0760572682966389,0.00414944307440679,0.0679243598708015,0.0841901767224762,1.24616373491765e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0573653168528653,0.003132222432804,0.0512261608845694,0.0635044728211611,2.01550380824705e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.131299981530484,0.00717037877358034,0.117246039134266,0.145353923926701,2.13199301919722e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.138350671591403,0.00755754004699009,0.123537893099303,0.153163450083504,2.28068026325897e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0823727310194133,0.00450187523616956,0.0735490555565209,0.0911964064823056,2.67735014867885e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL2,C-C motif chemokine 2,29169,0.0672831271328557,0.00368076897205696,0.0600688199476241,0.0744974343180874,3.1267559397181e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0846144379797237,0.00463584281804303,0.0755281860563593,0.093700689903088,5.17757114253655e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0401801722897966,0.00220394807561547,0.0358604340615902,0.0444999105180029,8.87982080541827e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0562721062443031,0.00308960594079038,0.050216478600354,0.0623277338882523,1.24352686802875e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG6,Large proline-rich protein BAG6,28916,0.0464459478748787,0.00255311566821173,0.0414418411651837,0.0514500545845737,1.54152252825526e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX4,Syntaxin-4,29349,0.0756079448307694,0.0041575084567971,0.067459228255447,0.0837566614060917,1.69382860766917e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7,Interleukin-7,29434,0.082172088823103,0.00451896847777794,0.0733149106066582,0.0910292670395478,1.75336694753287e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18,Interleukin-18,29335,0.0586061893364927,0.00322483671310614,0.0522855093788046,0.0649268692941807,2.12285863774354e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0840066899695255,0.00462278649455067,0.0749460284402062,0.0930673514988448,2.15477698980736e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.0702435612603539,0.00386506178351956,0.0626680401646556,0.0778190823560523,2.48610769288348e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICALL2,MICAL-like protein 2,24195,0.087133408644878,0.00479594067765069,0.0777333649166826,0.0965334523730734,2.83579723204803e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.0584894274097704,0.00322162674066797,0.0521750389980612,0.0648038158214796,2.9196348508355e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB1,Heat shock protein beta-1,29039,0.0874911790507739,0.00482189596688795,0.0780402629556735,0.0969420951458743,3.60105728354634e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX8,Syntaxin-8,29434,0.0614989165557039,0.00339076428793276,0.0548530185513557,0.0681448145600521,4.06136893361099e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0621654590783154,0.00342744203286734,0.0554476726938954,0.0688832454627354,4.90510416231848e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDT,D-dopachrome decarboxylase,24938,0.0519063661687124,0.0028639232706027,0.0462930765583311,0.0575196557790937,6.04047335993637e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0628379677882178,0.00346957199961071,-0.0696383289074547,-0.0560376066689808,6.4845409745756e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.141962028173508,0.00783972070970216,0.126596175582492,0.157327880764525,6.82819767299447e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPSE,Heparanase,24688,0.119145419860286,0.00658940866951443,0.106230178868038,0.132060660852535,1.31634064201591e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0412306322304452,0.0022835297344572,0.0367549139509091,0.0457063505099813,1.75953015524404e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,LARP1,La-related protein 1,24793,0.0794199907313661,0.00440538132551155,0.0707854433333635,0.0880545381293687,3.4037442326459e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.114478015206742,0.00635865074258487,0.102015059751276,0.126940970662209,5.39385603142468e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.0418137389006256,0.0023229208269104,0.0372608140798812,0.04636666372137,5.69066796285688e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0328650344924551,0.00182639425371513,-0.0364447672297367,-0.0292853017551734,6.13668704850128e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.0604251503694843,0.00336225535912035,0.0538351298656085,0.0670151708733602,9.24668614109846e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARK7,Parkinson disease protein 7,29443,0.0656885583181123,0.00366062038160868,0.0585137423701593,0.0728633742660653,1.27382793890365e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0504038043534867,0.00280829161675299,0.0448995527846508,0.0559080559223226,1.40504198223417e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0453136982519371,0.00253053722086636,0.0403538452990391,0.0502735512048352,2.49714696721198e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0815363217257094,0.00455184421850557,0.0726147070574385,0.0904579363939803,2.63427450758181e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0345324312624672,0.00192941420344553,0.0307507794237139,0.0383140831012204,3.4226366613383e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC3B,Tetranectin,24381,0.0268475692990039,0.00150188239373208,0.023903879807289,0.0297912587907187,5.16309804557914e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD244,Natural killer cell receptor 2B4,29786,0.0338972562139695,0.00189757959106013,0.0301780002154916,0.0376165122124473,5.34068836774106e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.109633124877653,0.00614745599642447,0.097584111124661,0.121682138630645,1.06685838358537e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.060061230749857,0.00336913716285848,0.0534577219106543,0.0666647395890596,1.23623517860726e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.124489605954223,0.00699006220967536,0.11078908402326,0.138190127885187,1.63817957709122e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0470519280129611,0.00264392878772504,0.04186982758902,0.0522340284369022,1.79886094236489e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0770180929705532,0.00432611417769021,0.0685389091822804,0.085497276758826,1.82981649951298e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0717630198639474,0.00403759532010149,0.0638493330365485,0.0796767066913463,2.65276873778134e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.117258331899246,0.00659840299468276,0.104325462029668,0.130191201768824,2.78581537902502e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRB1,Chymotrypsinogen B,29443,0.0693127034492891,0.0039039995891661,0.0616608642545236,0.0769645426440547,3.71196217736683e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGT1,Protein SGT1 homolog,28797,0.10044236127453,0.00565831677571584,0.0893520603941266,0.111532662154933,3.98772521477632e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2,Complement C2,29545,0.0290406729930841,0.00163765588316545,0.0258308674620798,0.0322504785240884,5.3771218254038e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM106A,Transmembrane protein 106A,24793,0.0879540953610502,0.00496018383260638,0.0782321350491417,0.0976760556729587,6.42177480397388e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0704661346607316,0.00398012413433615,0.0626650913574328,0.0782671779640305,8.85026310446513e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.117191512037555,0.00662045414465282,0.104215421914036,0.130167602161075,1.09858194777208e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.0625486458081963,0.00353578896005939,0.0556184994464799,0.0694787921699127,1.14714245351501e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,CERT,Ceramide transfer protein,28774,0.0762018775475592,0.0043104838279037,0.067753329244868,0.0846504258502505,1.44027297288188e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.11764360403588,0.0066566456113459,0.104596578637642,0.130690629434118,1.54579570663794e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0912250136968767,0.00516091070192773,0.0811096287210984,0.101340398672655,1.70241564813713e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0378584893293397,0.00214295038679279,0.0336583065712258,0.0420586720874536,1.73345114633533e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.105857473611835,0.00599450439917826,0.0941082449894454,0.117606702234224,1.9831427727165e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL8,C-C motif chemokine 8,29683,0.0746506101320265,0.00424281899165628,0.0663346849083802,0.0829665353556728,6.07585157959268e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0745334114586208,0.00423515114028947,0.0662325152236534,0.0828343076935882,6.72320580308256e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP3,Caspase-3,29820,0.108501462651115,0.00616973271135618,0.0964087865368566,0.120594138765373,7.02110747362386e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0806324957728843,0.00458551964187216,0.0716448772748148,0.0896201142709537,7.4702648304777e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0402024401858721,0.00228905795325512,0.0357158865974921,0.0446889937742522,1.05510000055113e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRGN,Neurogranin,24951,0.112429920205842,0.00640142801415721,0.0998831212980938,0.12497671911359,1.22049630625048e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,MESD,LRP chaperone MESD,29443,0.149326893055896,0.00850857297376542,0.132650090027316,0.166003696084476,1.32714487944365e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0985539952733056,0.00561607530008977,0.0875464876851296,0.109561502861482,1.62111977511464e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0829983675926631,0.00473669143446119,0.0737144523811191,0.092282282804207,2.18965975449001e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0453461190252008,0.00258995437108398,0.0402698084578762,0.0504224295925254,3.23261977893946e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0654276700337312,0.00373762082455485,0.0581019332176036,0.0727534068498587,3.36242592602208e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.0686150406605972,0.00392167188648077,0.0609285637630949,0.0763015175580995,3.44423030557363e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMFG,Glia maturation factor gamma,24922,0.0880824744064029,0.00503435483316549,0.0782151389333985,0.0979498098794073,3.91142280814482e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,APP,Amyloid-beta precursor protein,29395,0.0816080949780604,0.00466811360257166,0.07245859231702,0.0907575976391009,4.34654625628541e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0368581410822088,0.00211147153640697,0.0327196568708511,0.0409966252935665,6.75679627881415e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0640483415607745,0.00367685256361048,0.0568417105360979,0.071254972585451,1.52011838211157e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0690460492774735,0.00396510123647283,0.0612744508539867,0.0768176477009602,1.682326006852e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGLAP,Osteocalcin,24938,0.108266528565768,0.0062196928839758,0.0960759305131758,0.120457126618361,1.82952958593499e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSNAX,Translin-associated protein X,24111,0.0481018562596572,0.002763404913603,0.0426855826289953,0.053518129890319,1.8981112833273e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.078674749786352,0.00453438679408927,0.069787351669937,0.087562147902767,4.85420792270793e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.114496862160926,0.00660759051789602,0.10154598474585,0.127447739576003,6.24782910153496e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL18,C-C motif chemokine 18,29166,0.0854137904376452,0.00493128440582274,0.0757484730022327,0.0950791078730578,7.09128019505118e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.108845667504584,0.0062863859222942,0.0965243510968874,0.121166983912281,9.00128628445901e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,WDR46,WD repeat-containing protein 46,24793,0.0436679338074697,0.00252788440262285,0.0387132803783289,0.0486225872366105,1.79566475673031e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTF2,Transcription termination factor 2,24195,0.0594670947169668,0.0034464100832494,0.052712130953798,0.0662220584801357,2.57165309677658e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0739191224461406,0.00429080623496148,0.0655091422256161,0.0823291026666651,4.11201742914425e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.105406575840786,0.00612331025578213,0.0934048877394532,0.117408263942119,5.12828673146145e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFB,Complement factor B,24538,0.0396317829148333,0.00230514279088748,0.0351137030446939,0.0441498627849728,7.32249234070773e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0730429163543553,0.00426496801650936,0.0646835790419969,0.0814022536667136,2.23903849221267e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.151618096590122,0.00887429960990583,0.134224469354707,0.169011723825537,4.51304362641076e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTD,Deoxycytidylate deaminase,24381,0.113824574207752,0.00666275635307644,0.100765571755722,0.126883576659781,4.69801005568768e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRD2,Protein ZNRD2,24805,0.0823445571026616,0.00482234658491412,0.0728927577962299,0.0917963564090933,5.30845654825304e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,GET3,ATPase GET3,24922,0.066043961147001,0.00386873611655107,0.0584612383585609,0.0736266839354412,5.69838094212614e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTNB,Dystrobrevin beta,24752,0.0520062993418572,0.00305024337750519,0.046027822321947,0.0579847763617673,8.22023897100991e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0920960380507595,0.00541708475157101,0.0814785519376804,0.102713524163839,1.90906136931687e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0477275421903428,0.00281161272876381,0.0422167812419658,0.0532383031387199,2.8846725559344e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.0923554854252071,0.00544233946049495,0.081688500082637,0.103022470767777,3.16151643642737e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.0995128256339095,0.00586736505449122,0.0880127901271067,0.111012861140712,3.24839525287655e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNMT,Histamine N-methyltransferase,29082,0.0560502802367165,0.0033053593832476,0.0495717758455512,0.0625287846278818,3.45668871317744e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,MENT,Protein MENT,24381,-0.0269586250952499,0.00159163350849326,-0.0300782267718967,-0.0238390234186031,5.5143468090511e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0649424631191267,0.00383462062730926,0.0574266066896005,0.0724583195486528,5.71944739039546e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0724740055467523,0.00429030591774273,0.0640650059479765,0.080883005145528,1.02093679143408e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0708663120384546,0.00419601107752242,0.0626421303265106,0.0790904937503985,1.0998895266919e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.116100533092869,0.00688077768645149,0.102614208827424,0.129586857358314,1.59840958381893e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.127939215301122,0.0075813055302331,0.113079856461865,0.142798574140379,1.60389854972821e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMTN,Smoothelin,24776,0.111904156242051,0.00663531174088587,0.0988989452299148,0.124909367254187,1.843100540948e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0788386223360687,0.00467626892765961,0.0696731352378558,0.0880041094342815,2.07128878871749e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2R,Proteinase-activated receptor 1,29536,0.0677793370340203,0.00402377375986614,0.0598927404646827,0.075665933603358,2.26934174511804e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0620626376858045,0.00368451027091327,0.0548409975548145,0.0692842778167945,2.32921054488844e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0754287612747809,0.00450134207782994,0.0666061308022342,0.0842513917473275,1.00026537551469e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1R,Complement C1r subcomponent,24966,0.0228243599852934,0.00136195266748967,0.0201549327570136,0.0254937872135731,1.08051027633803e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,OCLN,Occludin,24867,0.0516019435865446,0.00308221104700869,0.0455608099344075,0.0576430772386816,1.43058925312204e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA3,Annexin A3,29640,0.0817928511912956,0.00489061086669899,0.0722072538925655,0.0913784484900256,1.68365129076488e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0734782957530177,0.00439652316653996,0.0648611103465994,0.082095481159436,2.03942065091167e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0528838724117992,0.00317259013577211,-0.0591021490779125,-0.0466655957456859,4.23820377907934e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0810496523271464,0.00486187450456966,0.0715203782981899,0.090578926356103,4.7881063318816e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0570214801730238,0.00342101374205142,0.050316293238603,0.0637266671074446,4.86676740582187e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.0956137726869018,0.00573897076310688,0.0843653899912123,0.106862155382591,4.89424898486045e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0654388305021698,0.00393152743780039,0.057733036724081,0.0731446242802585,7.30835776829588e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBI,Acyl-CoA-binding protein,29329,0.0914884679147677,0.00550131022592208,0.0807058998719604,0.102271035957575,8.07737800814035e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0738133923893354,0.00444758321089262,0.0650961292959858,0.0825306554826849,1.4120342595048e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0927502054999337,0.00559401487501977,0.081785936344895,0.103714474654972,2.07179075187028e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164,Sialomucin core protein 24,29443,0.0311282190184044,0.00188000876269582,0.0274434018435206,0.0348130361932882,2.67897749737002e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0886518203853124,0.0053561012319418,0.0781538619707065,0.0991497787999183,3.3252860133797e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.115340088101429,0.00697711519682363,0.101664942315654,0.129015233887203,4.63654603291533e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.027319214641767,0.00165380970573479,0.0240777476185268,0.0305606816650072,5.01171739314965e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.081538290443033,0.00493487281935635,0.0718659397170945,0.0912106411689714,5.44061982000533e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0646297504428737,0.00391381088662595,0.0569586811050868,0.0723008197806605,5.62288594578219e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0667842659203486,0.00404613934111241,0.0588538328117683,0.0747146990289289,6.38682924712923e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0789594660640288,0.00478243455094996,0.0695858943441669,0.0883330377838907,6.66746573636983e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.101340889254752,0.0061427662505099,0.0893010674037526,0.113380711105751,7.14758562027188e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.13802858013872,0.00838156098246834,0.121600720613082,0.154456439664358,1.15876447265502e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCA,Calcitonin,29163,0.0717635194233651,0.00436237086391341,0.0632132725300948,0.0803137663166354,1.55801581123563e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.119371872620832,0.00725577600414631,0.105150551652705,0.133593193588959,1.69940250633519e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0530230062938339,0.00322608857585093,0.0466998726851661,0.0593461399025018,2.25505308764499e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0499687589177351,0.00304173163279258,0.0440069649174616,0.0559305529180085,2.57126105549978e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0524783602521842,0.00320017080181138,0.0462060254806339,0.0587506950237345,4.05286387560889e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFASC,Neurofascin,29786,0.0325922766957765,0.00198956552436134,0.0286927282680283,0.0364918251235247,4.74249934125628e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0262538445240613,0.00160367770824237,0.0231106362159062,0.0293970528322164,6.43636415932439e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.127442799900472,0.00779684302276075,0.112160987575861,0.142724612225083,8.69957027867199e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN4,Cerebellin-4,29725,0.0363685939042066,0.00223034379287565,0.0319971200701703,0.0407400677382429,1.61608651833819e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0314539272261322,0.00192988493648097,0.0276713527506295,0.0352365017016349,1.83440797505185e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACYP1,Acylphosphatase-1,24297,0.0750773563117436,0.00460874960661281,0.0660442070827825,0.0841105055407047,2.39326125284485e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFP,Alpha-fetoprotein,29132,0.0776954570291714,0.00477806270024033,0.0683304541367004,0.0870604599216425,3.41252949100851e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB10,Ras-related protein Rab-10,24922,0.0611157182339279,0.00375815351310252,0.053749737348247,0.0684816991196089,3.69661312832971e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0540700482199321,0.00333147444029687,0.0475403583169502,0.060599738122914,5.60418461921725e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL1,Growth-regulated alpha protein,29420,0.108525948190928,0.00668690916941497,0.0954196062188744,0.121632290162981,5.62238519787808e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP5,Platelet glycoprotein V,24381,0.0411291687232856,0.00254033098626836,0.0361501199901997,0.0461082174563716,1.19182261633575e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1B,Meprin A subunit beta,29478,0.132602762516365,0.00820419656763244,0.116522537243805,0.148682987788924,1.64821322246232e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0478196447001157,0.00295888342767715,0.0420202331818685,0.0536190562183629,1.90195303298468e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAP3,Cytosol aminopeptidase,28931,0.0551439899508019,0.0034165580534361,0.0484475361660671,0.0618404437355366,2.39505072335796e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBN,Nibrin,28931,0.0594987734349668,0.00368746772511443,0.0522713366937425,0.066726210176191,2.58756735098839e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB1,Beta-crystallin B1,24922,0.07399885769141,0.00458678136513014,0.0650087662157549,0.082988949167065,2.95040972101712e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,RP2,Protein XRP2,29349,0.0473645217766049,0.00293817432524562,0.0416057000991235,0.0531233434540863,3.26502805927508e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.097742407174969,0.00606563176004681,0.0858537689252772,0.109631045424661,4.07336478151724e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLMH,Bleomycin hydrolase,29820,0.0359343349429535,0.00223303838253151,0.0315575797131918,0.0403110901727153,5.08995061378075e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.102292113757299,0.00635417554912097,0.0898379296810222,0.114746297833576,5.23849085836881e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBN1,Drebrin,24229,0.057974822833817,0.00360418046432222,0.0509106291237455,0.0650390165438886,6.44516733580219e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.110865827437465,0.00689583445512507,0.0973499919054201,0.12438166296951,7.23347497728796e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.092787033505485,0.00577532650384953,0.0814673935579399,0.10410667345303,8.63703623801379e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCA,Tubulin-specific chaperone A,24381,0.0966196302800715,0.00601625762309124,0.0848277653388127,0.10841149522133,9.67036558137771e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0428760898428017,0.00267239647514098,0.0376381927515254,0.048113986934078,1.10761444999844e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM2,Paralemmin-2,24845,0.0426805357934903,0.00266058714122661,0.0374657849966862,0.0478952865902945,1.27198784797499e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0459035168985927,0.00286504112860154,0.0402880362865337,0.0515189975106517,1.56948689981734e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0858630764304585,0.00536240836328689,0.0753527560384162,0.0963733968225008,2.04455493588088e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.048971165662277,0.0030616284480549,0.0429703739040894,0.0549719574204646,2.71611927743045e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0582299263544113,0.00364216356557816,-0.0653685669429445,-0.0510912857658781,2.99847263575013e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0970430575897201,0.006070171050919,0.0851455223299189,0.108940592849521,3.04695064396378e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.075786912699771,0.00474206688368621,0.0664924616077461,0.085081363791796,3.36731681669816e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0319702894025006,0.00200121688195319,0.0280479043138724,0.0358926744911289,3.64711173516226e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.0458633555535562,0.00287516006137815,0.040228041833255,0.0514986692738574,4.84037331937328e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0474422568658297,0.00297530559110587,0.0416106579072622,0.0532738558243972,5.28549349480076e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP6,Platelet glycoprotein VI,29400,0.0984645821477179,0.00617564714804656,0.0863603137375467,0.110568850557889,5.43998354013574e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0540110083222948,0.00338807879181221,0.0473703738903428,0.0606516427542467,5.72445733546868e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.0381438845288026,0.00239424402264303,0.0334511662444223,0.042836602813183,6.68697103788555e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,FEN1,Flap endonuclease 1,28797,0.0703177177351177,0.00442411522796363,0.061646451888309,0.0789889835819264,1.21161466510034e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.108495424260406,0.0068295276742789,0.095109550018819,0.121881298501992,1.52410632381406e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.0926056762432955,0.00583974185820642,0.0811597822012109,0.10405157028538,2.34187173254866e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.133827271403088,0.00844940891730231,0.117266429925176,0.150388112881001,2.87792743141873e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.078867987574059,0.00497769429860361,0.0691117067487959,0.0886242683993221,2.90063674016716e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.0445891010633989,0.00281610454966204,0.0390695361460613,0.0501086659807365,3.13126707876224e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0834395097678596,0.00527105822720645,0.073108235642535,0.0937707838931843,3.64639289069486e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSS,Cathepsin S,23389,0.0272018772022397,0.00172004206517381,0.023830594754499,0.0305731596499803,4.81603562328708e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0368477413312448,0.0023350479578742,0.0322710473338113,0.0414244353286782,7.22190303166975e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPLAH,5-oxoprolinase,24240,0.0761065556224257,0.00482184637492048,0.0666557367275815,0.0855573745172698,7.65001500154867e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0582189069162343,0.00369423724441101,0.0509782019171887,0.0654596119152798,1.01291524425444e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA2,Carboxypeptidase A2,29577,0.0720157859428216,0.00458221668588394,0.0630346412384891,0.0809969306471541,1.95984249248951e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.131816081859775,0.00838964483826993,0.115372377976766,0.148259785742784,2.10816087429762e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.034448816777238,0.002192144404316,-0.0387454198096973,-0.0301522137447786,2.16127832008946e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPB,Natriuretic peptides B,28916,-0.147875237349119,0.00941627671315247,-0.166331139706898,-0.129419334991341,2.39799259940386e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0382140482177613,0.00243593707768889,0.033439611545491,0.0429884848900315,3.06578560819111e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0471837875313789,0.00300833166438598,0.0412874574691823,0.0530801175935754,3.6027892145706e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0310313413716297,0.0019815061714882,0.0271475892755128,0.0349150934677466,5.24367838137466e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,POMC,Pro-opiomelanocortin,24240,0.0777719454505917,0.00496784363079573,0.0680349719342321,0.0875089189669514,5.70669759964156e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.068787629464769,0.00442063707276219,0.0601231808021552,0.0774520781273829,2.21381044977117e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0334403691005669,0.00214985285294812,0.0292266575087885,0.0376540806923452,2.42478543477852e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0327863399449845,0.00211350192024121,0.0286438761813117,0.0369288037086572,4.65453693079787e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.132112255550969,0.00852311942570394,0.11540694147659,0.148817569625349,5.6330949504801e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12A_IL12B,Interleukin-12,29349,0.0844860660243284,0.00545068796496363,0.0738027176129997,0.0951694144356571,5.67464863635606e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0581811824981536,0.00375820403064209,0.0508151025980951,0.0655472623982121,7.60297460637707e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,ING1,Inhibitor of growth protein 1,28719,0.0500187722333423,0.00323291303459221,0.0436822626855416,0.0563552817811431,8.87998322839771e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAEP,Glycodelin,29218,-0.143172001675814,0.0092622667999939,-0.161326044603802,-0.125017958747826,1.09538631098498e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.0329667760338482,0.00213257466626775,0.0287869296879634,0.037146622379733,1.16988610733565e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0415567669816284,0.002694754883071,0.0362750474108093,0.0468384865524476,2.07986761365162e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.0947534106091152,0.00614502961246579,0.0827091525686822,0.106797668649548,2.14396111059378e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0324566541448266,0.00210669919630612,0.0283275237200666,0.0365857845695865,2.41372142309531e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.0427798641788892,0.00278391613679463,0.0373233885507718,0.0482363398070067,4.44339163470274e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0470610252982838,0.00306472519470855,0.0410541639166551,0.0530678866799126,5.69054948164696e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN1,Ficolin-1,24919,0.0604142874415644,0.00393490010717159,0.0527018832315081,0.0681266916516207,5.87372432745425e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0516396197310248,0.0033664292537438,0.045041418393687,0.0582378210683627,7.27705317919336e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0811440437392566,0.00530196751646339,0.0707521874069883,0.0915359000715248,1.25203312590643e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPPK1,Epiplakin,24240,0.0791482575197209,0.00518328064006902,0.0689890274651856,0.0893074875742561,2.12889813891403e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0794522371745478,0.00520704146153879,0.0692464359099318,0.0896580384391638,2.51561966041495e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,XCL1,Lymphotactin,29725,0.0594407736766143,0.00389724438597929,0.0518021746800949,0.0670793726731337,2.52129010229521e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPH,Hephaestin,24922,0.0283159868525454,0.00185710403097153,0.0246760629518412,0.0319559107532496,2.95146577998968e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0310467713093446,0.0020404678338903,0.0270474543549197,0.0350460882637696,4.39649158525763e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0418331708332644,0.00275083274715497,-0.0472248030176881,-0.0364415386488407,4.97896924091049e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0405249618079588,0.00266779205490487,0.0352960893803452,0.0457538342355723,6.40743352233503e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0439772307644008,0.00289972155106593,0.0382937765243116,0.04966068500449,9.40157003088499e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0722837816254495,0.00476662342338402,0.0629411997156168,0.0816263635352822,9.47783050377636e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.122247286593666,0.00806836799034813,-0.138061287854748,-0.106433285332583,1.16587826042844e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0290701044016957,0.0019197797783415,-0.032832872767245,-0.0253073360361463,1.32910118469246e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0374769310744148,0.00247401820862561,-0.042326006763321,-0.0326278553855086,1.34245136208861e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLB,Beta-klotho,28774,-0.0788735798945564,0.00521037975437542,-0.0890859242131322,-0.0686612355759805,1.44247395592459e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMSB10,Thymosin beta-10,29443,0.0806055211631673,0.00532870699619031,0.0701612554506343,0.0910497868757003,1.68832776373503e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.025943045729269,0.00171683173797208,0.0225780555228437,0.0293080359356943,2.13893647532278e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.0936303609684935,0.00621530948019983,0.0814483543873018,0.105812367549685,4.66290313251358e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC79,Protein unc-79 homolog,24016,0.0593812894839061,0.00394472699614774,0.0516496245714565,0.0671129543963556,5.61167768750255e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.0198689330057492,0.00132028880164904,0.0172811669545171,0.0224566990569814,5.88024785090284e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0479979546802327,0.00319299497455061,0.0417396845301135,0.0542562248303519,7.65417052080353e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID1,Nidogen-1,29518,0.0400304075091477,0.0026643556396283,0.0348082704554762,0.0452525445628192,7.83592812556717e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL24,C-C motif chemokine 24,29536,0.0874074161426062,0.00581948595369999,0.0760012236733542,0.0988136086118582,8.39756552318104e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0443683836796968,0.00295749134106883,0.0385717006512019,0.0501650667081917,1.09428401534516e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF6,SLAM family member 6,28797,0.0403108340227915,0.00268922598738825,0.0350399510875105,0.0455817169580725,1.33038203038092e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.0924308835990551,0.00616911847124967,0.0803394113954058,0.104522355802704,1.46260991181974e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPT,Dermatopontin,29820,0.0277309308319812,0.00185162500070951,0.0241017458305906,0.0313601158333718,1.5965422395813e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP7,Matrilysin,28870,0.0525676139142708,0.00351054072556703,0.0456869540921594,0.0594482737363822,1.67578349738863e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0928372189543267,0.00620104897857853,0.0806831629563128,0.104991274952341,1.75154368345811e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA2,Integrin alpha-2,24381,0.0361116639700163,0.00241168039829077,0.0313847703893664,0.0408385575506662,1.83091498326322e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0294891843251774,0.00196944988566773,0.0256290625492687,0.0333493061010862,1.85090044990798e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0624103951882812,0.00416859198642205,0.054239954894894,0.0705808354816684,1.89408419550593e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0738667112642525,0.00493587691278971,0.0641923925151846,0.0835410300133203,2.05818192337254e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLNK,B-cell linker protein,24229,0.0419213203428295,0.00280306336716044,0.0364273161431951,0.047415324542464,2.4056588946178e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,FADD,FAS-associated death domain protein,29478,0.0800548052183865,0.00535831708851229,0.0695525037249024,0.0905571067118705,2.7545330415384e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0375813096078472,0.00252099584584829,0.0326401577499846,0.0425224614657099,4.92884067924434e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.049561467459774,0.00332729968929722,0.0430399600687514,0.0560829748507965,5.89345599006842e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0401731954242745,0.00269916413125955,0.0348828337270058,0.0454635571215432,6.91708740312222e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN2,Dynactin subunit 2,29349,0.0984512170202048,0.00662265165134034,0.0854708197835777,0.111431614256832,8.34229645742815e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0790107257769821,0.00531868017847225,0.0685861126271765,0.0894353389267877,9.83815018100301e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0691985532551511,0.00466253727958759,0.0600599801871595,0.0783371263231428,1.29109804399513e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA13,Carbonic anhydrase 13,29114,0.108657959367289,0.00732619111454992,0.0942986247827712,0.123017293951807,1.39265319542524e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0535017122874809,0.00360826532696396,0.0464295122466316,0.0605739123283303,1.48246890002157e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.0384819789973273,0.00259577114042065,0.0333942675621029,0.0435696904325518,1.52490720317786e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOL1,Apolipoprotein L1,24951,0.0625375148003783,0.00421872329449411,0.0542688171431698,0.0708062124575868,1.67072217243075e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF2,Fibroblast growth factor 2,29434,0.0700995711743593,0.00474217427444089,0.0608049095964551,0.0793942327522634,2.86986107391218e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF2,Growth/differentiation factor 2,29478,0.0370121939090002,0.00250437073910189,0.0321036272603605,0.0419207605576399,3.00304353775884e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0681407918012418,0.00461609448279578,0.0590932466149621,0.0771883369875216,3.91403628404881e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLO1,Lactoylglutathione lyase,28916,0.0599618365324857,0.00407092133117311,0.0519828307233863,0.067940842341585,6.29106703818306e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX,Glutaredoxin-1,29291,0.0580464543797008,0.00394244920627473,0.0503192539354024,0.0657736548239993,6.82012588038228e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0479470627045378,0.00325905531158379,0.0415593142938336,0.054334811115242,8.02044744708048e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0638986581763973,0.00434176281871932,0.0553888030517075,0.0724085133010872,8.03661761617383e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0485317114450227,0.00330101945016669,0.042061713322696,0.0550017095673494,9.40160181106667e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0753957805103057,0.00514364588118935,0.0653142345831745,0.0854773264374368,1.78114523252561e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.053557561747444,0.00365598801426568,0.0463918252394833,0.0607232982554048,2.01683390631478e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTC,Probetacellulin,28797,0.0765942911671668,0.00522989663360336,0.0663436937653042,0.0868448885690294,2.15111827949894e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,UMOD,Uromodulin,29750,-0.0554851024731629,0.00379327086920662,-0.0629199133768079,-0.0480502915695179,2.77109583076254e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABHD14B,Protein ABHD14B,29121,0.0589147283312709,0.00402827617169867,0.0510193070347415,0.0668101496278003,2.87484258879099e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.0791718147562307,0.00541537899132591,0.0685576719332319,0.0897859575792295,3.09946695636965e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0375043920208807,0.00256622767551757,0.0324745857768663,0.0425341982648951,3.64473086986737e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX9,Sorting nexin-9,29478,0.0700036661132633,0.00479750050406238,0.060600565125301,0.0794067671012255,4.66838923537401e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0424330713247681,0.00290844359391997,0.0367325218806849,0.0481336207688512,5.21433095614109e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0259298414361698,0.00177828721154805,0.0224443985015356,0.0294152843708039,5.82004371530676e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.088999683341017,0.00612262058488051,0.0769993469946512,0.101000019687383,1.13444196553037e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLF4,Krueppel-like factor 4,24101,0.0406171092526122,0.00279467424121661,0.0351395477398277,0.0460946707653968,1.17857316768169e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF23,Fibroblast growth factor 23,29693,0.0579515931906337,0.00399205031161655,0.0501271745798653,0.0657760118014022,1.38204229060141e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGR1,Prostaglandin reductase 1,24922,0.0832301078410683,0.00573799182213375,0.0719836438696861,0.0944765718124504,1.75708950855684e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0504644201672216,0.00348335596226505,0.0436370424811821,0.0572917978532611,2.32334886245207e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0769029969852731,0.00531073168614239,0.0664939628804341,0.0873120310901122,2.35571109822516e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASS1,Argininosuccinate synthase,24111,0.08078346000746,0.00557792883518568,0.0698507194904961,0.091716200524424,2.46425636510663e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.108010373210469,0.00745982641564395,0.0933891134358064,0.122631632985131,2.5667904162659e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN6,Dynactin subunit 6,28774,0.0725689795537984,0.00501745012142992,0.0627347773157957,0.082403181791801,3.02751143780942e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0323527767131293,0.00223660698273902,0.0279690270269608,0.0367365263992977,3.13299325106357e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN9,Septin-9,29349,0.0287987238942099,0.00199534975752632,0.0248878383694583,0.0327096094189615,4.65736770094809e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0478259247353177,0.00331309050843915,0.041332267338777,0.0543195821318584,4.8062607290015e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40LG,CD40 ligand,29786,0.0787531982109748,0.00545964783131602,0.0680522884615954,0.0894541079603542,5.22213078396629e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0453218255999338,0.00314091949436586,0.0391656233909767,0.0514780278088909,5.29135165720657e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.0693758981199145,0.00482544059530733,0.0599180345531121,0.0788337616867169,1.03590814857845e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP3,Stromelysin-1,29443,-0.0494882541995804,0.00344868212682682,-0.0562476711681609,-0.0427288372309998,1.53225831757984e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0534471184997525,0.00372396917455222,0.0461481389176302,0.0607460980818749,1.60213425025849e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0513064522557374,0.00358723526057229,0.0442754711450157,0.0583374333664591,3.01379416197121e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD84,SLAM family member 5,29434,0.0314051013826814,0.00219752052194068,0.0270979611596776,0.0357122416056851,3.54805559230953e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.032163036504342,0.00225157197786933,0.0277499554277181,0.0365761175809658,3.88777179082222e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0585639230051452,0.00410253275963977,-0.0666048872140391,-0.0505229587962512,4.45396108666621e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7,Complement component C7,24374,-0.0325565349217027,0.00228459547780671,-0.0370343420582039,-0.0280787277852016,6.81215473696428e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDCP1,CUB domain-containing protein 1,29218,0.0520907622521449,0.00365965974138674,0.0449178291590269,0.0592636953452629,8.05029845725517e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0444591515562206,0.00312768158984701,0.0383288956401205,0.0505894074723207,1.12280320806457e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0519728958005651,0.00365787820932937,0.0448034545102795,0.0591423370908506,1.15685224775951e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.0269205410384074,0.00189541153652923,-0.0306355476500047,-0.0232055344268101,1.24237512073765e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.044543206263942,0.00313797330518831,0.0383927785857729,0.0506936339421111,1.50109725216282e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.067024284349867,0.00472871801367008,0.0577559970430737,0.0762925716566604,1.89166841730033e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO1A,Coronin-1A,28847,0.0889661550920988,0.00627768674559087,0.0766618890707407,0.101270421113457,1.94628315823511e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0556270765032348,0.00392419491122219,0.0479356544772393,0.0633184985292303,1.96732346911824e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3C,Protein FAM3C,29433,0.0298679680664504,0.00210858581627152,0.0257351398665582,0.0340007962663426,2.13015890627455e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0415314556393998,0.00293361268823807,0.0357815747704532,0.0472813365083464,2.53423855962228e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX16,Syntaxin-16,28797,0.0577892848209579,0.00408460933817444,0.049783450518136,0.0657951191237798,2.72408233889569e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0356215469852195,0.00251797851622152,0.0306863090934253,0.0405567848770137,2.76961179876829e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSA,Arylsulfatase A,29443,0.0444957241991337,0.00314776327610942,0.0383261081779592,0.0506653402203082,3.2201286092636e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0229780308010259,0.00162797753365745,0.0197871948350573,0.0261688667669945,4.32347619325311e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSE,Cathepsin E,24381,0.0517373765205302,0.00367387682561329,0.0445365779423282,0.0589381750987323,7.29783287217318e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.0562496646390595,0.00399629883904228,0.0484169189145366,0.0640824103635823,7.57741840526795e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0575448900349066,0.00409592122846557,0.0495168844271141,0.0655728956426991,1.08776242750996e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0589399698397903,0.00419540034724187,0.0507169851591962,0.0671629545203844,1.16298477061053e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH7,Protocadherin-7,24805,0.0343670299027308,0.00244866960510112,0.0295676374767326,0.0391664223287289,1.41089018883281e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0593778129173951,0.0042344259457353,0.0510783380637539,0.0676772877710363,1.69574822386301e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRN1,Secernin-1,29434,0.0549920025539913,0.00392651241201598,0.04729603822644,0.0626879668815427,2.00975062194023e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA6,Integrin alpha-6,29434,0.0513086649472675,0.00366404604251594,0.0441271347039362,0.0584901951905987,2.06743806574749e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB2,Calretinin,28774,0.0300366963441438,0.00214912992827764,0.0258244016847197,0.034248991003568,3.03994113748811e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1F,Protein phosphatase 1F,24922,0.0517084943573359,0.00370740587932458,0.0444419788338598,0.0589750098808121,4.78267666296806e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0525595632731859,0.00378270546135725,0.0451454605689256,0.0599736659774461,9.44611041849517e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0653301118156912,0.00471661189469206,0.0560855525020947,0.0745746711292876,1.81849220465375e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0426169555023915,0.00308128144503481,0.0365776438701233,0.0486562671346597,2.28387982610348e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPAG1,Sperm-associated antigen 1,24867,0.0563019880130494,0.00407105272119274,0.0483227246795116,0.0642812513465871,2.43790290387793e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.039308536848052,0.00284956385405153,0.033723391694111,0.044893682001993,4.00808925523362e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0278147329031988,0.00201762624548556,0.0238601854620471,0.0317692803443505,4.22134211291625e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX6,Peroxiredoxin-6,29725,-0.0579481747690831,0.00420663850406249,-0.0661931862370456,-0.0497031633011206,4.86076046855987e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAL,Integrin alpha-L,24229,0.0422478917857943,0.00306672912363111,0.0362371027034774,0.0482586808681113,5.15061618314371e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO2,Gamma-enolase,29694,0.0633936298388119,0.00460436823813946,0.0543690680920585,0.0724181915855652,5.37308382228518e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0526638290916232,0.0038275634977463,0.0451618046360405,0.060165853547206,6.07921717329674e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0687045091484415,0.00500398399843023,0.0588967005115182,0.0785123177853647,9.12248921046578e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOE,Apolipoprotein E,24966,0.0700994516158233,0.00511149098202533,0.0600809292910537,0.080117973940593,1.19404705712804e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR2,Folate receptor beta,29694,-0.0282280518863771,0.00206018923607502,-0.0322660227890841,-0.02419008098367,1.33746102247158e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP1,Guanylate-binding protein 1,24816,0.0622949213610858,0.0045451153687914,0.0533864952382546,0.0712033474839169,1.33837643589233e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0652087542914581,0.00475785249998143,0.0558833633914945,0.0745341451914217,1.35308169782427e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0465827436644496,0.00340206040733713,0.0399147052660688,0.0532507820628303,1.60972485937183e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARFIP1,Arfaptin-1,24867,0.0662307829019848,0.00484165802867734,0.0567411331657773,0.0757204326381924,1.92203953600462e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR3,Toll-like receptor 3,29786,0.0587386905337497,0.00429566602449098,0.0503191851257473,0.067158195941752,1.95252804822932e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0325972008139016,0.00238584841362142,0.0279209379232036,0.0372734637045995,2.42614172928574e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA2,Annexin A2,23907,0.0682198257525706,0.00499529701582966,0.0584290436015445,0.0780106079035968,2.65111083866849e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMD,Dystrophin,24240,0.0496565306756321,0.00363668937333657,0.0425286195038924,0.0567844418473718,2.72881338297927e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0570675064638729,0.00418435061723055,0.048866179254101,0.0652688336736448,3.36009906578034e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.0314798818742947,0.00231340092535187,0.026945616060605,0.0360141476879843,5.09911737391917e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP2,Retinol-binding protein 2,29349,-0.0734619916889103,0.00540184953005253,-0.0840496167678132,-0.0628743666100073,5.41294169010172e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRBP,Acrosin-binding protein,24793,0.0370584521353879,0.00272660699313997,0.0317143024288336,0.0424026018419423,6.36606546593635e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRG,Histidine-rich glycoprotein,24833,0.029991636318821,0.0022072950689078,0.0256653379837617,0.0343179346538802,6.70902799965369e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.0326762111858427,0.00240876202380489,0.0279550376191851,0.0373973847525003,8.58028647487528e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.0186123242150141,0.00137178686961653,0.0159236219505657,0.0213010264794625,8.73463365253263e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSL,Cathepsin L1,29478,0.0232073028659659,0.00171120284897186,0.019853345281981,0.0265612604499507,8.98375317485541e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0748756002105715,0.00553776339308373,0.0640215839601274,0.0857296164610156,1.56280974161416e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0289788329960109,0.00214354017168224,0.0247774942595137,0.0331801717325081,1.60672308480698e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,APLP1,Amyloid-like protein 1,29478,-0.0488439081693237,0.00361709527138914,-0.0559334149012464,-0.041754401437401,1.97762259548009e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.0261393141166415,0.00193727254230291,0.0223422599337278,0.0299363682995552,2.40825921056344e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.021495406827875,0.00159358522450827,0.0183719797878387,0.0246188338679112,2.54800600011847e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML2,Trem-like transcript 2 protein,29443,0.0321640661713125,0.002385529874205,0.0274884276178707,0.0368397047247543,2.61312686450798e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA1,Apolipoprotein A-I,24966,-0.0260604987050866,0.00193274471360901,-0.0298486783437603,-0.022272319066413,2.72309351779299e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0358073263306235,0.0026577854414145,0.0305980668654511,0.041016585795796,3.02373448283023e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.03059740901635,0.00227384917470035,0.0261406646339373,0.0350541533987627,3.9413084929299e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA9,Serpin A9,29227,0.0683203232391161,0.00508442874530296,0.0583548428983223,0.0782858035799099,4.84956756186422e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMB1,Laminin subunit beta-1,24240,0.0287580046112001,0.00214107340164232,0.0245615007439811,0.032954508478419,5.53626947783146e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3,Galectin-3,29544,0.0280754677373495,0.00209491615405787,0.0239694320753961,0.0321815033993029,7.77854120926725e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,SWAP70,Switch-associated protein 70,24805,0.0337344334420444,0.00251998107184307,0.028795270541232,0.0386735963428569,1.00078902917798e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA4,Carbonic anhydrase 4,29820,-0.0223849801535831,0.00167269459108074,-0.0256634615521013,-0.0191064987550648,1.00228320865284e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDHB,Succinate dehydrogenase,24805,0.0647234779564785,0.00483834811922575,0.055240315642796,0.074206640270161,1.13766554042344e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0684849613364529,0.00512146053463666,0.058446898688565,0.0785230239843408,1.16337937898416e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3B,Protein FAM3B,29349,0.0335021171412475,0.00250572539701582,0.0285908953630965,0.0384133389193985,1.18749607357663e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADM,Pro-adrenomedullin,29725,0.0249799217131454,0.00186857792352693,0.0213175089830326,0.0286423344432581,1.21243023903752e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TF,Serotransferrin,24966,0.0203126957401683,0.00152000144544797,0.0173334929070902,0.0232918985732463,1.36096682367055e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN4,CCN family member 4,29725,0.0376190922318566,0.00281909935068822,0.0320936575045077,0.0431445269592055,1.67141288945726e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDA,Cytidine deaminase,24890,0.0438617871030323,0.0032861298130858,0.0374209726693841,0.0503026015366804,1.68742250658704e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0822915437567848,0.00616621438696032,0.0702057635583425,0.094377323955227,1.73485202845699e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCOF1,Treacle protein,24922,0.0293317645706829,0.00220149213452765,0.0250168399870087,0.033646689154357,2.32081084018401e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0570452930079455,0.00428349489086804,-0.0654409429940469,-0.0486496430218442,2.54008491893082e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF22,Kinesin-like protein KIF22,24111,0.115163038354618,0.00865046264558513,0.0982081315692709,0.132117945139965,2.70245691061458e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0599727300701279,0.00450490250566024,0.0511431211590339,0.068802338981222,2.70365797926614e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGRN,Neugrin,24845,0.0207227805287082,0.00155996748077806,0.0176652442663832,0.0237803167910332,3.92450099943786e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,NADK,NAD kinase,29478,0.0504643760358506,0.00380042086534869,0.0430155511397672,0.057913200931934,4.01725070204653e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0257598687226853,0.00194016058396418,-0.0295625834672551,-0.0219571539781155,4.09178935090994e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENR,Density-regulated protein,24229,0.0536634756617921,0.00404104717574796,0.0457430231973261,0.0615839281262581,4.2000017167245e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSTB,Cystatin-B,29030,0.0396971766567236,0.002990898395554,0.0338350158014377,0.0455593375120094,4.3661610503298e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0333753606203718,0.00251409181702207,0.0284477406590086,0.0383029805817351,4.40875548016819e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0915194895047236,0.00689877930682575,0.0779978820633451,0.105041096946102,4.75960847960927e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0454516999328335,0.00342626489300893,0.038736220742536,0.052167179123131,5.01447352300187e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL26,C-C motif chemokine 26,29434,0.0831143753039572,0.00627064234404605,0.070823916309627,0.0954048342982875,5.53265692555173e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0893685069097778,0.00675744519898333,0.0761239143197705,0.102613099499785,8.17695615759857e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.0264165407128716,0.00199756867501919,0.022501306109834,0.0303317753159092,8.26804734154136e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRIB,Protein scribble homolog,24240,0.0841784595353806,0.00636708298907933,0.0716989768767852,0.0966579421939761,9.13084333074001e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVR,Poliovirus receptor,29694,0.0344115327148321,0.00260459698249724,0.0293065226291375,0.0395165428005267,9.70833906171349e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0766440308105495,0.00580117131393554,0.0652737350352358,0.0880143265858631,9.73373749592247e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0257896993230783,0.00195188574845112,0.0219640032561141,0.0296153953900425,1.01790186702527e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0521768038408035,0.00395153915218117,-0.0599218205790786,-0.0444317871025284,1.07680294843989e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0546007767512218,0.00413509159338802,0.0464959972281812,0.0627055562742623,1.12816520217778e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID2,Nidogen-2,29443,0.0680434187424928,0.005155123958021,0.0579393757847717,0.078147461700214,1.15002401579683e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0497658541417531,0.00378782795831464,0.0423417113434564,0.0571899969400497,2.55523654749366e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0370505475814308,0.00282118720659702,0.0315210206565007,0.042580074506361,2.74671643270097e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0465678788618281,0.00355294299341699,0.0396041105947308,0.0535316471289254,4.05328352821545e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSHB,Follitropin subunit beta,24240,0.0596717423534585,0.00455582321961084,0.0507423288430213,0.0686011558638958,4.59546535498334e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0630827812369373,0.00482210927267064,0.0536314470625029,0.0725341154113718,5.64851429450998e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0292136471117148,0.00223946763207683,0.0248242905528442,0.0336030036705854,8.75665266475043e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0558740225163844,0.00428965917999201,0.0474662905236,0.0642817545091687,1.12647077859975e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD276,CD276 antigen,29454,-0.0328650397124553,0.00253067685592941,-0.0378251663500769,-0.0279049130748336,1.85795942375021e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0395452388115704,0.00304817579699433,0.0335708142494615,0.0455196633736793,2.21276070503645e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0220440676535582,0.00169992945748693,0.0187122059168838,0.0253759293902326,2.38034498855349e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0234585433973289,0.00181233382347239,0.019906369103323,0.0270107176913347,3.24649982874501e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0206304140443234,0.00159723436839016,-0.0237609934063681,-0.0174998346822787,4.61324178051793e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0322549399418328,0.00250282672290095,0.0273493995649469,0.0371604803187186,6.72434147297704e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.034724826713896,0.0026961161820419,0.0294404389970939,0.0400092144306981,7.46556509967212e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.0415957425019163,0.00322999436589316,0.0352649535447657,0.0479265314590669,7.56570256554712e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0264619276369425,0.00205606783116598,-0.0304918205860279,-0.0224320346878572,8.38483425053837e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0547427972040088,0.00425504365135253,0.0464029116473579,0.0630826827606598,8.91935332613269e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0395256549044171,0.0030734663090842,-0.0455496488702221,-0.0335016609386121,9.50639369615138e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0178661220276852,0.00138923822161951,-0.0205890289420594,-0.0151432151133109,9.51413405634271e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0889978519244303,0.00692317550463408,0.0754284279353475,0.102567275913513,1.0169288720804e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM1,Dynamin-1,24805,0.103345604295534,0.00804433648563366,0.0875787047836919,0.119112503807376,1.17920710859574e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0470593565823659,0.00366531459965195,0.0398753399670481,0.0542433731976837,1.25186358267386e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIT2,Slit homolog 2 protein,28774,0.046996879803228,0.0036646560570996,0.0398141539313128,0.0541796056751432,1.51808332741024e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0287197777057908,0.00223998949190808,0.024329398301651,0.0331101571099307,1.56409578067455e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0706108483311368,0.00551919042539929,-0.0814284615649194,-0.0597932350973542,2.23622396706384e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX7,Syntaxin-7,24229,0.0446812005450056,0.00349524981322457,0.0378305109110854,0.0515318901789257,2.67983981426554e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSB,Cathepsin B,29480,-0.0471499362666549,0.003692665253294,-0.0543875601631112,-0.0399123123701987,3.08481601540832e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100P,Protein S100-P,28916,0.0480201335799579,0.00376933950418042,0.0406322281517643,0.0554080390081515,4.47849769106864e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAP,Prosaposin,24761,0.0254990518875061,0.00200231945994132,0.0215745057460211,0.029423598028991,4.95414006954426e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0441983362904972,0.00347800102877678,0.0373814542740948,0.0510152183068997,6.66487654544843e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0314431190803825,0.00247688146239516,0.026588431414088,0.036297806746677,7.90817905227558e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0393450276817418,0.00310506753837719,0.0332590953065225,0.0454309600569611,1.06560820168271e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP1,Interstitial collagenase,28424,0.081562573234957,0.00644210770995387,0.0689360421234474,0.0941891043464665,1.22396185334213e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0595862571822271,0.00471420711644008,0.0503464112340045,0.0688261031304497,1.5929833449818e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0813809127865473,0.00643978461553646,0.0687589349400959,0.0940028906329988,1.70499595207444e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.0310660899068054,0.00246114252426103,0.0262422505592538,0.0358899292543571,2.05876444876656e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.0464978697368162,0.00369001928624801,0.0392654319357701,0.0537303075378623,2.71072938446333e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0327938418490231,0.00260777138620995,0.0276826099320516,0.0379050737659946,3.73335437044655e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA,Adenosine deaminase,29786,0.0307644127702856,0.00244786246765112,0.0259666023336894,0.0355622232068818,3.9182167021491e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD83,CD83 antigen,29434,0.0300123782424827,0.00239317496342543,0.0253217553141688,0.0347030011707965,5.51806044851826e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0298356663868747,0.00238491191154988,0.0251612390402369,0.0345100937335125,8.10727961826458e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA4,Ephrin-A4,29169,0.0270443402407596,0.00216423557979713,0.0228024385043573,0.031286241977162,9.69146948081356e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP2,Neuropilin-2,29443,-0.0251957010645429,0.00201702674446374,-0.0291490734836918,-0.0212423286453939,1.02348579675768e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.0644435187685222,0.00515994099985459,0.0543300344088072,0.0745570031282372,1.05094262833452e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.06088261006548,0.00487560248642588,0.0513264291920853,0.0704387909388747,1.08084640045049e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0200285293059442,0.00160433235328753,0.0168840378935007,0.0231730207183878,1.12324759389678e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK7,Kallikrein-7,23801,0.0343189125932765,0.00275556425632429,0.0289180066508809,0.0397198185356721,1.707756212278e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK4,Kallikrein-4,29725,-0.0551368132305402,0.00442898981373626,-0.0638176332654633,-0.0464559931956171,1.7349650930844e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.0580862043960405,0.00466787200850152,0.0489371752593775,0.0672352335327035,1.86530153767221e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH1,Acid ceramidase,24732,0.0407873538150256,0.0032797441299504,0.0343590553203228,0.0472156523097284,2.12328077720419e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.0755715114084729,0.00608524720576205,0.0636444268851793,0.0874985959317665,2.53306484603312e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.027867944167391,0.00224482271195306,0.023468091651963,0.032267796682819,2.78802589882713e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0776716444831883,0.00626036073595675,0.0654013374407131,0.0899419515256635,3.0640247903217e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0251411584894463,0.00202788485195827,0.0211665041796081,0.0291158127992845,3.29343240833818e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0402486503380605,0.00324955655661414,0.0338795194870967,0.0466177811890242,3.83020396932527e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA1,BolA-like protein 1,24101,0.0475905151136464,0.00384508614119767,0.0400541462768989,0.0551268839503938,4.45234508075132e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNF,Tumor necrosis factor,28868,0.0331758228229993,0.00269138032609149,0.02790071738386,0.0384509282621386,7.96220456184885e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0624496499553851,0.00507163087898549,0.0525092534325735,0.0723900464781967,9.36264145287885e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0350657900678262,0.00285122773156519,0.0294773837139584,0.0406541964216939,1.17120297240872e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLTA,Clathrin light chain A,28916,0.0406974687481352,0.00331230855167984,0.0342053439868427,0.0471895935094276,1.30230850796421e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGF,Hepatoma-derived growth factor,29688,0.080789324598343,0.00657830127721688,0.0678958540949979,0.0936827951016881,1.38723671891113e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0528344188347324,0.00430128488917382,0.0444039004519517,0.0612649372175131,1.40970255615901e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SBSN,Suprabasin,24905,-0.0298064965920291,0.00242800861835252,-0.034565393484,-0.0250475997000582,1.53219484928684e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL25,C-C motif chemokine 25,29786,0.0424263543993332,0.00345787761433761,0.0356489142752315,0.049203794523435,1.60091588845335e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.0417380113812605,0.00340454815099215,0.0350650970053159,0.0484109257572051,1.821874893904e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0295546347015641,0.00241026843167135,-0.03427876082764,-0.0248305085754883,1.82429790486581e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN2,Matrilin-2,29497,0.0256140044847781,0.00209362164367088,0.0215105060631832,0.029717502906373,2.46955153346954e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0626609302578003,0.00512438964612806,0.0526171265513893,0.0727047339642113,2.67107315363794e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0482300927822517,0.00394612448353383,0.0404956887945254,0.055964496769978,2.97775452539522e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.0539272405652472,0.0044226145327818,0.0452589160809948,0.0625955650494995,4.06763415767364e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0535834272575752,0.00439519680525429,0.0449688415192768,0.0621980129958736,4.32231372885267e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.021979303812941,0.00180427080597513,0.0184429330332297,0.0255156745926522,4.86133361088202e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPL14,60S ribosomal protein L14,24240,0.0345230147762572,0.00283592671420522,0.028964598416415,0.0400814311360995,5.41135627583947e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA4,Annexin A4,29341,0.0616329899416146,0.00506637013983594,0.0517029044675361,0.071563075415693,5.75699774635643e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0375402782808181,0.00308701884214399,0.0314897213502158,0.0435908352114203,6.09084481331955e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL19,C-C motif chemokine 19,29694,0.105177880779966,0.00864929322852102,0.0882252660520653,0.122130495507868,6.09242321197124e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0334231408712858,0.00275408890139283,0.0280251266245558,0.0388211551180157,8.20313879044924e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0485756871759421,0.00400591915544494,0.0407240856312701,0.0564272887206142,9.30065156228699e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK3,NT-3 growth factor receptor,29694,-0.0184776088533162,0.00152475963167254,-0.0214661377313944,-0.015489079975238,1.01421200728476e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0185397971893696,0.001530454616714,0.0155401061406101,0.021539488238129,1.07292858803871e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMS,Spermine synthase,24101,0.0545519152249716,0.00450430124023852,0.0457234847941041,0.0633803456558391,1.15613837892325e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0239505450308035,0.00198076809718258,0.0200682395603257,0.0278328505012814,1.40457398345673e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0348572700005999,0.00288644869581869,0.0291998305567952,0.0405147094444045,1.75313474742652e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.0189622652473131,0.00157103468302541,0.0158830372685833,0.0220414932260429,1.88949756761406e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0536143938512281,0.00444352532171945,0.044905084220658,0.0623237034817982,1.98571662604124e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0591222350101257,0.00490422610706314,0.049509951840282,0.0687345181799695,2.26483947202942e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD46,Membrane cofactor protein,29331,0.0242794372895774,0.00201550202214912,0.0203290533261652,0.0282298212529897,2.43070520054227e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0255390444833231,0.00211993726467106,0.0213839674445678,0.0296941215220784,2.4877854764159e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0463480333919225,0.00385147167430281,0.038799148910289,0.053896917873556,2.82586605799068e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0737466737941943,0.00612678758434677,0.0617381701288746,0.0857551774595139,2.82884216831528e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPR,Nucleoprotein TPR,24111,0.0404651131115821,0.00336187936520669,0.033875829555777,0.0470543966673873,2.84774616918593e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO2,Roundabout homolog 2,29694,0.0195984456505376,0.00162979117619197,0.0164040549452014,0.0227928363558739,3.13259987309663e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0466109361205307,0.00387619173668769,0.0390136003166228,0.0542082719244385,3.27386692807679e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBI3_IL27,Interleukin-27,29674,-0.0261477029669348,0.00217743745254378,-0.0304154803739206,-0.021879925559949,3.82851620932606e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS27,Serine protease 27,29395,0.0340114127877641,0.00283321005410475,0.0284583210817188,0.0395645044938094,4.02033198622649e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0433667031144358,0.00361308652594647,0.0362850535235807,0.0504483527052909,4.10307640632933e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0483253214099224,0.0040289005993547,0.0404286762351872,0.0562219665846576,4.54092289898753e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA14,Carbonic anhydrase 14,29725,-0.029974296509631,0.00250437237964355,-0.0348828663737324,-0.0250657266455297,6.16539215494046e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXN,"Frataxin, mitochondrial",29725,0.0614849277906424,0.00515860185751284,0.0513740681499172,0.0715957874313675,1.11995640205693e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.0677774695080283,0.00568671231075643,0.0566315133789457,0.0789234256371109,1.16896252718949e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.0591821637568466,0.00497005897428414,0.0494408481672497,0.0689234793464435,1.32779534535427e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0356268428187252,0.00299321333048961,0.0297601446909656,0.0414935409464848,1.36806291697125e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0399356099866065,0.00336261380406304,0.0333448869306429,0.04652633304257,1.92287971772036e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGN,Biglycan,28750,-0.0998931544046276,0.0084343076395869,-0.116424397378218,-0.0833619114310373,2.75916728751766e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0422118393330916,0.00356654501619458,0.0352214111013502,0.0492022675648329,3.0392060238656e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0202351895281581,0.00171098007284363,0.0168816685853846,0.0235887104709316,3.35976485895523e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK4,Dickkopf-related protein 4,29169,0.0381419731422078,0.00323008878987395,0.0318109991140548,0.0444729471703607,4.18391180011424e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0274699999208129,0.00232687526444372,-0.0320306754391226,-0.0229093244025033,4.45003248557541e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.0237190355685954,0.00201110373238709,-0.0276607988840741,-0.0197772722531167,4.9470798690214e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH5,Cadherin-5,29820,-0.025178243843622,0.00213800728800087,-0.0293687381281037,-0.0209877495591403,6.07327635380469e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGMN,Legumain,29581,0.0296798093479533,0.00252212437819332,0.0247364455666944,0.0346231731292123,6.74025908765617e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.0379327804814205,0.00323004361118623,0.0316018950034955,0.0442636659593456,8.96293226088046e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0802756239564875,0.00684929378674044,0.0668510081344762,0.0937002397784987,1.18013866692259e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0348636332274504,0.00297428114913218,0.0290340421751514,0.0406932242797495,1.20143946125521e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0611831634958955,0.00524119354318852,0.050910424151246,0.0714559028405451,2.04200823196797e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0308540309681809,0.00264533561251367,0.0256691731676541,0.0360388887687077,2.29427317466088e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD93,Complement component C1q receptor,28353,-0.0258366657602884,0.00221525290666188,-0.0301785614573457,-0.0214947700632311,2.32126104797301e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0615019260500746,0.00528030175760136,0.0511525346051759,0.0718513174949733,2.8609245964332e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP8,Caspase-8,29632,0.0502888697735784,0.00433195676708847,0.041798234510085,0.0587795050370718,4.34114367445214e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0322891863140772,0.0027825208969177,0.0268354453561185,0.0377429272720359,4.59273500301172e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CX3CL1,Fractalkine,29218,-0.02753336856297,0.00237930793865479,-0.0321968121227333,-0.0228699250032066,6.67299977279427e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK3,Dickkopf-related protein 3,29820,-0.0239711745666502,0.0020724547490566,-0.0280331858748012,-0.0199091632584993,7.08605514437634e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0197782231944441,0.00171041948836377,0.0164258009972511,0.0231306453916371,7.36700850237244e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0414595147191381,0.00358781004837655,0.03442740702432,0.0484916224139561,8.33313184300322e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX6,Syntaxin-6,28797,0.0547207466479864,0.00473716053377306,0.0454359120017912,0.0640055812941816,8.49480220034185e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0342959965231942,0.00297123693944094,-0.0401196209244984,-0.0284723721218899,9.36925760237029e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA2,Carbonic anhydrase 2,29368,0.0557021398596346,0.0048320150692858,0.0462313903238344,0.0651728893954347,1.11359818193134e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0387488712543006,0.0033622478139902,0.0321588655388798,0.0453388769697214,1.15438201696192e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0271464089680293,0.00235751994804946,0.0225256698698524,0.0317671480662063,1.29660020723815e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0955670941751649,0.00829830690974432,0.0793024126320661,0.111831775718264,1.3042217562994e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PER3,Period circadian protein homolog 3,24229,0.0971780570241319,0.00845067953446889,0.0806147251365728,0.113741388911691,1.59377782756101e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0790071490407406,0.00688005962384149,0.0655222321780113,0.09249206590347,1.90681533011663e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0353881724117075,0.00308513197641501,0.0293413137379341,0.0414350310854809,2.15953586631118e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL1,Fc receptor-like protein 1,29478,0.0366493288262453,0.00319667186528527,0.0303838519702862,0.0429148056822045,2.29818109214054e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,XRCC4,DNA repair protein XRCC4,28774,0.0298947567785716,0.00260923497689532,0.0247806562238568,0.0350088573332864,2.51566059276165e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMM2,Phosphomannomutase 2,24111,0.0485147649873496,0.00423588702215861,0.0402124264239187,0.0568171035507805,2.71249627941367e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,C5,Complement C5,24966,0.0122056066503404,0.00106727552001859,0.010113746631104,0.0142974666695768,3.27789008046161e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,VGF,Neurosecretory protein VGF,24867,0.0244283298095524,0.00213749339299521,0.0202388427592818,0.028617816859823,3.58412651154439e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0432864200816715,0.00378973157963944,0.0358585461855782,0.0507142939777648,3.87813004588448e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRH,Corticoliberin,28751,0.0698279496718012,0.00611758360472391,0.0578374858065423,0.0818184135370601,4.11932946168224e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0321726578367645,0.00281948375059905,0.0266464696855904,0.0376988459879386,4.38772559619305e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFR,Epidermal growth factor receptor,29820,0.0131634164798059,0.00115416536121248,0.0109012523718294,0.0154255805877824,4.5504652139228e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0436326554626323,0.0038256895812525,0.0361343038833774,0.0511310070418872,4.69821682993551e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.0290370973757513,0.00254947629867051,0.0240401238303571,0.0340340709211455,5.46518534576259e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXN,Thioredoxin,24647,0.0350872338699625,0.00308476211814287,0.0290411001184025,0.0411333676215225,6.66273432405234e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0182427621805505,0.00160575388628603,0.0150954845634299,0.0213900397976711,7.75538872317825e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0286856495361837,0.00252774281718709,0.023731273614497,0.0336400254578704,8.9897846161777e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0476008281222202,0.0042059280913057,0.0393572090632611,0.0558444471811794,1.23763622564071e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0272404310188861,0.00241579037276345,-0.0319753801495025,-0.0225054818882698,1.98657786432322e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0303683907850498,0.00269335008661859,0.0250894246152774,0.0356473569548222,1.99661017378784e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0327840858636939,0.00290861392431977,0.0270832025720271,0.0384849691553606,2.1526684664154e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL14,C-C motif chemokine 14,29435,0.0313715133379127,0.00278704784361502,0.0259088995644273,0.0368341271113982,2.47905676687431e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPK2,Death-associated protein kinase 2,24229,0.0425311982171028,0.00377867155454758,0.0351250019701895,0.049937394464016,2.57044717361524e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.0538034260216345,0.00479171737557803,0.0444116599655016,0.0631951920777674,3.47672954922566e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0405132422061207,0.00361107322357796,0.0334355386879079,0.0475909457243335,3.76313370133278e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0489684723567521,0.00436432648359207,0.0404143924489117,0.0575225522645926,3.8323333122518e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0224846132703957,0.00200543330515133,-0.0264152625484924,-0.0185539639922991,4.08553960989399e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPQ,Carboxypeptidase Q,24920,0.0290822058391851,0.00259844196289419,0.0239892595919125,0.0341751520864577,5.22402341327186e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0470306738486853,0.00420650891852013,0.0387859163683859,0.0552754313289848,5.82846446537632e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0520564267577754,0.00466319606403433,0.0429165624722681,0.0611962910432827,7.2267034741057e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA,Lymphotoxin-alpha,29434,0.0314372613732503,0.00282374171478808,0.0259027276122656,0.0369717951342349,9.87118339800277e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOB,Elongin-B,24111,0.0310738899227161,0.00279339013326543,0.0255988452615159,0.0365489345839164,1.12510363194172e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.018741568068131,0.00168789055178041,-0.0220498335496206,-0.0154333025866414,1.37477292845627e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0497906659726037,0.00449958552780597,0.040971478338104,0.0586098536071034,2.15469618779188e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.0645488896459067,0.0058453082986964,0.0530920853804617,0.0760056939113516,2.69849854693535e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML1,Trem-like transcript 1 protein,24951,0.0410246403077199,0.00371521461422529,0.0337428196638383,0.0483064609516014,2.77664715576755e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD248,Endosialin,24938,-0.0311911118900151,0.00283467044125305,-0.0367470659548711,-0.0256351578251591,4.26941516400757e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX5,Sorting nexin-5,24240,0.023145527720198,0.00210375800670184,0.0190221620270624,0.0272688934133336,4.35657708386373e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL8,Interleukin-8,29218,0.0523403722679992,0.00477424773778914,0.0429828467019325,0.0616978978340659,6.52024211886192e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHPS,Deoxyhypusine synthase,24793,0.0314379761948446,0.00287009804040987,0.0258125840356413,0.037063368354048,7.39635605296921e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0565044274624161,0.00516251779693727,0.046385892580419,0.0666229623444131,7.95703491374567e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0184356898972377,0.00168645449715322,-0.0217411407116581,-0.0151302390828174,9.19812369185952e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0328434753945022,0.00301717342570778,0.0269298154801149,0.0387571353088894,1.5599367568429e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPOCK1,Testican-1,29218,0.0197255506145298,0.00181353303922229,0.0161710258576541,0.0232800753714055,1.67785763646936e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0870647601273419,0.00800874736169433,0.071367615298421,0.102761904956263,1.82355394762578e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0271847878336221,0.00250193255551659,0.0222810000248096,0.0320885756424346,1.90141654232415e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0523220512299264,0.00481672325988838,0.0428812736405452,0.0617628288193077,2.00356740783564e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0559424504227554,0.00515174721381901,0.0458450258836702,0.0660398749618407,2.03848610780954e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB8,Serpin B8,29786,0.0429824068937753,0.00396289824821738,0.0352151263272692,0.0507496874602814,2.33883003914337e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP9,Caspase-9,24229,0.0480544443918129,0.00443613339637514,0.0393596229349176,0.0567492658487082,2.78881013132462e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRSF1,G-rich sequence factor 1,23862,0.061562061793469,0.00569021954912737,0.0504092314771794,0.0727148921097587,3.2393054476123e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENAH,Protein enabled homolog,28931,0.036309095774846,0.00335908021867696,0.0297252985462392,0.0428928930034529,3.50829101007052e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL15,C-C motif chemokine 15,29820,0.033369453327943,0.00309895071077419,0.0272955099348256,0.0394433967210604,5.46653067260508e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0398921521523864,0.00370935213557844,0.0326218219666526,0.0471624823381201,6.47052591783578e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAT,Catalase,24587,0.0405111175515213,0.00377008396492243,0.0331217529802733,0.0479004821227693,7.14647477410846e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.05010573112457,0.00466713738584855,0.0409581418483068,0.0592533204008331,7.94341959831172e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,KITLG,Kit ligand,29478,-0.0281533432278,0.00262529007954675,-0.0332989117837116,-0.0230077746718884,8.81000634321797e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB2,Plexin-B2,29701,0.0180214124371695,0.00168055328917152,0.0147275279903933,0.0213152968839457,8.84036889503249e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0576538090222361,0.0053759397697771,0.047116967073473,0.0681906509709993,8.98594950803293e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.0837654231935709,0.00781120425295853,-0.0990753835293696,-0.0684554628577721,9.08767338251808e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,MET,Hepatocyte growth factor receptor,29507,-0.0149183004578908,0.00139237170652776,-0.0176473490026852,-0.0121892519130964,9.76731861370565e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0504231138287128,0.00470784233904054,0.0411957428441934,0.0596504848132323,1.01825355119268e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIT,Citron Rho-interacting kinase,24195,0.0341578632890073,0.00319461494724987,0.0278964179923975,0.040419308585617,1.26804049947838e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA12,Carbonic anhydrase 12,29349,-0.0245030832639164,0.00229515394256005,-0.0290015849913341,-0.0200045815364987,1.47492726675791e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCT,Secretin,24195,0.035301462986866,0.00330698556887459,0.0288197712718718,0.0417831547018602,1.52999025492979e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0275817045144847,0.00258757297647701,0.0225100614805898,0.0326533475483797,1.80027247608914e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.0886977544122224,0.00834435463314056,0.0723428193312669,0.105052689493178,2.48062808068533e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0291026820684512,0.00274259703588496,0.0237271918781167,0.0344781722587857,3.01359311126076e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR3,Small proline-rich protein 3,24845,0.0507751225114522,0.00478801525997836,0.0413906126018946,0.0601596324210098,3.22699768996205e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0253113083591087,0.00239065674417987,0.0206256211405162,0.0299969955777013,3.78685019285077e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0404438757369088,0.0038226353036701,0.0329515105417154,0.0479362409321021,4.18998586288512e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARCO,Macrophage receptor MARCO,29478,0.019581853735073,0.00185266885371794,0.0159506227817859,0.0232130846883602,4.59344891134948e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPA,Apolipoprotein(a),24484,-0.132837418068742,0.0125805491244328,-0.157495294352631,-0.108179541784854,5.25304779674904e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0255420768704872,0.00242067217347675,0.0207975594104728,0.0302865943305016,5.55662442850941e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0288123021919419,0.00273251658246703,0.0234565696903066,0.0341680346935773,6.00127646698474e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0263388052343568,0.00249902483933215,-0.0312368939194478,-0.0214407165492657,6.43168496284992e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF7,SLAM family member 7,29434,-0.0434932284262477,0.00412861079172938,-0.0515853055780373,-0.0354011512744582,6.65520908655844e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.0369404527714955,0.00350770145255064,0.0300653579244962,0.0438155476184947,7.03564518318163e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD302,CD302 antigen,29349,0.0225639487003019,0.00214838925842405,0.0183531057537908,0.026774791646813,9.32381368151084e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.044113435665242,0.00420092256639918,0.0358796274350996,0.0523472438953844,9.72124301767646e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0272691143083198,0.002597812799451,0.0221774012213958,0.0323608273952437,1.01382261852637e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0322172239225728,0.00307363037386826,0.026192908389791,0.0382415394553546,1.18835916194568e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0316237133847684,0.00301739867286585,0.0257096119859513,0.0375378147835855,1.2019550973726e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0168930259086572,0.0016155808107173,0.0137264875196513,0.0200595642976631,1.52024397671917e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0256845151135373,0.0024578344799818,0.020867159532773,0.0305018706943017,1.6236299885819e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX1,Heme oxygenase 1,29165,-0.0353438818018519,0.0033852417100865,-0.0419789555536214,-0.0287088080500824,1.79468819680534e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBD,Thrombomodulin,29478,0.0210444313609731,0.00201747874873157,0.0170901730134593,0.024998689708487,1.98109413278289e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0373540269182884,0.00359222971981718,0.0303132566674467,0.04439479716913,2.84830781171807e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTN,Pleiotrophin,28916,0.0366135676993083,0.00352421127361921,0.0297061136030146,0.043521021795602,3.07759124451226e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAM,Basal cell adhesion molecule,29443,-0.0175979650059722,0.00169592031165785,-0.0209219688168216,-0.0142739611951228,3.50038577310806e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0350497524032398,0.00337914029000622,0.0284266374348276,0.041672867371652,3.66859749714614e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAST,Gastrin,24845,0.0952021778371337,0.0091795223722262,0.0772103139875703,0.113194041686697,3.77600954516122e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB6,Heat shock protein beta-6,29725,0.028055330569254,0.00270640326191164,0.0227507801759072,0.0333598809626008,3.89635507039464e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.0193395211511431,0.00186585615470245,0.0156824430879263,0.0229965992143599,4.02571778690213e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI2,Serpin I2,24805,0.0414472387339076,0.00399982608117329,0.0336075796148079,0.0492868978530072,4.14303006970797e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0309907384301219,0.0029980876484143,0.0251144866392299,0.0368669902210139,5.29800696933088e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0439054093461427,0.00426060448511769,0.035554624555312,0.0522561941369733,7.51487439559556e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIT,Vitrin,24922,0.0273192618031735,0.0026529982034723,0.0221193853243678,0.0325191382819792,8.10974389531852e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX1,Peroxiredoxin-1,28669,-0.06535324968626,0.00636138260046487,-0.0778215595831712,-0.0528849397893489,1.02477730572336e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0210211005689365,0.00205499962883207,-0.0250488998414473,-0.0169933012964256,1.6106960808527e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN2,Nectin-2,29433,0.0214215981458525,0.00209828078010366,0.0173089678168493,0.0255342284748557,1.98257430147428e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDK,Midkine,29455,0.0365041697783912,0.00358044665254942,0.0294864943393943,0.0435218452173881,2.28158979408919e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0311251586361249,0.00305431720787788,0.0251386969086842,0.0371116203635655,2.39876111592e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0375943568449872,0.00370755203777267,-0.0448611588390217,-0.0303275548509528,4.02463419967504e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0455878350646896,0.004500947215951,0.0367659785214256,0.0544096916079535,4.53206150796301e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA12,Serpin A12,28628,0.0797635106101134,0.00788272857531557,0.0643133626024949,0.0952136586177319,5.0064673857606e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.039999159832017,0.00395651297040759,0.0322443944100181,0.0477539252540159,5.57814044667099e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0188774391046799,0.00186878792136409,0.0152146147788063,0.0225402634305535,5.95425615273994e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0303903185595509,0.00301032744353678,0.0244900767702189,0.036290560348883,6.45912236807472e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.046449986640623,0.00460281168171468,0.0374284757444622,0.0554714975367837,6.57994879792955e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0439141733512958,0.0043538674706348,0.0353805931088517,0.05244775359374,7.0885453863908e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP6,Gastrotropin,28872,0.0399007448273605,0.00396398489348065,0.0321313344361385,0.0476701552185826,8.56434835999047e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0649096966187079,0.00645111591481677,0.052265509425667,0.0775538838117488,9.07681900152137e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRL,Prolactin,29694,-0.0536989277165348,0.00533942936116863,-0.0641642092644253,-0.0432336461686443,9.33552647284092e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY75,Lymphocyte antigen 75,29434,0.0274582850441928,0.00273779443629614,0.0220922079490524,0.0328243621393332,1.23620357031608e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,FST,Follistatin,29536,0.0356629067231059,0.00355793189224677,0.0286893602143022,0.0426364532319096,1.31099480083831e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0317286792732833,0.00316547060125798,0.0255243568948176,0.0379330016517489,1.33852655352343e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0334669420941293,0.00334637277486504,0.0269080514553938,0.0400258327328648,1.67193033937883e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0381096820362476,0.00381280514113629,0.0306365839596205,0.0455827801128747,1.74458393197848e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0290897171841491,0.00291107648571036,0.0233840072721568,0.0347954270961414,1.78974330410472e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.0147316276577049,0.00147664209137641,0.0118374091586071,0.0176258461568026,2.10622432255418e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0206521593167786,0.00207044666850659,-0.0247102347870515,-0.0165940838465057,2.14129343111145e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0348497837699723,0.00349419100154628,0.0280011694069416,0.041698398133003,2.20579528590977e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0230836112530012,0.00231702224825183,0.0185422476464276,0.0276249748595748,2.41685322510285e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA4,Laminin subunit alpha-4,29581,0.0234475336239526,0.00235404308609751,0.0188336091752015,0.0280614580727037,2.46885799428112e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM,Paralemmin-1,24657,0.0209839157820502,0.00210696810336725,0.0168542582994504,0.02511357326465,2.54234215606139e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL20,C-C motif chemokine 20,29786,0.06151396122435,0.00617787464213777,0.0494053269257599,0.07362259552294,2.55289739238686e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,COLEC12,Collectin-12,29454,0.0184676514330148,0.00185728425530815,0.0148273742926108,0.0221079285734187,2.9333669262424e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST5,Cystatin-D,28890,0.0389262865131853,0.00391764619407454,0.0312476999727992,0.0466048730535714,3.15832913918795e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0467334684557042,0.00470549245222771,0.0375107032493378,0.0559562336620705,3.29478047087486e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNC,Tenascin,29594,-0.0333651617437247,0.00335980501725683,-0.0399503795775481,-0.0267799439099013,3.32866463162731e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS1,Nephrin,24229,0.0238557601208198,0.00240195454163426,0.0191479292192167,0.0285635910224229,3.35279472957614e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBS,Cystathionine beta-synthase,24240,0.0358686278842073,0.00361170138660343,0.0287896931664646,0.0429475626019501,3.37226341204543e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2,Brorin,29114,0.0278988841033332,0.00281006809447054,0.022391150638171,0.0334066175684955,3.41744909963047e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0259804976190973,0.00262468873430227,0.0208361076998649,0.0311248875383298,4.67356857343214e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0249074304304232,0.00252138682313353,-0.0298493486037649,-0.0199655122570815,5.60043840646717e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0283445512716751,0.00287708341182323,-0.0339836347588487,-0.0227054677845016,7.30369567989788e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0584365071095166,0.00594797128475383,0.0467784833913991,0.0700945308276341,9.56293623515195e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0336364207505398,0.003450640118234,0.0268731661188012,0.0403996753822785,2.0365371404e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAM,Signal transducing adapter molecule 1,24793,0.0253198502482087,0.0025976673117739,0.0202284223171319,0.0304112781792856,2.08158079071358e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0325501988962338,0.00334044932511389,0.0260029182190106,0.0390974795734571,2.11410097531414e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPF,Centromere protein F,24445,0.0371940976696835,0.00382326750520076,0.02970049335949,0.044687701979877,2.5058988821234e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A12,Protein S100-A12,29023,0.0513434912711742,0.00528239663934843,0.0409899938580513,0.0616969886842971,2.68681384343111e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0381359547788317,0.00392886832394293,0.0304353728639035,0.0458365366937598,3.10397201624387e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN3,Calsyntenin-3,24845,0.020866948666428,0.00215205124945275,0.0166489282175006,0.0250849691153553,3.42273637063565e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0392921056608722,0.00405496353286962,0.0313443771364478,0.0472398341852967,3.59008107161122e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.040112975107952,0.00415467506485807,0.0319698119808301,0.0482561382350738,5.06081305579782e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0237080200214802,0.00246628402505216,0.0188741033323779,0.0285419367105824,7.72002270316645e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0257482317194673,0.00268435396411379,0.0204868979498042,0.0310095654891303,9.43981998099864e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPL,Periplakin,24229,0.0221060841074366,0.00230516339871151,0.0175879638459621,0.0266242043689112,9.6457670779937e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS2,Growth arrest-specific protein 2,24445,0.0357088442030398,0.00372480016706756,0.0284082358755874,0.0430094525304923,9.92439759136484e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0161942595101844,0.00169400797952759,0.0128740038703103,0.0195145151500584,1.28904243858054e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSF,Cathepsin F,29566,0.0269831278510073,0.0028253417806269,0.0214454579609786,0.032520797741036,1.38817046698212e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0344904368870269,0.00361266934249181,0.027409604975743,0.0415712687983109,1.45587718020848e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM3,Myomesin-3,24381,-0.0628360433268977,0.00658302314190216,-0.075738768685026,-0.0499333179687695,1.48215024233877e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR2,Complement factor H-related protein 2,24789,0.0383086528804513,0.00401929594035281,0.0304308328373597,0.0461864729235428,1.69275237169649e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0201462121003103,0.00211584801603435,0.015999149988883,0.0242932742117376,1.83179781952719e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.020657119269814,0.00217248053799569,-0.0249151811242856,-0.0163990574153425,2.07814975397706e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_E,,29434,0.0193136876729534,0.00204444217625559,0.0153065810074925,0.0233207943384144,3.73882937576202e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0314229972724098,0.00334398328053307,0.024868790042565,0.0379772045022546,6.02287028680583e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0162989923210022,0.00173524047576593,-0.0197000636535034,-0.0128979209885009,6.23745455756748e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEK,Angiopoietin-1 receptor,29566,0.0144538764824973,0.00153940979179413,0.0114366332905808,0.0174711196744138,6.46335037210287e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0244898171374887,0.00261444701098148,0.019365500995965,0.0296141332790124,8.06925289728965e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0284545269233714,0.00304374471945194,0.0224887872732456,0.0344202665734972,9.61496750533778e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,GC,Vitamin D-binding protein,24966,0.0170384705824884,0.00182390678908336,0.013463613275885,0.0206133278890918,1.02433199795024e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0190871027122136,0.00204429749973871,0.0150802796127257,0.0230939258117014,1.07416688133921e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0322195292711484,0.00345409233903383,0.0254495082866421,0.0389895502556547,1.16706853614273e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.0267243393291827,0.00287047552399357,0.0210982073021553,0.0323504713562101,1.36364060596487e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0375819570238916,0.00405467531872958,0.0296347933991816,0.0455291206486016,2.00941362600442e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0169433777484569,0.00183604600440933,0.0133447275798147,0.0205420279170992,2.9658846253438e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0167276435718089,0.00181306211154736,0.0131740418331761,0.0202812453104418,2.98622660292774e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX2,Sorting nexin-2,24793,0.052873225653621,0.0057332382978435,0.0416360785898477,0.0641103727173943,3.13504477401485e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0547489460789343,0.00593893100691252,0.0431086413053858,0.0663892508524829,3.20778760783783e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA1,Carbonic anhydrase 1,28867,0.0387567043712292,0.00420758004934924,0.0305098474745047,0.0470035612679537,3.43834602810882e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.0629035580304048,0.00683038062366159,-0.0762911040527815,-0.0495160120080281,3.49136957364334e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFC1,Cryptic protein,28797,0.030538797621865,0.00331681563345878,0.0240378389802858,0.0370397562634442,3.56568083025858e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0228898114813343,0.00248832114488435,0.018012702037361,0.0277669209253077,3.85381499208417e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK6,Kallikrein-6,29519,0.0198164813500295,0.00215801394673094,0.0155867740144369,0.0240461886856222,4.4693865143031e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH15,Cadherin-15,29639,0.0373598291129219,0.00407357453929472,0.0293756230159043,0.0453440352099396,4.96908578432797e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYGD,Gamma-crystallin D,24845,0.0622748353804768,0.00682433130036853,0.0488991460317545,0.0756505247291991,7.67472058277316e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0336914046550954,0.00369513515191111,-0.0409338695528412,-0.0264489397573496,8.14257420517125e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPB2,Coatomer subunit beta',24111,0.0276126508660018,0.00303510850823823,0.0216638381898549,0.0335614635421487,9.91708293859524e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMB,RGM domain family member B,29694,0.0172368451988891,0.00189778022092054,0.0135171959658849,0.0209564944318934,1.12372895811093e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH1,Cadherin-1,28477,0.0256661240941244,0.00282678520666997,0.0201256250890513,0.0312066230991976,1.15813944666299e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCOR1,REST corepressor 1,28916,0.0285054167901386,0.00314816034542189,0.0223350225131117,0.0346758110671655,1.45428223474237e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR2,Anterior gradient protein 2 homolog,28553,0.064304330234562,0.00711159033460981,0.0503656131787268,0.0782430472903973,1.63042907875172e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0369948049765132,0.00409561521386123,0.0289673991573452,0.0450222107956812,1.77315953257605e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A14,Protein S100-A14,24867,0.0335472510745481,0.0037286688479859,0.0262390601324958,0.0408554420166005,2.47887264953594e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA9,Carbonic anhydrase 9,29725,-0.0289701607351837,0.00322310126635954,-0.0352874392172484,-0.022652882253119,2.65621345024494e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0332320874957821,0.00369819591222853,0.0259836235078142,0.04048055148375,2.7114057539862e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0365825992233649,0.00407520711662903,0.028595193274772,0.0445700051719578,2.95139075380515e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0249949138632573,0.00279199014341686,0.0195226131821602,0.0304672145443543,3.67913859684697e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA11,Integrin alpha-11,29434,-0.0216147331982608,0.00241561769319414,-0.0263493438769213,-0.0168801225196002,3.83032478285368e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAM,Integrin alpha-M,29443,-0.0199352951825819,0.00222974963279926,-0.0243056044628684,-0.0155649859022953,4.09171593221582e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0231358687121157,0.00258782730198786,0.0180637272002195,0.0282080102240119,4.10131502503519e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17D,Interleukin-17D,28931,0.0215305931038091,0.0024088709174568,0.0168092061055938,0.0262519801020244,4.19124029987251e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0212232858642455,0.00237712981878622,-0.0258824603090665,-0.0165641114194245,4.57890391775611e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0529374150407653,0.00593012955421001,0.0413143611145136,0.0645604689670169,4.68485515748218e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFA,Protransforming growth factor alpha,29434,0.0293078983460157,0.00329296591660893,0.0228536851494622,0.0357621115425692,5.88974848668147e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0163357485305592,0.00183748110799936,0.0127342855588804,0.0199372115022379,6.49796050809821e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0162160219183211,0.00182468671333531,0.0126396359601839,0.0197924078764583,6.69158391256253e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.02437008897055,0.00274263872597432,0.0189945170676404,0.0297456608734597,6.71235808384434e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHCY,Adenosylhomocysteinase,29478,0.0421898377386036,0.00475660342211608,0.0328668950312561,0.0515127804459511,7.7365059026005e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.0262059413886321,0.00295594924533578,0.020412280867774,0.0319996019094902,8.03886231086521e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A13,Protein S100-A13,24229,0.0219817270096607,0.00247934896948954,0.0171222030294612,0.0268412509898602,8.09868474892751e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPG,Macrophage-capping protein,29174,0.0363110709332617,0.00410816508438339,0.0282590673678703,0.0443630744986531,1.0211546759526e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0275362847877268,0.0031150203592952,-0.0336417246919454,-0.0214308448835082,1.02274404623416e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRN,Progranulin,29313,0.0153562239318844,0.0017385221206067,0.0119487205754953,0.0187637272882735,1.07548476216901e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0246268501114117,0.0027884821108461,0.0191614251741534,0.03009227504867,1.10034395907867e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR1,Complement receptor type 1,24903,0.0223688632270041,0.00253291278544558,0.0174043541675308,0.0273333722864775,1.10161144114629e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGT,Angiotensinogen,24951,0.0143759206558756,0.00162796593281673,0.0111851074275548,0.0175667338841964,1.10815196332355e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0240200968581952,0.00272019648421821,0.0186885117491275,0.0293516819672629,1.11340923871053e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDM1,Nuclear protein MDM1,24195,0.0195015644685727,0.00220904204041028,0.0151718420693685,0.0238312868677769,1.13571736912156e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.020041882451782,0.00227107735551628,0.0155905708349701,0.0244931940685939,1.15500945334422e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMD,Osteomodulin,29581,-0.0267936694143879,0.00303989762783674,-0.0327518687649479,-0.0208354700638279,1.27230416773925e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.0224736846313352,0.002553556355317,-0.0274786550877565,-0.0174687141749139,1.43006002393056e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0308217468624811,0.00350330851185813,0.0239552621792392,0.0376882315457231,1.46847381651173e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSC2,Desmocollin-2,29135,-0.0212979087591374,0.00242211898972868,-0.0260452619790056,-0.0165505555392692,1.53353093238267e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYZL2,Lysozyme-like protein 2,24016,0.0223414772092497,0.00254174633835186,0.01735965438608,0.0273233000324193,1.59651431808371e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0283297660765025,0.00322494409984452,0.0220088756408073,0.0346506565121978,1.67201989155812e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0202576713678309,0.00230794782187428,0.0157340936369574,0.0247812490987045,1.77873664959796e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA6,Carbonic anhydrase 6,29372,-0.0390581056749852,0.00445291130060802,-0.0477858118241769,-0.0303303995257935,1.85865669417761e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0157868034313634,0.0018006285871833,-0.0193160354622427,-0.0122575714004842,1.9457205527248e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0368246301798221,0.00420241542281287,0.0285878959511089,0.0450613644085353,2.02832410460064e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0223533472853878,0.00255181152358699,0.0173517966991573,0.0273548978716183,2.05919903420461e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB6,Integrin beta-6,28931,0.0187141341127274,0.00214439749923538,0.0145111150142261,0.0229171532112288,2.7532721048304e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.0384752100818719,0.00441534544276565,-0.0471292871496926,-0.0298211330140512,3.08661226042734e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLU,Clusterin,24966,0.019492815478352,0.00223796759800639,0.0151063989862595,0.0238792319704445,3.22212011609768e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR5,Complement factor H-related protein 5,24623,0.0255229624214717,0.00294616609024326,0.0197484768845949,0.0312974479583485,4.86775904851501e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0258948584063505,0.00298953749655227,0.020035364913108,0.0317543518995929,4.88179100785043e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0325803802417299,0.00376297862472332,0.0252049421372722,0.0399558183461876,5.080673260806e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0308572791212588,0.00356594927860863,0.0238680185351859,0.0378465397073317,5.25850811723898e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAD,Chondroadherin,24381,0.0315630290928844,0.00365472807859874,0.0243997620588309,0.038726296126938,6.16035072099411e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0247338324024484,0.00286891705352008,0.019110754977549,0.0303569098273477,7.01742329727433e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1A,Protein phosphatase 1A,28797,0.0189254111449773,0.00219567868359884,0.0146218809251236,0.023228941364831,7.07019781973149e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOBR,Apolipoprotein B receptor,24240,-0.0258711410513624,0.00300507621842959,-0.0317610904394844,-0.0199811916632404,7.8009180641683e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0187194804969374,0.00217660691744507,0.014453330938745,0.0229856300551297,8.42410312665033e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.032971768821382,0.00384101492852489,0.0254433795614733,0.0405001580812908,9.67816462864892e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.0211313034648651,0.00246563410648262,0.0162986606161592,0.0259639463135711,1.080875673274e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0342555009985589,0.00400292207757584,0.0264097737265102,0.0421012282706075,1.2074629596609e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0269031738178342,0.0031451207983956,0.0207387370529789,0.0330676105826896,1.2589198656873e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN3,Matrilin-3,29169,-0.0193738371714941,0.00226717032610522,-0.0238174910106603,-0.0149301833323278,1.34261918649977e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0203152100336339,0.00237885743234438,0.0156526494662389,0.0249777706010289,1.42114888967868e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0463889807132451,0.00543208614515151,0.0357420918687482,0.0570358695577421,1.4223998027181e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0351946832857998,0.00412364315940665,0.0271123426933627,0.0432770238782368,1.48460579656576e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0178958503879541,0.00209808571773872,0.0137836023811862,0.022008098394722,1.53828807449908e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0222859329683512,0.00261760144563747,0.0171554341349017,0.0274164318018006,1.7759146261467e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.0149299478629558,0.00175845068750196,-0.0183765112104596,-0.0114833845154519,2.15346314762472e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0149911133534362,0.00176800662645947,0.0115258203655757,0.0184564063412968,2.39618494204559e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD209,CD209 antigen,29527,-0.0231625038264913,0.00274225046176431,-0.0285373147315493,-0.0177876929214332,3.13661928137739e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0234538148366594,0.00277697090119579,0.0180109518703157,0.0288966778030032,3.1817777190514e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CABP2,Calcium-binding protein 2,24195,0.0388802319342776,0.00460770252863391,0.0298491349781551,0.0479113288904,3.40370169410958e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.0257850831484791,0.00305651086478579,0.0197943218534989,0.0317758444434593,3.42863526787654e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL3,Insulin-like 3,24845,0.0449202867931104,0.00532573825290925,0.0344818398174082,0.0553587337688125,3.50278507167535e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0149389872769226,0.00177681318643641,0.0114564334315073,0.018421541122338,4.36587233681557e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMBS,Porphobilinogen deaminase,29725,0.0254864269583195,0.00303643478647081,0.0195350147768367,0.0314378391398023,4.923974007592e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0289037295528553,0.00345420342434728,-0.035673968264576,-0.0221334908411346,6.18031230023224e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0223106274190099,0.00266804657784078,0.017081256126442,0.0275399987115778,6.43129827535845e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0152207034490763,0.00182482949249974,0.0116440376437768,0.0187973692543758,7.68822304363452e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MILR1,Allergin-1,28931,-0.0296850518986085,0.00355997399927545,-0.0366626009371884,-0.0227075028600286,7.84997540406909e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVALB,Parvalbumin alpha,29599,0.0659259127600301,0.00791126778093544,0.0504198279093966,0.0814319976106636,8.20720293338234e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.02641480539829,0.00317335737999621,0.0201950249334975,0.0326345858630826,8.94326960033894e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENSA,Alpha-endosulfine,24793,0.0309682370717946,0.00372410376519275,0.0236689936920169,0.0382674804515724,9.59080579317636e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD1,Leiomodin-1,24867,-0.02080650622398,0.00250301469411934,-0.0257124150244539,-0.0159005974235061,9.83789237274928e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMPD3,AMP deaminase 3,24845,0.0414902360657779,0.00499911973138624,0.0316919613922609,0.051288510739295,1.09799652364123e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASET2,Ribonuclease T2,29697,0.0155245792246862,0.00187195309659371,0.0118555511553625,0.0191936072940098,1.14797029618209e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.0164206778213774,0.00198027560680804,0.0125393376320337,0.0203020180107212,1.16852582550362e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0680526220792127,0.00821548588800977,0.0519502697387135,0.0841549744197118,1.24731597255971e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLC,Galectin-10,29426,-0.0386559249679257,0.0046740011237869,-0.0478169671705481,-0.0294948827653034,1.39061963846112e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0294645164766701,0.0035752615284631,0.0224570038808824,0.0364720290724577,1.77468390162452e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0420550833128668,0.00510341578987891,0.0320523883647041,0.0520577782610295,1.79897474917077e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0577576090207163,0.00701728783386279,0.0440037248663452,0.0715114931750874,1.95356803483133e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0162613761243766,0.00198454405075275,0.0123716697849012,0.020151082463852,2.65034597258126e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.032022619575439,0.00392345776431356,-0.0397125967934935,-0.0243326423573844,3.43030093609781e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.00910951770017935,0.00111723708133242,0.0069197330207678,0.0112993023795909,3.66938141455029e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALY,RNA-binding protein Raly,24793,0.0275776032846571,0.00339361357298394,0.0209261206816086,0.0342290858877056,4.62984870325653e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0312181453566945,0.0038438647563239,0.0236841704342997,0.0387521202790893,4.82049382971801e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0218967431603956,0.00270634414252654,-0.0272011776797477,-0.0165923086410436,6.14670231349014e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO1,Roundabout homolog 1,29497,0.013736678321625,0.0016985142676297,0.0104075903570708,0.0170657662861792,6.32348628250497e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,XG,Glycoprotein Xg,29693,0.0183321341405546,0.00226930047369645,0.0138843052121095,0.0227799630689996,6.81345257975432e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0145194487589777,0.00179844296386095,0.0109945005498102,0.0180443969681451,7.09917107746912e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH1,Protocadherin-1,29713,0.012067629903815,0.00149622410631383,0.0091350306554399,0.0150002291521901,7.5728425094464e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTB,Lymphotoxin-beta,24793,0.0198256860150506,0.00246324670521761,0.0149977224728241,0.0246536495572771,8.74756269618029e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSG,Basigin,29760,0.0116359581783617,0.00144721847524998,0.00879940996687179,0.0144725063898517,9.29767160661874e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZU1,Azurocidin,28534,0.0432894485590859,0.00539812685653947,0.0327091199202686,0.0538697771979033,1.10351531631157e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0206367358773227,0.00257422255288253,0.0155912596736729,0.0256822120809724,1.12722430734148e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0232810145363214,0.00290487545018638,0.0175874586539561,0.0289745704186867,1.14780099149553e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.026541851513971,0.00331261712971995,0.0200491219397199,0.0330345810882221,1.16772011928425e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM2,Junctional adhesion molecule B,29694,0.0150695670559731,0.00188295350352491,0.0113789781890643,0.018760155922882,1.25664115638587e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFIC,Nuclear factor 1 C-type,24867,0.0250843936290906,0.00313952346587307,0.0189309276359794,0.0312378596222019,1.40899832211008e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSPN,Persephin,29434,0.0525376046266741,0.00662673775545197,0.0395491986259883,0.06552601062736,2.30308310903581e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0309093273599591,0.00391812209252903,0.0232298080586022,0.038588846661316,3.17602793252089e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN2,Alpha-actinin-2,24111,-0.0329920937814743,0.00418255924769907,-0.0411899099069645,-0.0247942776559841,3.19998858966362e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0199287206102159,0.00252965804431295,0.0149705908433625,0.0248868503770693,3.46562730441871e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.0189476061489018,0.00241198359607307,0.0142201183005986,0.023675093997205,4.13808586672494e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,LUZP2,Leucine zipper protein 2,24793,0.0248091449017505,0.00315872496874317,0.0186180439630139,0.0310002458404871,4.18688009366337e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0181121797493305,0.00230871133168005,0.0135871055392376,0.0226372539594234,4.49727112567005e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0246609612569368,0.00314801825724997,0.0184908454727268,0.0308310770411468,4.89569273927198e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPE,Carboxypeptidase E,29468,-0.0213161372322005,0.00272228361137056,-0.0266518131104868,-0.0159804613539142,5.03219454475477e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0247725908875506,0.00316508138518837,0.0185690313725814,0.0309761504025198,5.170489261341e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0233266002226487,0.00298038455592237,0.0174850464930409,0.0291681539522566,5.20678507043032e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE3,Eosinophil cationic protein,29343,0.0598666863205755,0.00765473134535794,0.0448634128836739,0.074869959757477,5.42115154274451e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0168786444927123,0.00215895265068153,-0.0211101916880481,-0.0126470972973766,5.58751942735098e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.0176196079449423,0.00225412722124058,0.0132015185913108,0.0220376972985739,5.64681456963082e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN2,Calsyntenin-2,29786,-0.0217718347556448,0.00279033415350173,-0.0272408896965082,-0.0163027798147814,6.26272149314432e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR15L,Protein GPR15L,24805,0.0336319377610574,0.00431265197475772,0.0251791398905323,0.0420847356315826,6.51365483869551e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPO,Myeloperoxidase,29443,0.025194544250761,0.00323571760217349,0.018852537750501,0.0315365507510211,7.12101376608227e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0210992951282941,0.00271094613687248,0.015785840700024,0.0264127495565641,7.36595564779018e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.017722735122768,0.00227994464220682,-0.0221914266214933,-0.0132540436240426,7.94674434771578e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAX,Apoptosis regulator BAX,28722,0.0495101019592836,0.00637059685161717,0.0370237321301139,0.0619964717884532,8.00455134377726e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0200055163024404,0.00257662898336639,0.0149553234950422,0.0250557091098385,8.54055116381382e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.00445161733536519,0.000574106590253875,-0.00557686625226279,-0.0033263684184676,9.24967523967067e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.0197482386675009,0.00254891912628778,0.0147523571799769,0.024744120155025,9.66148639915232e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.017911556299293,0.00231447959672162,0.0133751762897186,0.0224479363088673,1.03497806573306e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0364344709375353,0.00471030069358842,0.027202281578102,0.0456666602969686,1.07404551485889e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAN,Versican core protein,29694,-0.0163724727514985,0.00211891464691311,-0.0205255454594482,-0.0122194000435488,1.1373583655873e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGCR6,Protein DGCR6,24101,0.0238628998775619,0.00308941178617179,0.0178076527766652,0.0299181469784586,1.17029965805592e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0281141031650843,0.00364134580792445,0.0209770653815524,0.0352511409486162,1.1934268594814e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL2,Fc receptor-like protein 2,29645,0.0267578171179226,0.00347500065340246,0.0199468158372538,0.0335688183985915,1.40197462139924e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0134807360363198,0.00176053538438148,-0.0169313853897075,-0.0100300866829322,1.97149112286588e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0265035566452619,0.00347242336500464,-0.033309506440671,-0.0196976068498528,2.37030808574211e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0183034547754979,0.00240266555702766,0.0135942302837236,0.0230126792672721,2.66880742718672e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0181746616967236,0.00238880825644602,0.0134925975140894,0.0228567258793578,2.860963938992e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0308094116113073,0.00405513864463849,-0.0387574833547987,-0.0228613398678158,3.10571195915426e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0193635458700753,0.00254867234590506,0.0143681480721014,0.0243589436680492,3.12816987299525e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0289002362624577,0.00382045042680928,0.0214121534259115,0.0363883190990039,4.00563350377223e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0246864264748344,0.00326501907493369,0.0182869890879644,0.0310858638617045,4.11998413780947e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.00985783071544706,0.00130600207153767,0.00729806665523322,0.0124175947756609,4.56757063567713e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.01737308294204,0.00231009091518164,0.012845304748284,0.021900861135796,5.61070166306056e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK14,Kallikrein-14,29725,-0.0244197368209842,0.0032511212348953,-0.030791934441379,-0.0180475392005894,6.02448010123139e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.0192408942204068,0.00256324217664236,0.0142169395541878,0.0242648488866258,6.28479634784075e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0227733863359457,0.00304506902952751,0.0168050510380718,0.0287417216338196,7.71464454355478e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICOSLG,ICOS ligand,29349,0.0100056715334812,0.00134613186023448,0.00736725308742165,0.0126440899795408,1.09135486229565e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0112410769211503,0.00151289588673097,-0.014206352859143,-0.00827580098315755,1.11455480492891e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0419449748854851,0.00565431974005122,0.0308625081949847,0.0530274415759855,1.21909276159091e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0207751962710278,0.00280394261815801,0.0152794687394381,0.0262709238026175,1.31139208257949e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0535905419159848,0.00724383136259922,0.0393926324452903,0.0677884513866793,1.42540098602357e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA7,Carbonic anhydrase 7,24445,-0.0179246552522695,0.00242630367752903,-0.0226802104602264,-0.0131691000443126,1.54248416575536e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOB,Apolipoprotein B-100,24951,0.0117075551132995,0.00158719774237883,0.00859664753823698,0.014818462688362,1.67898362076362e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG3,Desmoglein-3,29589,0.0176937341642444,0.00241111758566153,0.0129679436963478,0.022419524632141,2.21727897740583e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.123955021513705,0.0168965446995857,0.0908377939025169,0.157072249124893,2.2662068102054e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0140167896203278,0.00191145509879467,-0.0177632416139653,-0.0102703376266902,2.31893521883207e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.030643132485094,0.00418483253666576,0.0224408607132291,0.0388454042569589,2.5095038772572e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.017214672089244,0.00235362962828739,-0.0218277861606872,-0.0126015580178007,2.66939361155782e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN3,CCN family member 3,29795,0.0174410784828565,0.00238660610767596,0.0127633305118116,0.0221188264539013,2.78164172098226e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECM1,Extracellular matrix protein 1,24349,0.0189352453578463,0.00259344468457139,0.0138520937760864,0.0240183969396062,2.93978720171024e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD6,Programmed cell death protein 6,29478,-0.0359330937846419,0.00493725719811575,-0.0456101178929488,-0.0262560696763351,3.47404625852705e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM2,Myomesin-2,24111,-0.0261099773024331,0.00360277166789006,-0.0331714097714976,-0.0190485448333686,4.38309380688095e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR2,Complement receptor type 2,29594,0.0237774077593928,0.00328288431620818,0.0173429544996248,0.0302118610191609,4.50105277346276e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0135034051726235,0.00186477402340451,0.00984844808675067,0.0171583622584964,4.55213719116851e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB37,Ras-related protein Rab-37,28931,0.0419807344437067,0.00580383668578333,0.0306052145395714,0.053356254347842,4.83201275059182e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0202665459850163,0.00280234524993409,-0.0257591426748871,-0.0147739492951455,4.89680783357747e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0126484784325539,0.00175554873747599,0.00920760290710092,0.0160893539580068,5.95136444107983e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0245816145494342,0.00341173981314285,0.0178946045156742,0.0312686245831942,5.97411402082392e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0201620119117268,0.00279984756142939,0.0146743106913252,0.0256497131321284,6.14270790891926e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.030197645581778,0.00419692998718728,0.0219716628068909,0.038423628356665,6.41545099911779e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0134315655070653,0.00186750647773951,-0.0170918782034348,-0.00977125281069592,6.55328670775812e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.0116452677483273,0.00162285184223025,-0.0148260573590986,-0.00846447813755604,7.35855420954611e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.025940114027786,0.00361753813803105,-0.0330304887783268,-0.0188497392772451,7.63938638229567e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH1,Neurexophilin-1,28774,0.0193347301697993,0.00269638330884703,0.0140498188844591,0.0246196414551395,7.64621523136492e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.0324362192179876,0.00452997174742813,0.0235574745930285,0.0413149638429468,8.27274459072208e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0269166396028897,0.00376175697647297,0.0195435959290027,0.0342896832767767,8.54543455856282e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.0266300320774703,0.00372800220919724,0.0193231477474437,0.0339369164074969,9.33174133004076e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300A,CMRF35-like molecule 8,24381,0.0151023198397779,0.00211535134604301,0.0109562312015336,0.0192484084780222,9.63741127966262e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0399284736214912,0.00559535995517283,0.0289615681093525,0.05089537913363,9.83601592536727e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0351598093658922,0.00492709666426424,0.0255026999039343,0.0448169188278502,9.87841024016906e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.0131196105650141,0.00183937625341611,-0.0167247880217096,-0.00951443310831849,1.00704568998771e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.0129223557426911,0.00181932165283787,0.00935648530312889,0.0164882261822533,1.24977622415971e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.02046429646634,0.00288156730922783,0.0148164245402535,0.0261121683924265,1.26005185240797e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0189508045836617,0.00266996639164387,-0.0241839387112836,-0.0137176704560397,1.30191569821782e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0149850329281732,0.0021126565922522,0.0108442260073589,0.0191258398489875,1.34192431024377e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0169345890788983,0.00238970963745574,0.012250758189485,0.0216184199683116,1.40673877921312e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSHB,Thyrotropin subunit beta,29478,0.0383672797346193,0.00542163548442294,0.0277408741851504,0.0489936852840883,1.50927808494131e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ULBP2,UL16-binding protein 2,29218,0.0190540497602764,0.00269300618801173,0.0137757576317735,0.0243323418887794,1.52394230228947e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0168411673783161,0.00238030989708547,0.0121757599800286,0.0215065747766037,1.53182128025649e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0173739192251744,0.00246630883040027,0.0125399539175899,0.022207884532759,1.90166575512122e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0153443789168024,0.00217961912615918,-0.0196164324040744,-0.0110723254295304,1.96528575469072e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0211613293194569,0.00300594786714838,0.015269671499846,0.0270529871390677,1.96782742275946e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSH,Pro-cathepsin H,28852,0.0363010192845351,0.00517137289578927,0.0261651284087881,0.0464369101602821,2.27408543632048e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGA,Chromogranin-A,24938,-0.0434404871435143,0.00619717334392476,-0.0555869468976068,-0.0312940273894217,2.44869750256422e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0163192192184775,0.0023302052030814,0.0117520170204379,0.020886421416517,2.56461800839254e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC1,Glypican-1,29725,0.0145405474870135,0.00207671460992338,0.0104701868515637,0.0186109081224633,2.5823303302955e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF16,Fibroblast growth factor 16,24229,0.0235737735410053,0.00337942094743064,0.0169501084840412,0.0301974385979693,3.12218514127423e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LF,CMRF35-like molecule 1,29725,0.0295245519702255,0.00425335694951181,0.0211879723491824,0.0378611315912687,3.96003816568051e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL1,Follistatin-related protein 1,24240,-0.0111344897817131,0.0016128478244221,-0.0142956715175804,-0.0079733080458458,5.19447947426819e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0416861990352186,0.00604254591841504,0.0298428090351251,0.0535295890353121,5.3748825178941e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRK1,Protein BRICK1,28774,0.021766310713032,0.00315814224804204,0.0155763519068696,0.0279562695191944,5.60984589895132e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.0345457048399387,0.00501346394902486,0.02471931549985,0.0443720941800275,5.67097715640949e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0331647142590384,0.00481875021614886,0.0237199638353866,0.0426094646826901,6.02772689389352e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0149596720893138,0.00217428020943035,0.0106980828788303,0.0192212612997973,6.11874427277963e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSR,Insulin receptor,24229,0.00823762616291899,0.00119789503417635,0.00588975189593333,0.0105855004299046,6.272181904208e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB2A2,Mammaglobin-A,24111,-0.0152741067729328,0.00223028125502032,-0.0196454580327726,-0.010902755513093,7.6416320277976e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB2,Lamin-B2,24845,0.0135069508211487,0.00197585310788416,0.00963427872969574,0.0173796229126017,8.33149442050813e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL,Podocalyxin,29349,0.00726289756584213,0.00106822056105337,0.00516918526617752,0.00935660986550673,1.0731961170968e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARCL1,SPARC-like protein 1,29489,-0.0131610930039603,0.00193698881777987,-0.0169575910868089,-0.0093645949211118,1.10667090071071e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0174294635568263,0.00257089655991408,0.0123905062993947,0.0224684208142579,1.22886192650145e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0126603382888898,0.00187203807436286,-0.016329532914641,-0.00899114366313857,1.37827741549803e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL34,Interleukin-34,28722,0.0172152840601662,0.00255109966276464,0.0122151287211475,0.0222154393991849,1.52554312342125e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA4,Apolipoprotein A-IV,24966,0.017006752349973,0.00252214362426225,0.012063350846419,0.021950153853527,1.58562110943065e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN1,Contactin-1,29820,-0.0129243944754395,0.00192223949935197,-0.0166919838941694,-0.00915680505670965,1.80470095936115e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0286308716528982,0.00425881103344585,-0.036978141278452,-0.0202836020273443,1.81598173108833e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0124744404723386,0.00186503640564337,-0.0161299118273996,-0.00881896911727763,2.30116261097841e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP12,Macrophage metalloelastase,29466,0.0250401466456907,0.00374423231606714,0.0177014513061991,0.0323788419851823,2.3082244926757e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0138409802015946,0.00207183469354765,0.00978018420224121,0.017901776200948,2.43266835984679e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,0.0289470940545604,0.00433577201605385,0.0204489809030948,0.0374452072060259,2.49334744780769e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA1,Annexin A1,24281,0.0201147081624039,0.00301980328598985,0.0141958937218638,0.026033522602944,2.77912970391382e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0251979075787048,0.00378702583035609,0.0177753369512069,0.0326204782062028,2.91680307090595e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0148891421509214,0.00223888455555495,-0.0192773558798091,-0.0105009284220337,2.97714110412814e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0134008418370675,0.00201604876460125,-0.017352297415686,-0.00944938625844905,3.04220789564158e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SATB1,DNA-binding protein SATB1,24867,0.0139177861142692,0.00209526205473904,0.00981107248698068,0.0180244997415577,3.14766867235584e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG4,Desmoglein-4,29242,0.0231560311487267,0.00349403090751225,0.0163077305700027,0.0300043317274507,3.47796066949554e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLVRB,Flavin reductase,29443,0.0304051845093922,0.00458990204436245,0.0214089765024418,0.0394013925163426,3.54752797340735e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCP1,Plastin-2,24938,0.0220881635231114,0.00334790712370325,0.015526265560653,0.0286500614855698,4.26233167757109e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.022496557685752,0.00341163089233199,0.0158097611367813,0.0291833542347228,4.36764654448636e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.0148235245629683,0.00225102398735077,-0.0192355315781758,-0.0104115175477608,4.63479601919362e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAP,Cartilage-associated protein,24195,0.0226565915675121,0.00344313450548116,0.015908047936769,0.0294051351982551,4.79351764957915e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGA4,Pepsin A-4,24951,0.0329470267074046,0.00501647884355678,0.0231147281740333,0.0427793252407759,5.20831041273608e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD59,CD59 glycoprotein,28277,0.0106418449880051,0.00162577622849534,0.00745532358015425,0.013828366395856,6.02305899159766e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNU13,NHP2-like protein 1,24111,0.0288883733395085,0.00441748529767666,0.0202301021560623,0.0375466445229548,6.29393082461436e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1B,Interleukin-1 beta,28745,0.0258707008493684,0.00397284985566611,0.0180839151322628,0.033657486566474,7.54428558158232e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPP1,Osteopontin,29757,-0.0211352988656121,0.00325201368823534,-0.0275092456945533,-0.0147613520366708,8.20563358484057e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,C8B,Complement component C8 beta chain,24966,0.0139384089557234,0.00214494835211257,0.00973431018558274,0.018142507725864,8.27925329283557e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.040810642186322,0.00628228976859093,0.0284973542398838,0.0531239301327602,8.37163698306967e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST1,Cystatin-SN,21656,0.0479886038092435,0.00742040801659483,0.0334446040967176,0.0625326035217693,1.02027953845148e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LXN,Latexin,29117,-0.0306468235773696,0.00474608698043583,-0.0399491540590238,-0.0213444930957153,1.08279084513297e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A11,Protein S100-A11,29208,0.0207146678931363,0.0032084072230117,0.0144261897360334,0.0270031460502392,1.08926459511403e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0199915055587042,0.00310390781119081,0.0139078462487702,0.0260751648686382,1.2111279558115e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0124950562713959,0.00194218411079183,0.00868837541424392,0.0163017371285479,1.26956791004845e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN2,Prefoldin subunit 2,28774,0.0252389112666751,0.00392626106504969,0.0175434395791777,0.0329343829541725,1.3111960333797e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1,Programmed cell death protein 1,29661,0.0194307100850295,0.00302533146275147,0.0135010604180366,0.0253603597520224,1.35930211768973e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTPN,Myotrophin,28916,0.0148487202469763,0.00231315715216172,0.0103149322287394,0.0193825082652133,1.3907514895875e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.025390988560773,0.00396708084869899,0.017615510097323,0.033166467024223,1.57799699090956e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRUNE2,Protein prune homolog 2,24445,0.0131974394457708,0.00206315966082162,0.00915364651056045,0.0172412323809812,1.61631813421219e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP4,Guanylate-binding protein 4,28774,0.0221710445483875,0.00346656455028418,0.0153765780298305,0.0289655110669445,1.62285860191107e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.013838039239322,0.00216644143005214,-0.0180842644422242,-0.00959181403641981,1.71709464468593e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.013612678653578,0.00213234596384731,0.00943328056443731,0.0177920767427188,1.75267281149636e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALCAM,CD166 antigen,29820,0.00878709732448681,0.00137970897969889,0.00608286772427699,0.0114913269246966,1.93281501282052e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0165814159871256,0.00260548904753117,0.0114746574539645,0.0216881745202867,2.00041485937525e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0183974045371972,0.00289313824600356,-0.0240679554993641,-0.0127268535750302,2.06082504702711e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR1,Cadherin-related family member 1,28774,0.0191890458965801,0.00301942364989469,0.0132709755427865,0.0251071162503736,2.11269948866284e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN10,Ataxin-10,28774,0.0326157593034099,0.00513408795060664,0.0225529469202208,0.0426785716865989,2.14611605840021e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0275119714453796,0.00433293929318645,0.0190194104307341,0.036004532460025,2.19891221905455e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0315030169270416,0.00497391237275924,-0.0412518851776497,-0.0217541486764334,2.43536931240519e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWF,von Willebrand factor,29820,-0.0323237918775817,0.00511555414470316,-0.0423502780011999,-0.0222973057539635,2.67449880306098e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.018650042549497,0.00295199941714775,0.0128641236918874,0.0244359614071066,2.69854499343511e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOC,Brother of CDO,28916,-0.0104422324209657,0.00165345731834229,-0.0136830087649166,-0.00720145607701482,2.73392755330011e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0279217031948754,0.00443118925256089,0.0192365722598561,0.0366068341298948,3.00478750785034e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.0129365556352931,0.00205734856332859,0.00890415245116912,0.0169689588194172,3.26211606370385e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PZP,Pregnancy zone protein,24966,0.0236595957487444,0.00376314804389424,0.0162838255827117,0.0310353659147772,3.28633494817313e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCN,Decorin,28916,-0.0101230226702076,0.00161520146371725,-0.0132888175390934,-0.0069572278013218,3.72438911597792e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0127729931159499,0.00204512149938046,0.00876455497716418,0.0167814312547356,4.27929315764895e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0204651508471851,0.00327887553169082,-0.0268917468892991,-0.0140385548050711,4.39199661346625e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROCR,Endothelial protein C receptor,24111,-0.0157781493883478,0.00253199943862993,-0.0207408682880625,-0.0108154304886331,4.6964627414734e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,REN,Renin,29478,-0.0333723608765384,0.00536015206474184,-0.0438782589234324,-0.0228664628296444,4.84912231334521e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0204207852459803,0.00328065147515494,0.0139907083546766,0.026850862137284,4.90468996978737e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD1,Polycystin-1,24922,0.0116278635453523,0.00187508065454641,0.00795270546244138,0.0153030216282633,5.68928452949584e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLASP1,CLIP-associating protein 1,24016,0.0317097623898394,0.00515370215187883,0.0216085061721569,0.0418110186075219,7.73246910288544e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0152433213293415,0.00248136597231659,0.010379844023601,0.020106798635082,8.21493310655022e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0113438403662732,0.00184690771345771,0.00772390124789608,0.0149637794846503,8.26829261635664e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0334483713596446,0.00545162414638054,0.0227631880327387,0.0441335546865504,8.62139989334022e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTG,Protogenin,29725,0.010782338888376,0.00175770226230574,0.00733724245425673,0.0142274353224952,8.65931235943243e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH6,Cadherin-6,29478,-0.0165705322905378,0.00270520594901932,-0.0218727359506157,-0.0112683286304599,9.15862020433127e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL3,Myosin light chain 3,24240,-0.0316026771873832,0.00516344351030575,-0.0417230264675825,-0.021482327907184,9.47343381202377e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0267235972330134,0.00436732841643138,-0.0352835609292189,-0.0181636335368079,9.53480935796748e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL21,C-C motif chemokine 21,29581,0.0174633594454537,0.00286286618244185,0.0118521417278677,0.0230745771630397,1.07412360550264e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0161232170734902,0.00264329413091862,0.0109423605768897,0.0213040735700907,1.07899132198089e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR4,Complement factor H-related protein 4,24892,0.0314601059885095,0.00516674221426142,0.0213332912485571,0.0415869207284619,1.15307838870263e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE6,Ribonuclease K6,24828,0.0131222613130419,0.00216784658012919,0.00887328201598871,0.0173712406100951,1.44094093428259e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MBL2,Mannose-binding protein C,24610,-0.046163733484382,0.00762772076226546,-0.0611140661784223,-0.0312134007903417,1.45036770645544e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200,OX-2 membrane glycoprotein,29434,-0.01130926561659,0.0018719647054748,-0.0149783164393206,-0.00764021479385941,1.54626544347726e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMB,Granzyme B,29434,0.0277584522167763,0.00460079829086745,0.0187408875666761,0.0367760168668765,1.62462037395808e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0163546529455204,0.00271249484919043,0.0110381630411072,0.0216711428499337,1.66920661096244e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.017357953842922,0.00288251005417355,0.0117082341367418,0.0230076735491021,1.74895165837922e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0136602483290107,0.00227007342107837,-0.0181095922343243,-0.00921090442369705,1.79230089226905e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0116652414559091,0.00194122981407998,0.00786043102031232,0.0154700518915058,1.88603052575118e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB1A1,Uteroglobin,29523,0.0233955075091516,0.00389954584149449,0.0157523976598224,0.0310386173584808,2.0017173283379e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0169256261644992,0.00282152216652628,0.0113954427181077,0.0224558096108907,2.01590270966668e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0286848259329208,0.00480635775379268,-0.0381052871303545,-0.0192643647354872,2.43286476772467e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0227290166238876,0.00381557246190738,0.0152504945985491,0.030207538649226,2.60024208683295e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0110243882210166,0.00185109148150489,-0.0146525275247662,-0.00739624891726701,2.62701377650535e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLFM4,Olfactomedin-4,23498,0.0516460415026777,0.00870684620464629,0.0345806229415709,0.0687114600637844,3.04088419161642e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLGN,Calmegin,24195,0.018763310015417,0.00317316575207702,0.0125439051413461,0.024982714889488,3.4019590655682e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0178653762964897,0.0030259118243611,0.011934589120742,0.0237961634722375,3.58378083272692e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0115090319747676,0.00195117912067316,0.00768472089824816,0.015333343051287,3.70917382102979e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0162373714426161,0.00275301794113089,0.0108414562779995,0.0216332866072327,3.72767643661862e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0148943296977704,0.00253601660272432,0.00992373715643073,0.0198649222391101,4.32260059538806e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0289326270379518,0.00492785549891693,0.0192740302600747,0.038591223815829,4.37218750086997e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOSB,Protein fosB,28774,0.0160402805626758,0.00273557711998942,0.0106785494074965,0.021402011717855,4.57932356524777e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0160596913176376,0.00274152081972193,0.0106863105109826,0.0214330721242925,4.73612517130967e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK8,Kallikrein-8,28443,0.0148838777512729,0.00254121995638312,0.00990308663676198,0.0198646688657838,4.76539205817903e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGBL1,Integrin beta-like protein 1,24938,0.0153915128818956,0.00262983652695005,0.0102370332890735,0.0205459924747177,4.89855835452196e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.019884744039879,0.00340589278441682,-0.0265602938973359,-0.013209194182422,5.32781922754475e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0116234679632393,0.00199418690632304,-0.0155320742996324,-0.0077148616268461,5.65710645190892e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0137893881579769,0.00237150571112186,0.00914123696417804,0.0184375393517757,6.13957017231725e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDI2,Protein DDI1 homolog 2,24381,0.0314234382602409,0.00540916953995075,0.0208214659619375,0.0420254105585444,6.35182022152873e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.0272143897501094,0.00468643914463775,0.0180289690266194,0.0363998104735994,6.42328825468185e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0348860275713953,0.0060129411586883,0.0231006629003663,0.0466713922424244,6.62843837398299e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.0336468627226886,0.00580012119202768,0.0222786251863144,0.0450151002590629,6.65662019246497e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN1,Nectin-1,24229,0.0132516145103471,0.00228477765214063,0.00877345031215147,0.0177297787085427,6.71563266438574e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,F3,Tissue factor,29541,-0.0111662911891972,0.00192755460563904,-0.0149442982162497,-0.00738828416214468,6.98482451083931e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300C,CMRF35-like molecule 6,29694,0.0141094120272883,0.00243881409085141,0.00932933640921955,0.0188894876453571,7.30843435702531e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.0122900619369355,0.00212464316591015,0.00812576133175162,0.0164543625421194,7.35871178263467e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0135500121755631,0.00234410716809477,-0.0181444622250288,-0.00895556212609735,7.54168114022647e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.00990324113151363,0.00171504426794274,-0.0132647278966814,-0.00654175436634586,7.80337494319593e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0283377465258302,0.00491179173449681,0.0187106347262164,0.0379648583254439,8.05481475079754e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAN,Aggrecan core protein,29192,0.0115066481599838,0.00199465558112441,0.00759712322097996,0.0154161730989876,8.06729843154513e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB44,Ras-related protein Rab-44,24793,0.0171501213821943,0.0029729805529942,0.0113230794983257,0.0229771632660629,8.08536612378151e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0348064735443939,0.00603604592193747,-0.0466371235513914,-0.0229758235373965,8.18014092617804e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.0250541132703575,0.0043499188802859,-0.0335799542757178,-0.0165282722649971,8.51299472652401e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00788258321532916,0.00137196333109929,-0.0105716313442838,-0.00519353508637455,9.2728316880145e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNG,Interferon gamma,28931,0.0460984853641321,0.00802982321708988,0.0303600318586359,0.0618369388696283,9.51109438784147e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.0116925541296577,0.00204178170309415,0.00769066199159312,0.0156944462677222,1.0364960910963e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0130054529995681,0.00227312672522363,-0.0174607813810064,-0.00855012461812976,1.06891466727424e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0252942796975144,0.00444444232952632,0.0165831727316428,0.034005386663386,1.27558393797685e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN4,Contactin-4,29443,-0.00965117694493488,0.00169797394400507,-0.0129792058751848,-0.00632314801468494,1.32872185098161e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG1,Arginase-1,29216,0.0207629770465412,0.00365322130697076,0.0136026632848786,0.0279232908082039,1.33244314208239e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPS10,40S ribosomal protein S10,24111,-0.0168065560026445,0.00296361586328519,-0.0226152430946835,-0.0109978689106055,1.43622071461255e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0210436183930314,0.00371106893220694,0.0137699232859058,0.028317313500157,1.43743563283844e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0183288971451745,0.00323231388886553,0.011993561922998,0.0246642323673509,1.43972004051719e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX3,Syntaxin-3,24845,0.015323902608955,0.00270965618826868,0.0100129764799484,0.0206348287379616,1.57288685622061e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNLY,Granulysin,29443,0.0208104876312225,0.00368078873270795,0.0135961417151149,0.02802483354733,1.58379795431558e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.0175936811415793,0.00311274902024606,0.011492693061897,0.0236946692212616,1.60256130622398e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB1,Calbindin,29349,0.0173810860551754,0.00307842550366697,0.0113473720679881,0.0234148000423626,1.65647597911611e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCA2A,Guanylin,29333,-0.0136150739601321,0.00241572236091301,-0.0183498897875216,-0.00888025813274258,1.75615580856356e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0174082135439894,0.0030920764018247,-0.0234686832915658,-0.011347743796413,1.81909945034393e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0245131655362934,0.0043608714997639,0.0159658573967561,0.0330604736758306,1.91424399534465e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA11,Serpin A11,29820,-0.0162234422068591,0.00288827964809549,-0.0218844703171262,-0.0105624140965919,1.96041359361208e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2,Ataxin-2,24101,0.0436769443269049,0.00783068335630781,0.0283288049485416,0.0590250837052682,2.46381559608789e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.0127231663152734,0.00228196262467834,0.00825051957090389,0.017195813059643,2.49396806338201e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS4,Thrombospondin-4,29518,0.0177300422109873,0.00318849035988941,0.0114806011056041,0.0239794833163705,2.71114469679718e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC3,Membrane primary amine oxidase,29594,-0.0118060087767475,0.00212914990728576,-0.0159791425950276,-0.00763287495846742,2.9656395787233e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0154113636517049,0.00278252485331381,-0.0208651123642,-0.00995761493920986,3.0793206824422e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.00976446445481792,0.00176379971683693,-0.0132215118998183,-0.00630741700981754,3.11991876610767e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18BP,Interleukin-18-binding protein,29594,0.0120184839103439,0.00217685045358475,0.00775185702131781,0.01628511079937,3.39821848353294e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGA,Fibrinogen alpha chain,24407,0.0120355085646158,0.00218236176665797,0.00775807950196622,0.0163129376272655,3.5251492040569e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0154595061488915,0.00281172783088941,0.00994851960034824,0.0209704926974347,3.86893486837058e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.040191011156993,0.00731609615669324,0.0258514626898742,0.0545305596241117,3.98003337639091e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.0218539109760176,0.0039824308029958,0.0140483466021458,0.0296594753498894,4.11557475524972e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT2,Angiopoietin-2,29725,-0.0147246537842685,0.002689325276864,-0.019995731326922,-0.0094535762416151,4.40496351321162e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMS1,PMS1 protein homolog 1,24195,0.019552397546419,0.00358611748282009,0.0125236072800916,0.0265811878127463,5.02239182765746e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP9,Fatty acid-binding protein 9,29434,0.0214063834481453,0.00395195287366723,0.0136605558157575,0.029152211080533,6.11984046035339e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN8,Septin-8,24801,0.0122993821363109,0.00227097715670262,0.00784826690917379,0.0167504973634481,6.15485883643952e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0114540732015576,0.00211746968173538,0.0073038326253563,0.015604313777759,6.37680079734912e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD9,COMM domain-containing protein 9,24793,0.0150580967653712,0.00278585559639377,0.00959781979643938,0.020518373734303,6.53348510457572e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN8,Tetraspanin-8,24805,0.0381675820074707,0.00706775028402959,0.0243147914507727,0.0520203725641687,6.71616994255014e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0552701676375571,0.0102439716289675,0.0351919832447807,0.0753483520303335,6.89164711872003e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0142048308553942,0.00263638757175398,0.00903751121475637,0.019372150496032,7.18991030642709e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0166986489589271,0.00309935756674171,0.0106239081281134,0.0227733897897409,7.19936961091316e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0119546620746095,0.00222759702642799,-0.0163207522464084,-0.00758857190281068,8.09672749255132e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0202919366266142,0.00378773094860664,0.0128679839673452,0.0277158892858832,8.51337137368864e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.0129842595074655,0.00242737632355835,-0.0177419171016399,-0.00822660191329114,8.90523724686449e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXTL1,Exostosin-like 1,24111,0.0179854148095153,0.0033627021856717,0.0113945185255987,0.0245763110934318,8.94937540514152e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0191002047988667,0.00357675495255157,0.0120897650918657,0.0261106445058678,9.3716290936574e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL4,Delta-like protein 4,24240,0.0322914148625903,0.00607025158517691,0.0203937217556436,0.0441891079695371,1.04908379471653e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0229389868339867,0.00433100747235648,0.014450212188168,0.0314277614798055,1.19073322610455e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP1,Dipeptidase 1,29163,-0.0181266602676301,0.00342673896984933,-0.0248430686485348,-0.0114102518867254,1.23353415649386e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0260444669892101,0.00492541320962578,-0.0356982768800767,-0.0163906570983436,1.24723361311822e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEG1,Protein LEG1 homolog,23603,-0.026136527781033,0.00494458350659511,-0.0358279114539594,-0.0164451441081066,1.26206714942852e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.00783676887393427,0.00148340993728067,-0.0107442523510044,-0.00492928539686415,1.28223514516688e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0195295604308926,0.00370088272729528,0.0122758302853938,0.0267832905763913,1.32419364683441e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.0137491013740305,0.00260929777091458,-0.0188633250050231,-0.0086348777430379,1.38138690681874e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX18,Sorting nexin-18,24805,0.0165902235770566,0.00314947357258573,0.0104172553747885,0.0227631917793246,1.39358625830995e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0153395369140742,0.00291816688403863,-0.0210591440067899,-0.00961992982135852,1.48020003599359e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.00999944946022461,0.00190257892821447,0.00627039476092425,0.013728504159525,1.48651464563921e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEO1,Neogenin,24867,0.00812805361798181,0.00154797279256527,0.00509402694455388,0.0111620802914097,1.5270746569381e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0284217626775954,0.00541317897539584,0.0178119318858196,0.0390315934693713,1.52998479843331e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHB,Lutropin subunit beta,28797,0.0321949291338322,0.00613698329216357,0.0201664418811916,0.0442234163864727,1.56492357896519e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.0193425150493334,0.00369346817293622,0.0121033174303784,0.0265817126682884,1.64359787501356e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0213058333744518,0.00407717684397472,0.0133145667602613,0.0292970999886422,1.74768219270434e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.0104291412780894,0.00199795520393965,0.00651314907836768,0.0143451334778111,1.80225184483203e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0122530010978019,0.00234903912168581,0.00764888441929774,0.0168571177763061,1.83904151306598e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC16,Mucin-16,29349,0.0694980091741606,0.0133244431711402,0.0433821005587259,0.0956139177895953,1.84238848115189e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0152259674131956,0.00291932255842659,0.00950409519867946,0.0209478396277117,1.84500312814632e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERC2,ERC protein 2,24195,0.0277731902037805,0.0053258090216903,0.0173346045212675,0.0382117758862935,1.85499403837758e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH12,Protocadherin-12,24867,0.00940059682950141,0.00180366208881257,0.00586541913542877,0.012935774523574,1.88358393439649e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO4,Roundabout homolog 4,24240,-0.00661875037942672,0.0012718392119576,-0.00911155523486362,-0.00412594552398983,1.96550534750716e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0138108859241118,0.00266170646106811,-0.0190278305878053,-0.00859394126041834,2.13437451729899e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD109,CD109 antigen,29443,-0.0123135253514953,0.00238072294654302,-0.0169797423267196,-0.00764730837627098,2.32894038059078e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBLN2,Fibulin-2,24938,-0.011438991220515,0.00221777212773811,-0.0157858245908817,-0.00709215785014829,2.51678840376643e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0138230338946598,0.00268489813920742,0.00856063354181324,0.0190854342475063,2.64334044174181e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0375565608534512,0.00729660480059347,0.023255215444288,0.0518579062626144,2.66208788062824e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AREG,Amphiregulin,29349,-0.0165690574980914,0.00322009784225062,-0.0228804492689026,-0.0102576657272802,2.68506717604565e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0176284020474472,0.00343381169314586,0.0108981311288814,0.0243586729660131,2.85832771571699e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.0164623581786413,0.00321333436394479,0.0101642228253095,0.0227604935319731,3.02775206206992e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMH,Granzyme H,28916,0.0276272939067839,0.00539414732048116,0.0170547651586408,0.0381998226549269,3.04709249855844e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHI3L1,Chitinase-3-like protein 1,28935,0.0284359076692678,0.00555457995336134,0.0175489309606795,0.039322884377856,3.08532558011885e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY2,Protein canopy homolog 2,28916,0.0219552213068059,0.00429886703278171,0.0135294419225537,0.030381000691058,3.29023276413082e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99,CD99 antigen,29443,-0.00707375998457674,0.00138775583516924,-0.00979376142150845,-0.00435375854764502,3.46726201956732e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0216203398252357,0.00424454964545078,0.0133010225201522,0.0299396571303193,3.53374283618368e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.0343706413730531,0.00675659576205949,0.0211277136794165,0.0476135690666897,3.66531319717373e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG3,Secretogranin-3,29497,-0.011853417536548,0.00234739644096874,-0.0164543145608467,-0.00725252051224923,4.45367476032646e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIF,Leukemia inhibitory factor,28774,0.0182935348151972,0.00362908180722834,0.0111805344730297,0.0254065351573648,4.66360469268883e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0112551745554539,0.0022465605261083,0.00685191592428162,0.0156584331866262,5.48248019894772e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK2,Protein AHNAK2,24240,0.0105254866459009,0.00210129772473952,0.00640694310541142,0.0146440301863903,5.5086248003165e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0198122882334017,0.00395692610946389,0.0120567130588525,0.0275678634079509,5.5679372955068e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX2,Peroxiredoxin-2,24556,0.0217500057808247,0.00435086621878464,0.0132223079920068,0.0302777035696426,5.8023235342918e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDK2,Protein sidekick-2,24381,0.0136251552394077,0.00273592461621194,0.00826274299163227,0.0189875674871831,6.39883005345547e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0185784590691269,0.00373768983688812,0.0112525869888262,0.0259043311494276,6.72080508985583e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.00943411279785622,0.00189980174975696,0.00571050136833257,0.0131577242273799,6.87847475882266e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS53,Serine protease 53,24845,0.0130870931649482,0.00263803403718646,0.00791654645206277,0.0182576398778337,7.06210006518481e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.00848710167328278,0.00171164546212135,0.00513227656752492,0.0118419267790406,7.14522617010828e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0145464720372371,0.00294850253035797,0.00876740707773543,0.0203255369967387,8.12078514567843e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0120174162410222,0.00243724241080899,0.00724042111583658,0.0167944113662078,8.23644414469266e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL1,Chordin-like protein 1,29536,0.0109378113309931,0.00222266901198307,0.00658138006750623,0.0152942425944799,8.65551236088803e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KEL,Kell blood group glycoprotein,28774,0.0124633376665727,0.0025346069676587,0.00749550800996164,0.0174311673231838,8.82444834892404e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.0100632233649098,0.002048761378645,0.00604765106276563,0.014078795667054,9.0709870173739e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0131395663718015,0.00267861481238324,-0.0183896514040726,-0.00788948133953033,9.386463668957e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0134595529907596,0.00275095480669512,0.00806768156963718,0.018851424411882,9.99968062601938e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.00696410197587656,0.0014276937793296,-0.00976238178336257,-0.00416582216839054,1.07794656903205e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G1B,Phospholipase A2,29787,-0.014806772506637,0.00304027779997213,-0.0207657169945824,-0.0088478280186916,1.12054715758822e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIM,Vimentin,28916,0.0400784471447076,0.00823023616805757,0.0239471842553148,0.0562097100341005,1.12380901530581e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0154404663407763,0.00317164324303389,0.00922404558442984,0.0216568870971227,1.13262972018475e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.0144119054681838,0.002966987783104,-0.0202272015230677,-0.00859660941329998,1.19649150295717e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0134326969065164,0.0027680314817511,0.00800735520228421,0.0188580386107485,1.2236904937381e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.00893597048447404,0.00184299041984639,0.00532370926157512,0.012548231707373,1.24957328371772e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0167561395766091,0.00346864030526842,-0.0235546745749352,-0.00995760457828304,1.36700599317833e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP1,Caspase-1,28774,0.0230908936459307,0.00479530762193048,0.013692090706947,0.0324896965849145,1.47718088222912e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.0123181916085722,0.00257785568910781,0.00726559445792094,0.0173707887592236,1.77683383822046e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.00785683492207774,0.00164461927302115,0.00463338114695629,0.0110802886971992,1.78529299478618e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSM,Oncostatin-M,29293,0.0239336858613901,0.00501118885756157,0.0141117557005695,0.0337556160222108,1.79636848286077e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAFB2,Scaffold attachment factor B2,24867,0.00921343948953962,0.00193738550125831,0.00541616390707334,0.0130107150720059,1.98962288573225e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN5,CCN family member 5,29443,0.0130398690093995,0.0027442077248174,0.00766122186875738,0.0184185161500416,2.02585691520137e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPO,Erythropoietin,29434,0.0252953369041082,0.0053549611161015,0.0147996131165493,0.0357910606916672,2.32637250127863e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.0105144585474265,0.00223380226575791,-0.014892710988312,-0.00613620610654096,2.52544811635385e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR4,Proline-rich protein 4,24203,-0.0231014138164848,0.00492688600757906,-0.0327581103913398,-0.0134447172416299,2.76247447033082e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPTC,Opticin,29349,-0.0149064325691755,0.00318400499241454,-0.021147082354308,-0.008665782784043,2.85831285121756e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI1,Neuroserpin,24329,0.0100790349910122,0.00216009807986973,0.00584524275446753,0.0143128272275569,3.08742993231591e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.00906762706123314,0.00194526570646789,0.00525490627655607,0.0128803478459102,3.1546239338096e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0141115259952823,0.0030323745353254,0.0081680719060445,0.0200549800845201,3.2788004595972e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.0211270687732958,0.00455011034544535,0.012208852496223,0.0300452850503687,3.44855317432075e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.0165709210902386,0.0035761653195101,0.00956163706399884,0.0235802051164784,3.60983814118089e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0148637447463678,0.00321192819412727,-0.0211591240068572,-0.00856836548587832,3.71364355630042e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0190060981994244,0.0041117111019095,0.0109471444396817,0.027065051959167,3.81208903610082e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0218142250033059,0.00472039869180397,0.0125622435673701,0.0310662064392416,3.83322977304027e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD27,CD27 antigen,29566,-0.0135635006600242,0.00293538555082598,-0.0193168563396432,-0.0078101449804053,3.84083071505326e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN1,Prorelaxin H1,24867,-0.0222407576723238,0.00486363126392188,-0.0317734749496107,-0.0127080403950369,4.83406011974426e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0100443007773979,0.00220358324272125,0.00572527762166424,0.0143633239331315,5.18541652426376e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0176546963661586,0.00387753440839706,0.0100547289257003,0.0252546638066168,5.31188648463573e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00565374528501039,0.00124302673388013,0.00321741288660533,0.00809007768341545,5.42783724191197e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA2,Adenosine deaminase 2,29328,-0.0137075442675176,0.00301886310781922,-0.0196245159588432,-0.00779057257619189,5.63090854457657e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00852077751707996,0.00187686698570245,-0.0121994368090568,-0.00484211822510315,5.65457902634274e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.017752199812994,0.00392302303224677,0.0100630746697903,0.0254413249561976,6.0598902812347e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0120286710805872,0.00266125622589355,-0.0172447332833385,-0.00681260887783582,6.21565350547657e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00910430629993697,0.0020207621809542,0.00514361242526674,0.0130650001746072,6.65561388697126e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0586986425669959,0.0130732553868808,0.0330750620087095,0.0843222231252822,7.15013744944712e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPS,Colipase,29400,0.0224419356034566,0.00500302441996763,0.0126360077403201,0.0322478634665932,7.29590594867623e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRELP,Prolargin,29454,0.00735936345174815,0.00164141870505856,0.00414218278983337,0.0105765441136629,7.36924016404806e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0111207316237401,0.00249198908091374,0.0062364330251492,0.0160050302223311,8.12796017585452e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,B2M,Beta-2-microglobulin,24966,0.00978227780545627,0.00219488159670271,0.00548030987591895,0.0140842457349936,8.35311634573301e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.0111540493649337,0.00250817197048287,0.00623803230278723,0.0160700664270801,8.73696678667801e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0141000392618927,0.00317259062586054,0.00788176163520601,0.0203183168885793,8.84875742849862e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.016403086446033,0.00369348028490261,0.00916386508762388,0.0236423078044421,8.98999193193353e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.00845141118233229,0.00190924748946936,0.00470928610297234,0.0121935362616922,9.61526896932501e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.019081445966566,0.00431201911185624,0.0106298885073278,0.0275330034258043,9.67742960876482e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300E,CMRF35-like molecule 2,29642,0.0127124666177329,0.00287332813299157,0.00708074347706939,0.0183441897583963,9.71000094003142e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0221871889618904,0.00503462119160766,0.0123193314263393,0.0320550464974414,1.05288061259386e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC2,Mucin-2,24938,0.0284576378013925,0.00646251499320004,0.0157911084147204,0.0411241671880646,1.06964979825418e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX5,Syntaxin-5,24229,0.0127049620655555,0.00288532226625639,0.00704973042369299,0.018360193707418,1.07069169385046e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDS,Iduronate 2-sulfatase,29786,0.00275180047883355,0.000626991298657699,0.00152289753346447,0.00398070342420264,1.14318451034845e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0323841906900346,0.00738049952220171,0.0179184116265193,0.04684996975355,1.14901413490654e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.0109157339138447,0.00248940792117526,0.00603649438834116,0.0157949734393482,1.16530628417985e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0125074631899791,0.00285505741645257,-0.0181033757262261,-0.00691155065373203,1.18650520562351e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00575544943039169,0.00131846361539807,0.00317126074421147,0.00833963811657191,1.27476218295246e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100G,Protein S100-G,24867,-0.0143064560500741,0.00328015578716987,-0.0207355613929271,-0.00787735070722121,1.29683084528477e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY96,Lymphocyte antigen 96,29218,-0.0109313584276732,0.00251066975522754,-0.0158522711479192,-0.00601044570742724,1.34153927038078e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0123043981260267,0.00282745373462904,0.00676258880615377,0.0178462074458996,1.35586169573925e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDHB15,Protocadherin beta-15,24793,-0.012292165184389,0.00282653657615038,-0.0178321768736437,-0.00675215349513425,1.37403293759514e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0102032481535891,0.00234781096028126,0.00560153867143785,0.0148049576357404,1.39284451183665e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.0178827598942013,0.004115757176805,0.00981587582766354,0.0259496439607391,1.3985994608065e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0198932199888199,0.0045810232546796,0.0109144144096478,0.0288720255679919,1.41419531094682e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0231694026366747,0.00534760496747157,-0.033650708372919,-0.0126880969004304,1.47890089140714e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA4,Carboxypeptidase A4,23902,0.0133878517287483,0.00309947939915102,0.00731287210641234,0.0194628313510843,1.57093930176743e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH3,Cadherin-3,29694,0.0110105255354655,0.00255454129880129,0.00600362458981496,0.016017426481116,1.63648760859669e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.0149357796257956,0.00347349821280739,-0.0217438361228981,-0.00812772312869308,1.71404696632576e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTL1,Cytokine-like protein 1,24938,0.0073299449929686,0.00170517942605188,0.00398779331790691,0.0106720966680303,1.72504750103995e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.0104065654847173,0.0024245253372169,-0.0151586351456624,-0.00565449582377218,1.77596202291907e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.0124096572724514,0.00289263138258064,-0.0180792147823094,-0.00674009976259335,1.79286283543382e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0111364484558267,0.00259690568512663,-0.0162263835986749,-0.00604651331297855,1.8057598726792e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCC1,Regulator of chromosome condensation,24793,0.0155665363234483,0.00363532379242019,0.00844130169030469,0.0226917709565918,1.85899101656091e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD7,T-cell antigen CD7,24177,0.0131942364581967,0.00308303417090313,0.00715148948322653,0.0192369834331668,1.87927114812685e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.0100974793002449,0.00236439254700525,-0.0147316886923752,-0.00546326990811464,1.95521848796549e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0160663837237925,0.00376463474823735,-0.0234450678303377,-0.00868769961724728,1.98240720577799e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0154795681009438,0.00363245325353933,0.00835995972400673,0.0225991764778809,2.03863274156301e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.0180052770628166,0.00422739508832059,-0.026290971435925,-0.00971958268970826,2.0592053323601e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF3,Neurotrophin-3,29434,0.0104157339046135,0.00244987636897053,0.00561397622143129,0.0152174915877958,2.12964979357822e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_DRA,,29322,-0.0107963448232894,0.00255067612589505,-0.0157956700300437,-0.00579701961653509,2.31565081668015e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUK1,Guanylate kinase,24111,-0.0119798106857976,0.00283515722687143,-0.0175367188504656,-0.0064229025211296,2.39341923568195e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0211707642434559,0.00502086639145749,0.0113298661161992,0.0310116623707126,2.48795882146791e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD3,Bromodomain-containing protein 3,24111,0.0141615206501901,0.00338452085556532,0.00752785977328205,0.0207951815270981,2.87182197322434e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.008433305063775,0.00202268565282653,0.00446884118423499,0.012397768943315,3.06351027960119e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPJ,Centromere protein J,24445,0.0211062875417576,0.00507342315870323,0.0111623781506993,0.0310501969328159,3.19101524624616e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17C,Interleukin-17C,28931,-0.0206369274619666,0.00497398394391038,-0.0303859359920309,-0.0108879189319023,3.34923512682141e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST7,Cystatin-F,29498,0.0271168615436057,0.00656123701722914,0.0142568369898366,0.0399768860973748,3.5922132206355e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.015689739777252,0.00381004901047943,0.00822204371671234,0.0231574358377917,3.83462165401603e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0118096818423356,0.00287308641887647,0.00617843246133767,0.0174409312233334,3.9618634275666e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0100638807234607,0.00245279693200848,0.00525639873672406,0.0148713627101973,4.0887104256643e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0140780325525205,0.00344611788718824,0.00732364149363158,0.0208324236114095,4.41795558632037e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.00845825562444447,0.00207419971851581,-0.0125236870727355,-0.00439282417615349,4.56011595637129e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.00858166156928851,0.0021060246345408,0.00445385328558855,0.0127094698529885,4.61715632464108e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF15,Growth/differentiation factor 15,29820,-0.0127580586250837,0.00313352742119391,-0.0188997723706237,-0.00661634487954362,4.68381709746827e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EP300,Histone acetyltransferase p300,24229,0.00868090544584857,0.00213315367725063,0.00449992423843733,0.0128618866532598,4.72600269970228e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG3,Proteoglycan 3,24938,-0.014294755712758,0.00352575685730686,-0.0212052391530794,-0.00738427227243651,5.04202391515332e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0116517512162946,0.00288413863091734,-0.0173046629328926,-0.00599883949969666,5.36302223704256e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.00624916524534856,0.00154719713575193,-0.00928167163142234,-0.00321665885927478,5.38396115468497e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCC,Netrin receptor DCC,24195,0.00652282977690137,0.00161654998486198,0.00335439180657188,0.00969126774723085,5.47628362339188e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0165724398536409,0.00411394881490969,0.00850910017641792,0.0246357795308639,5.63123056727498e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN3,Perilipin-3,29478,0.0120826987409409,0.00300145609109225,0.00619984480240007,0.0179655526794817,5.69693013739879e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0246703837300287,0.00614188244498512,0.0126322941378579,0.0367084733221995,5.91852128677904e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0157922899170534,0.00393851529316952,0.00807279994244109,0.0235117798916656,6.09748898904698e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO3,R-spondin-3,29725,0.00800298724596427,0.00200083843232548,0.00408134391860633,0.0119246305733222,6.35449008899667e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.00657298416275367,0.00164485291449952,0.00334907245033461,0.00979689587517274,6.4552037372676e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0196145395221541,0.00492018232578598,0.00997098216361356,0.0292580968806946,6.72365985584534e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0151390374948426,0.00380818888901251,0.00767498727237808,0.0226030877173071,7.04355008842641e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFLAM,Pikachurin,24805,0.00862817194565088,0.00217470249359653,0.00436575505820169,0.0128905888331001,7.28291872886465e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.00752627050693909,0.00189863533959669,0.00380494524132959,0.0112475957725486,7.38647785188831e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMOD4,Tropomodulin-4,24016,-0.0114825037403207,0.00289679171458971,-0.0171602155009165,-0.00580479197972482,7.39581182673275e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.0119287123741796,0.00300975428790546,0.00602959396988494,0.0178278307784743,7.41146170804101e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.0076057312345227,0.00192139891384618,-0.0113716731056612,-0.00383978936338419,7.56176304259136e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRLB,Fc receptor-like B,28797,0.0170465642154438,0.00432248159486651,0.00857450028950545,0.0255186281413822,8.04244685071031e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0165053595347912,0.00419452295890739,0.00828409453533272,0.0247266245342497,8.34382759324478e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00724026468142868,0.00184046628165803,0.00363295076937895,0.0108475785934784,8.37605932343346e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA1,Ephrin-A1,29390,0.0078299917283898,0.00199370255082856,0.00392233472876581,0.0117376487280138,8.60787635872812e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00922911582770312,0.00236439603087225,-0.0138633320482127,-0.00459489960719351,9.50770967535345e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0142051230801424,0.00365025777848774,0.00705061783430644,0.0213596283259784,9.98343292867812e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF4,Neurotrophin-4,28797,0.0108330013123584,0.00278604971424751,0.00537234387243326,0.0162936587522835,0.000101174720467348
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0248131435116545,0.00638439181842681,0.0122997355475379,0.037326551475771,0.000101958651581247
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE1,Ribonuclease pancreatic,24951,0.00668702183762528,0.0017206360128842,0.00331457525237225,0.0100594684228783,0.000102019035287493
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.0114389217762704,0.00294736662012165,0.00566208320083199,0.0172157603517089,0.000104277951378358
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN4,Nectin-4,29566,-0.00875005387633104,0.00225590729717548,-0.013171632178795,-0.0043284755738671,0.000105230875932111
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.00938008214627105,0.00242638078488121,0.00462437580790388,0.0141357884846382,0.000110930663588476
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00673439059735995,0.00175491988310237,-0.0101740335682406,-0.0032947476264793,0.000124633140270206
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.00728586726766315,0.00190195165745219,0.00355804201905687,0.0110136925162694,0.000128026518237709
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKCQ,Protein kinase C theta type,28931,0.0117840517640957,0.00307802638795548,0.00575112004370297,0.0178169834844884,0.000129227619886316
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0143573341667776,0.00375023704294158,0.00700686956261207,0.0217077987709431,0.000129310925390754
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.0125672367588844,0.00330490825592081,0.00608961657727965,0.0190448569404892,0.00014347574872963
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.0113165003267106,0.00298717357744849,0.00546164011491152,0.0171713605385096,0.000152012643503027
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00926785427357957,0.00244716348180246,-0.0140642946979124,-0.00447141384924675,0.000152723084211568
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0165476634282201,0.00437581814316425,0.00797105986761814,0.025124266988822,0.000156187934240377
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00976997279790657,0.00258365945910754,0.00470600025805579,0.0148339453377573,0.000156293530151028
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00904030768947258,0.00239256969273654,-0.0137297442872362,-0.00435087109170897,0.00015809116725394
NMR metabolomics,X23501.Triglycerides in Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00782039261076791,0.00207833670609454,0.00374685266682261,0.0118939325547132,0.000168408835522088
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0113059043029202,0.0030051683171142,0.00541577440137638,0.017196034204464,0.000168781626003296
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0110278773537456,0.00293618900363825,-0.0167828078008766,-0.00527294690661463,0.00017316407519094
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS4,Galectin-4,29454,0.0144524286622652,0.00384813955575171,0.00691007513299188,0.0219947821915386,0.000173195630350731
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.012839561298319,0.00341938769368178,0.00613756141870266,0.0195415611779352,0.000173729513865784
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN2,Neuroligin-2,24101,-0.0126125329799501,0.00335894313980773,-0.0191960615339733,-0.00602900442592699,0.000173810716309872
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00785107633085006,0.00210121237233375,0.00373270008107592,0.0119694525806242,0.000187065157712139
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL1,Delta-like protein 1,29566,-0.00787863319156532,0.00211001426757127,-0.012014261156005,-0.00374300522712564,0.000188873007558028
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0138285024884953,0.00370359830006129,0.00656944982037512,0.0210875551566154,0.00018897331395062
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,0.0323596212187354,0.0086854535477697,0.0153361322651068,0.049383110172364,0.000195196096435399
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG4,Proteasome assembly chaperone 4,24229,0.0147660272970041,0.00396358319791261,0.00699740422909542,0.0225346503649129,0.000195430048352997
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH3,Neurexophilin-3,24229,0.00795838079485899,0.00213670740519398,0.0037704342806788,0.0121463273090392,0.000196068814075987
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.00888289702237406,0.00238896799124498,-0.0135652742852142,-0.00420051975953389,0.000201023223243825
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYT1,Synaptotagmin-1,24845,0.0103593694893465,0.00279203652052272,0.00488697790912198,0.015831761069571,0.000207442781348849
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDRG1,Protein NDRG1,28774,0.0176734890245911,0.00476383580469431,0.00833637084739022,0.0270106072017919,0.000207708117532776
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0164973781646672,0.00445583868098053,0.00776393434994534,0.025230821979389,0.000213950880295798
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00720500751096802,0.00194902678904499,-0.0110251000174962,-0.00338491500443983,0.000218886508194949
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD9,Enhancer of filamentation 1,24229,0.00869372357441715,0.00235485580822114,0.00407820619030372,0.0133092409585306,0.000223136268318068
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171B,Protein FAM171B,24793,0.00706888071920849,0.00191725251614638,0.00331106578756159,0.0108266956508554,0.000227411242272935
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9orf40,Uncharacterized protein C9orf40,24805,0.0208332134318115,0.00566366937445402,0.00973242145788165,0.0319340054057414,0.000235202477282617
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRAL,GDNF family receptor alpha-like,24025,-0.0162448345727648,0.00442785099927791,-0.0249234225313495,-0.00756624661418011,0.000244232481400686
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.0119747440943665,0.00326433124965313,-0.0183728333436866,-0.00557665484504636,0.00024454510194949
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDN1,Endothelin-1,24240,0.00753908976465464,0.00206222883789136,0.00349712124238758,0.0115810582869217,0.000256926354660268
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00817690486940686,0.0022427673452096,-0.0125727288660177,-0.00378108087279605,0.000267016555193081
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0222994681783547,0.0061369593692593,0.0102710278146065,0.0343279085421029,0.000279942536222971
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP2,Guanylate-binding protein 2,28931,0.0153560658545714,0.00423368714447536,0.00705803905139966,0.0236540926577431,0.000287099615946602
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1A,Lithostathine-1-alpha,29353,-0.0125771881667904,0.00347331359663376,-0.0193848828161926,-0.00576949351738827,0.000293856229829559
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0125794925364143,0.00348312175072807,0.0057525739049873,0.0194064111678413,0.000304882048215712
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.00976154742230224,0.00271778239562439,0.00443469392687844,0.015088400917726,0.000329120471152557
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN2,Transcobalamin-2,29757,-0.00758961034103011,0.00211737381081146,-0.0117396630102206,-0.00343955767183964,0.000338335734963278
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0155353256691315,0.00433851811799035,-0.0240388211803926,-0.00703183015787045,0.000343229866376436
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0154648690384112,0.00436317730766202,0.00691304151539362,0.0240166965614287,0.000394244950130681
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF3,Trefoil factor 3,29426,-0.0115775193707283,0.00326957131321161,-0.017985879144623,-0.00516915959683351,0.000399244614793624
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHISA5,Protein shisa-5,24938,0.00632590133123678,0.00178815067951803,0.00282112599938144,0.00983067666309212,0.000404395528104253
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1,Methionine aminopeptidase 1,28774,0.0074732394699498,0.00211275737879887,0.00333223500750402,0.0116142439323956,0.000405034092810612
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.0244870439316298,0.00693651260797398,0.0108914792200008,0.0380826086432588,0.000416074114875712
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00651817725798725,0.00184760917186124,-0.0101394912348353,-0.00289686328113921,0.000419648119561882
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN2,Contactin-2,29725,0.0110418411683176,0.00314914717676001,0.00486951270186794,0.0172141696347672,0.000455060081470962
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE,Angiotensin-converting enzyme,24951,-0.00648101860513968,0.00184875879247583,-0.0101045858383923,-0.00285745137188705,0.00045637003367083
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACHE,Acetylcholinesterase,24381,0.00816096080827297,0.00233329377973851,0.00358770499998549,0.0127342166165604,0.000470276419774374
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.00786061971480616,0.00225152644026588,0.00344762789188504,0.0122736115377273,0.00048149475416906
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.011305307722537,0.00323841988104431,0.00495800475569016,0.0176526106893839,0.000482085947388621
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN1,Calsyntenin-1,28774,0.0127258675508544,0.00364914256642301,0.00557354812066534,0.0198781869810436,0.000488545546469668
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCG22,Protein PBMUCL2,24111,-0.0136402767702486,0.00392003805180563,-0.0213235513517876,-0.00595700218870958,0.000502996449192254
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00983179452578638,0.00283780795125547,-0.0153938981102471,-0.00426969094132565,0.000531996164208655
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00808007407456624,0.00233870618300229,-0.0126639381932507,-0.00349620995588175,0.000551217999617494
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0150082461733437,0.00435673425937748,-0.0235474453217236,-0.00646904702496386,0.000572373536936554
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.0121692576531191,0.00353376276903076,-0.0190954326804194,-0.00524308262581883,0.000574764572402898
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAVL4,ELAV-like protein 4,24101,0.0205624876577831,0.00598378352340787,0.00883427195190366,0.0322907033636625,0.000590562345913888
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RA,Interleukin-17 receptor A,29443,0.0106090002471057,0.00310942825911207,0.00451452085924604,0.0167034796349654,0.00064602939946204
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.0255087834681088,0.00749300914416313,0.010822485545549,0.0401950813906685,0.000664305844259245
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15,Interleukin-15,29434,0.00785828731280468,0.0023150098199851,0.00332086806563388,0.0123957065599755,0.000688462436374806
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.0114665746378412,0.00338292466714596,-0.0180971069854473,-0.00483604229023517,0.000701209743143344
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB1,Lamin-B1,24756,0.0140337934577314,0.00415227761217407,0.00589532933787024,0.0221722575775926,0.000726553468260813
NMR metabolomics,X23501.Triglycerides in Large VLDL,RYR1,Ryanodine receptor 1,24111,-0.00814182954099369,0.00241220498011945,-0.0128697513020278,-0.00341390777995958,0.000738611585090702
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD70,CD70 antigen,29434,-0.0101763920264008,0.00301692441952262,-0.0160895638886652,-0.00426322016413652,0.000744223837683594
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0166574994375129,0.00494064712348224,0.00697383107548772,0.0263411677995381,0.000748490744931728
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00692124217874689,0.00205942872120047,0.00288476188519398,0.0109577224722998,0.000778489115318752
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMA,Repulsive guidance molecule A,29694,-0.00744656363112214,0.00222088510131607,-0.0117994984297016,-0.00309362883254264,0.000800489572675036
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GL3,Endophilin-A3,24307,0.0198303036741812,0.00592118451860125,0.00822478201772276,0.0314358253306397,0.000812143898915124
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH4,Myosin-4,24111,-0.011042866865721,0.00330134784882132,-0.0175135086494108,-0.00457222508203124,0.00082420867609552
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM1,Myomesin-1,24101,0.0112607708156938,0.00337200428140168,0.00465164242414648,0.0178698992072411,0.000840600499657261
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00683338398877085,0.00204724633441108,-0.0108459868042166,-0.00282078117332513,0.000845592315117498
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELENOP,Selenoprotein P,24966,0.00526924555264233,0.00159753780425914,0.00213807145629442,0.00840041964899025,0.000973894048149189
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.00697153110603974,0.00211405415146759,0.00282798496916326,0.0111150772429162,0.000976149445096226
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX1,Neuronal pentraxin-1,29443,0.00943544026701088,0.00286938479247258,0.00381144607376462,0.0150594344602571,0.00100907286978697
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD5,Sushi domain-containing protein 5,24273,-0.0079624452172427,0.00242394470003746,-0.0127133768293161,-0.00321151360516928,0.00102158775539597
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNXB,Tenascin-X,29443,-0.00598011640943608,0.00182194190729758,-0.00955112254773934,-0.00240911027113282,0.00103092649714506
NMR metabolomics,X23501.Triglycerides in Large VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.0101670339452728,0.00310069075594567,-0.0162443878269263,-0.00408968006361925,0.00104336877616117
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0129507845297001,0.00395596755018555,0.0051970881313364,0.0207044809280638,0.00106281670283803
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0680344085008475,0.0208368631311972,0.0271941567637009,0.108874660237994,0.00109551005213695
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA7A,Semaphorin-7A,29736,0.00636505920904411,0.00195071948002843,0.00254164902818839,0.0101884693898998,0.00110391541775117
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC1,Hamartin,24229,0.0172289136874156,0.00530337100828322,0.00683430651118054,0.0276235208636508,0.00116103028376663
NMR metabolomics,X23501.Triglycerides in Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0109752315981309,0.0033811198183138,-0.0176022264420259,-0.00434823675423582,0.0011718442745777
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLN,Mesothelin,29293,0.0127889300457841,0.00394929708195115,0.00504830776515983,0.0205295523264083,0.00120386619508542
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0134224482217977,0.00414543731710711,-0.0215475053633277,-0.00529739108026782,0.00120582338235856
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAG,S-arrestin,24101,-0.0120670980027571,0.00373222279531923,-0.0193822546815828,-0.0047519413239314,0.00122567950784459
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP1,"Fatty acid-binding protein, liver",29454,0.021417737227056,0.00663168988288872,0.00841962505659409,0.0344158493975179,0.00124097402996068
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0083178358096255,0.00257833015343384,-0.0133713629103558,-0.00326430870889518,0.00125646216229815
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0160579032374327,0.00497766817204265,0.00630167362022914,0.0258141328546363,0.0012570336991864
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.00711936653490499,0.00220812052812761,-0.0114472827700351,-0.00279145029977489,0.0012650391410241
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0154032611653428,0.0048102547694344,0.00597516181725135,0.0248313605134342,0.00136544102958834
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.00756882464351361,0.00237411797672585,0.00291555340913094,0.0122220958778963,0.00143383034112386
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.00897264480109951,0.00282370193617141,0.00343818900620355,0.0145071005959955,0.00148647504952159
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0221226891031312,0.0069658886243356,-0.035775830806829,-0.0084695473994334,0.00149581046265711
NMR metabolomics,X23501.Triglycerides in Large VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00630948724078041,0.00198830069486211,-0.0102065566027101,-0.00241241787885067,0.00150902748488499
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.0064072252941759,0.00202151048488336,0.00244506474380452,0.0103693858445473,0.00152877825686091
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00575199787590352,0.00181576071485,-0.00931088887700952,-0.00219310687479753,0.00153774090353412
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL3,Follistatin-related protein 3,29351,0.00712380930593019,0.00225089258991262,0.00271205982970145,0.0115355587821589,0.00155304356708425
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0106068501566506,0.00335565840026254,0.00402975969213602,0.0171839406211652,0.00157453730782164
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANPEP,Aminopeptidase N,29531,0.00622071003210953,0.00197978552802378,0.00234033039718292,0.0101010896670361,0.00167899049947205
NMR metabolomics,X23501.Triglycerides in Large VLDL,GM2A,Ganglioside GM2 activator,24421,0.00852306476656006,0.00271277187530715,0.00320603189095805,0.0138400976421621,0.00168096857167175
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRXN3,Neurexin-3,24195,0.00783472714058991,0.0024948287028925,0.00294486288292061,0.0127245913982592,0.00168928102087899
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00451495981656295,0.00144450048374893,-0.00734618076471085,-0.00168373886841505,0.00177641325910578
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0095135020138222,0.00304601422687954,0.0035433141291383,0.0154836898985061,0.0017906287108469
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0133885649784878,0.00429163176170131,-0.0218001632314223,-0.0049769667255532,0.00181253352004366
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00668900604756286,0.00214466402691206,0.00248546455481522,0.0108925475403105,0.00181730656698753
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP10,Bone morphogenetic protein 10,24381,-0.0062845639373155,0.00201516586172507,-0.0102342890262966,-0.00233483884833437,0.00181903432896128
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTN,Titin,24111,-0.0147963764680045,0.00474792650972911,-0.0241023124270736,-0.00549044050893546,0.00183296945046844
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3D,Protein FAM3D,24805,0.0185661752149717,0.00596985353995328,0.00686526227666323,0.0302670881532801,0.00187306763902796
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00461430444749865,0.00148431516201449,0.00170504672995025,0.00752356216504705,0.00188086174523121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.00741846680040113,0.00239837371759824,0.00271765431390859,0.0121192792868937,0.00198246928995783
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPN1,Epsin-1,24445,0.00955059951366008,0.00308856100796764,0.00349701993804351,0.0156041790892767,0.00198869918028505
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0139703827910607,0.00452582153232736,-0.0228409929944223,-0.00509977258769908,0.00202539105348304
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.00963231022585969,0.0031267233377517,0.00350393248386635,0.015760687967853,0.00206785403985581
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.00848399697730914,0.00275500497844399,0.00308418721955892,0.0138838067350594,0.00207549453308217
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP2,Dipeptidase 2,29349,-0.00635989637895156,0.00206649947409978,-0.0104102353481871,-0.00230955740971599,0.00208854415502911
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.00467870843577532,0.0015222925997067,-0.00766240193120044,-0.00169501494035019,0.00211819080855707
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK1,Kallikrein-1,29199,-0.0274862755477515,0.00899880718035433,-0.045123937621246,-0.009848613474257,0.00225687753490768
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRTN,Neurturin,28931,0.0105954283070532,0.00349308612168909,0.0037489795085426,0.0174418771055638,0.00242143903064528
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH7B,Myosin-7B,24016,-0.00950419471265926,0.0031361871211523,-0.0156511214701178,-0.00335726795520076,0.00244414408024787
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.0162690319658486,0.00537903989711497,0.00572611376750322,0.0268119501641939,0.00249244734128517
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.0107372467749851,0.0035649398431073,-0.0177245288674754,-0.00374996468249479,0.00259886260019912
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO6,Unconventional myosin-VI,24867,0.00793991640727233,0.00263937507997169,0.00276674125052782,0.0131130915640168,0.0026301455857011
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,0.00977959405164401,0.00325728601263513,0.00339531346687915,0.0161638746364089,0.00268107068397497
NMR metabolomics,X23501.Triglycerides in Large VLDL,GKN1,Gastrokine-1,28114,0.00594914465668821,0.00198495643871416,0.00205863003680845,0.00983965927656797,0.00272785047463139
NMR metabolomics,X23501.Triglycerides in Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00805876129671398,0.00268926536589629,0.00278780117955725,0.0133297214138707,0.00273249392276732
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.009218834942439,0.00307646704120533,-0.0152487103432015,-0.00318895954167655,0.00273271289863698
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.00755006067220747,0.00253332098160863,0.00258475154825455,0.0125153697961604,0.00288243271680187
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH23,Cadherin-23,24845,-0.00558404606699531,0.00187455235276465,-0.00925816867841403,-0.0019099234555766,0.00289594015245863
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFAP,Glial fibrillary acidic protein,28753,0.00971897122486256,0.00326445105037114,0.00332064716613512,0.01611729528359,0.00291122797551264
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0181981846537269,0.00611380341553671,0.00621512995927498,0.0301812393481789,0.00291779973545171
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.00597756843351326,0.00201003669422358,-0.00991724035419148,-0.00203789651283504,0.00294318207063983
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00911086053163902,0.00309916023364501,0.00303650647369479,0.0151852145895832,0.00328753430501751
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00587596357681841,0.00200059159095234,0.00195480405855182,0.00979712309508499,0.00331539705149246
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.00727653972611696,0.00248214055792758,-0.012141535219655,-0.00241154423257889,0.00337525557563993
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARTN,Artemin,28931,0.00926850087224507,0.00316273325436957,0.00306954369368071,0.0154674580508094,0.00338643363680768
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL28,C-C motif chemokine 28,29327,0.0122531472922088,0.00418356211659437,0.00405336554368386,0.0204529290407338,0.00340448705658523
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0110317015791444,0.00377424472146717,0.00363418192506872,0.01842922123322,0.00347117159619479
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.00828694133791178,0.00283748439902488,0.00272547191582303,0.0138484107600005,0.00349757576269615
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPN,Asporin,24922,0.00567414153103297,0.00194442775955047,0.00186306312231404,0.0094852199397519,0.00352424112720105
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBN,Ameloblastin,28931,-0.00586666411065156,0.00202000240096251,-0.00982586881653807,-0.00190745940476505,0.0036837067995815
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI3,Elafin,29014,0.0112815179005582,0.00388822602053456,0.00366059490031044,0.0189024409008059,0.00371711906454424
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00689727140934944,0.00238050822036803,-0.0115630675212708,-0.0022314752974281,0.00376615111549023
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO1,Alpha-enolase,29392,0.0161256648832582,0.00556576599670928,0.00521676352970802,0.0270345662368084,0.00376673846970802
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJP3,Tight junction protein ZO-3,24101,-0.00876038464559646,0.00302779884281495,-0.0146948703775138,-0.00282589891367917,0.00381536894126937
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK11,Kallikrein-11,29296,0.00630037416702893,0.00217818166593366,0.00203113810179896,0.0105696102322589,0.0038247976603994
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.00581021651904717,0.00201605324342562,0.00185875216193295,0.00976168087616138,0.00395474627676563
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAYN,Layilin,29163,-0.00711012120025631,0.00246786149285195,-0.0119471297262461,-0.0022731126742665,0.00396596517230366
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0129802037238838,0.00451479754020107,0.00413120054508968,0.0218292069026779,0.00404282249437441
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00993367210649169,0.00346442037942669,-0.016723936050168,-0.00314340816281538,0.00414295348470129
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0112677405727314,0.00393378530474876,0.0035575213754238,0.018977959770039,0.00418165906371215
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.0102860056728481,0.00359186555957697,-0.017326062169619,-0.00324594917607723,0.00419093042089973
NMR metabolomics,X23501.Triglycerides in Large VLDL,WIF1,Wnt inhibitory factor 1,29725,-0.00686681412460329,0.002403722815637,-0.0115781108432518,-0.00215551740595477,0.00428311570236766
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0258394652297666,0.00905795799043677,-0.0435930628910227,-0.00808586756851058,0.00433820636486764
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTNNA1,Catenin alpha-1,24101,-0.00706228599080055,0.00248320206230333,-0.0119293620329151,-0.00219520994868603,0.00445852239974429
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B4,Protein ATP1B4,24016,-0.00843992328891778,0.00297222623429247,-0.014265486708131,-0.00261435986970453,0.00452085879191873
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0111825607431726,0.00397831467910383,0.00338506397212909,0.0189800575142161,0.00494462613451148
NMR metabolomics,X23501.Triglycerides in Large VLDL,MELTF,Melanotransferrin,24922,0.00586569583103751,0.00209193981284022,0.00176549379787068,0.00996589786420434,0.00505196996873119
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHPK,Sedoheptulokinase,24445,-0.00820154031391901,0.00293313139423505,-0.0139504778466197,-0.00245260278121831,0.00517522306785415
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.00960798053981865,0.0034450638289771,-0.0163603056446138,-0.00285565543502355,0.00529265214663568
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00568870559104629,0.00204165368152177,-0.00969034680682896,-0.00168706437526361,0.00533514965423368
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOC,Myocilin,29443,-0.00897876836782709,0.00322329155958356,-0.0152964198246109,-0.00266111691104332,0.00534645913604165
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0123924917984528,0.00445587837582291,-0.0211260134150657,-0.00365897018183993,0.00542076573004296
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0144376874809187,0.0051951434048877,0.00425520640733876,0.0246201685544986,0.00545487064221263
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTOA,Otoancorin,24101,-0.0105408317788899,0.0037967225533398,-0.0179824079834359,-0.00309925557434393,0.00550242975039209
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0136373810818226,0.00493270006459933,-0.0233054732084373,-0.00396928895520793,0.00570190052564848
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0229766211133885,0.00833643138373663,0.00663721560126466,0.0393160266255123,0.00585192456198346
NMR metabolomics,X23501.Triglycerides in Large VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.0075972108370067,0.00275679886182991,0.00219388506782007,0.0130005366061933,0.00585909666157224
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM25,Transmembrane protein 25,24867,-0.00876352481779504,0.00319245790680698,-0.0150207423151367,-0.00250630732045337,0.00605411949614788
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00918791925694275,0.00335026049442821,0.00262140868786347,0.015754429826022,0.00610266647459574
NMR metabolomics,X23501.Triglycerides in Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0169653377315557,0.0062022245961523,0.00480897752309718,0.0291216979400142,0.0062357303867426
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.0101002008535271,0.00370336169783462,-0.017358789781283,-0.00284161192577128,0.00639002664125182
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0142110254745551,0.00521786870956701,0.00398400280380372,0.0244380481453064,0.00646332182272159
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPS,Calcyphosin,24845,0.0181950684464516,0.00669503156547206,0.00507280657812635,0.0313173303147768,0.00657835624874053
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRAXIN,Draxin,29218,0.00820160076318638,0.00302907352560116,0.00226461665300812,0.0141385848733646,0.00678056017472742
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST6,Cystatin-M,28830,0.0093236518767065,0.00344724072062973,0.00256706006427223,0.0160802436891408,0.00684122381123936
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.00876512983191879,0.00324225718657561,0.00241030574623059,0.015119953917607,0.00686814779217346
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.00518727303391497,0.00192978966702255,-0.00896966078127918,-0.00140488528655077,0.00719218428470065
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.00992873283627314,0.00369401192980065,0.00268846945386387,0.0171689962186824,0.00719750799158428
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO1,R-spondin-1,29218,-0.0066016630211247,0.00247499059108227,-0.0114526445796459,-0.00175068146260345,0.00764944555807004
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0282247679401408,0.0105881521980735,0.00747198963191676,0.0489775462483649,0.00768716785410632
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.00960917897325981,0.00361160562749113,0.0025304319433772,0.0166879260031424,0.00780443781847768
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.00750108316770101,0.00282469451839118,0.0019646819116543,0.0130374844237477,0.00792341377588887
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS5,Transmembrane protease serine 5,29079,-0.00712941725096799,0.00268968287341041,-0.0124011956828524,-0.00185763881908359,0.00803797442248326
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00746174327656596,0.00281545301584855,-0.0129800311876291,-0.0019434553655028,0.00804772416774499
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.00789160104740307,0.00298368096555207,0.00204358635492102,0.0137396157398851,0.00817533274604128
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0157294182905817,0.00596649588547851,0.00403508635504386,0.0274237502261196,0.00838713988092178
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0126792751684953,0.00481623421564499,0.00323945610583113,0.0221190942311595,0.00847835182257387
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00799230969515688,0.00303899674105886,-0.0139487433076323,-0.00203587608268151,0.00854599676678358
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNN,Tenascin-N,24938,0.00805772990632038,0.00307234065272076,0.00203594222698769,0.0140795175856531,0.00872972833614456
NMR metabolomics,X23501.Triglycerides in Large VLDL,MN1,Transcriptional activator MN1,24195,-0.0109342081009992,0.00418719912855896,-0.0191411183929747,-0.0027272978090236,0.00902433891284772
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,0.00708320301009243,0.00271336852642066,0.00176500069830794,0.0124014053218769,0.00904612876332252
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.00504990759411575,0.00194163623328436,-0.0088555146113531,-0.00124430057687841,0.00930394536767918
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,0.00546814177495313,0.0021030946681058,0.00134607622546577,0.0095902073244405,0.00932665934987261
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.00948575651235494,0.00366635407025091,0.00229970253466316,0.0166718104900467,0.00968031542765326
NMR metabolomics,X23501.Triglycerides in Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.0040638778624272,0.00157144794507175,0.000983839890086566,0.00714391583476784,0.0097124192238454
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL2,Chordin-like protein 2,29478,0.00972507754241014,0.00376669319379137,0.00234235888257906,0.0171077962022412,0.00983170315590504
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0110935390620078,0.00431298860850905,0.00264008138933009,0.0195469967346855,0.0101126324269762
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0089610374779434,0.00348658461917253,0.00212733162436524,0.0157947433315216,0.0101713042087373
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00835517449632908,0.00326265146429184,-0.0147499713663411,-0.00196037762631707,0.0104475540001201
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0222687663909625,0.00871074427907832,0.005195707603969,0.039341825177956,0.0105790699609684
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00974423632267533,0.00382224652652983,-0.0172358395146738,-0.00225263313067688,0.0107985958277258
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.0041984997116557,0.00164908985762248,0.000966283590715634,0.00743071583259576,0.0109042315147181
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.00659961766093074,0.00260405619137524,0.00149566752583527,0.0117035677960262,0.0112714609395033
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,-0.00895520354003061,0.00355694425650073,-0.015926814282772,-0.00198359279728917,0.0118197220572758
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00695950583067302,0.00276620783446862,0.00153773847511453,0.0123812731862315,0.0118790983152499
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTO1,Protein LTO1 homolog,28931,0.00728100505787135,0.00290816684407301,0.00158099804348826,0.0129810120722544,0.0122977428289094
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00533268137443297,0.0021318798232109,-0.00951116582792632,-0.00115419692093961,0.0123767789207168
NMR metabolomics,X23501.Triglycerides in Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0163341419976284,0.00654127674891817,0.00351323956974883,0.029155044425508,0.012528442951994
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00566482574543508,0.00227079658089445,0.00121406444688197,0.0101155870439882,0.0126150529596227
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNW1,Interferon omega-1,24111,-0.00634564561052134,0.00254893609167161,-0.0113415603501977,-0.00134973087084499,0.0127980051126123
NMR metabolomics,X23501.Triglycerides in Large VLDL,TG,Thyroglobulin,24793,-0.0196367762269815,0.00788843992332104,-0.0350981184766907,-0.00417543397727225,0.0128056216525685
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0124055761355349,0.00499883496052119,-0.0222032926581564,-0.00260785961291334,0.0130827337310659
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD55,Complement decay-accelerating factor,28490,0.00459878845634253,0.00185556204636807,0.000961886845461111,0.00823569006722395,0.0132037877801295
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0148390146332464,0.00600679335113431,-0.0266123296014696,-0.00306569966502314,0.0135040912861305
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00702440171035323,0.00284523351943323,-0.0126010594084424,-0.0014477440122641,0.0135623566243285
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.0116523933566049,0.00472684174853088,-0.0209170031837254,-0.00238778352948434,0.0137023284043863
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD7,FERM domain-containing protein 7,24195,0.005846261413059,0.00237163976972302,0.00119784746440187,0.0104946753617161,0.013705490243007
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALB,Ras-related protein Ral-B,24229,0.0051187527724029,0.00208895878680018,0.00102439355027455,0.00921311199453125,0.0142773877797517
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.00466845089497176,0.00191285792121405,-0.0084176524205513,-0.000919249369392215,0.0146702236254555
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00661151739595193,0.00271832093268077,-0.0119394264240062,-0.00128360836789761,0.0150143868568669
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00518536794935246,0.00213865468672966,-0.0093771311353426,-0.000993604763362324,0.0153328752441004
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA6C,Semaphorin-6C,24229,0.00448054392307546,0.00185092792354184,0.000852725192933457,0.00810836265321746,0.0154978986994929
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0103994055920758,0.00430313919206312,0.00196525277563207,0.0188335584085195,0.0156679173055248
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00815173925439155,0.00338560094662243,-0.0147875171097715,-0.00151596139901159,0.0160578726990295
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00346422016587424,0.00144061139789464,0.000640621826000754,0.00628781850574773,0.016193760109163
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLMP,CXADR-like membrane protein,29725,0.0035825507285461,0.00149460239700435,0.000653130030417569,0.00651197142667463,0.0165364004824458
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.0100774277665837,0.00420570608894159,0.00183424383225813,0.0183206117009092,0.0165754268971231
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,-0.00809465244127777,0.00339773074625294,-0.0147542047039335,-0.001435100178622,0.0172079194433292
NMR metabolomics,X23501.Triglycerides in Large VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.0072135677511065,0.00304777864960202,-0.0131872139043265,-0.00123992159788654,0.0179491015405756
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.00967271801712284,0.00408695299620388,0.00166229014456323,0.0176831458896825,0.0179538380187628
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.0111088615802894,0.00470782471051962,0.00188152514767091,0.0203361980129078,0.0182996615903759
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI2,Protein-arginine deiminase type-2,28931,0.00940567122151708,0.00398644737570872,0.00159223436512798,0.0172191080779062,0.0183105367176335
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX9,Transcription factor SOX-9,24195,0.00455633224047926,0.00193127401923996,0.00077103516276894,0.00834162931818958,0.0183204831761529
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1B,Protein phosphatase 1B,24229,0.0104059424320203,0.00441666775940196,0.00174927362359246,0.0190626112404482,0.0184777657031018
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSB,Lupus La protein,28774,0.00991462558815342,0.00421214154270811,0.00165882816444553,0.0181704230118613,0.0185882655107166
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP13,Collagenase 3,28774,-0.00544329453883637,0.00231352313952194,-0.00997779989229938,-0.000908789185373358,0.0186385428302324
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK3,Prostate-specific antigen,24938,-0.014745627996219,0.00628308955867462,-0.0270604835312212,-0.0024307724612167,0.0189393712454279
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLNL,Mesothelin-like protein,24195,-0.00624328656735278,0.00266432433512715,-0.011465362264202,-0.00102121087050355,0.0191225387470871
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,-0.00968389012156456,0.00413742803835616,-0.0177932490767426,-0.0015745311663865,0.019261528895631
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0115641298319819,0.0049572714570471,0.00184787777616961,0.0212803818877942,0.0196686348746362
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00714416559306589,0.00306556935435446,-0.0131526815276006,-0.00113564965853114,0.0197904261477586
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00678866605500519,0.00292204576362273,-0.0125158757517057,-0.00106145635830463,0.0201720805196702
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNG,Uracil-DNA glycosylase,24793,0.00562581731503148,0.00243224223962949,0.000858622525357676,0.0103930121047053,0.0207298596397805
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.00540444246064422,0.00234279687974771,0.000812560576338701,0.00999632434494973,0.0210711647997818
NMR metabolomics,X23501.Triglycerides in Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.00814499614431465,0.00353841084600244,0.00120971088614987,0.0150802814024794,0.0213490663275292
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGF,Beta-nerve growth factor,29218,0.00197229764757896,0.000858859109557124,0.000288933792846996,0.00365566150231092,0.021659162341346
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYMP,Thymidine phosphorylase,29301,0.0107519809072186,0.00469153222758289,0.0015565777411561,0.019947384073281,0.0219251425946992
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTTG1,Securin,24445,0.0067014698415971,0.00292448651699445,0.000969476268287969,0.0124334634149062,0.0219428026157473
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00702621473268513,0.00306851727446444,-0.0130405085906354,-0.00101192087473482,0.0220429123360162
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,0.011757994237838,0.00513990039117468,0.00168378947113565,0.0218321990045404,0.0221699279537191
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS2,Thrombospondin-2,29443,-0.00603619480016802,0.00264024104694221,-0.0112110672521747,-0.000861322348161291,0.0222479554392106
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.0105743693522686,0.00462576718884599,0.00150786566213042,0.0196408730424067,0.0222630347088044
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON1,Spondin-1,29497,0.00529443147549257,0.00231786934284085,0.000751407563524508,0.00983745538746062,0.0223680120071901
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERVV_1,,24111,-0.00745497308956888,0.00326380904351682,-0.0138520388148618,-0.00105790736427591,0.0223723876535063
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLI2,Zinc finger protein GLI2,24229,-0.0053586105377996,0.00235831876792472,-0.00998091532293204,-0.00073630575266715,0.0230821727182922
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSN,Gelsolin,24845,-0.00305409681441668,0.00134531438278457,-0.00569091300467444,-0.000417280624158929,0.0232056002015514
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.00621901120742564,0.0027473345632204,0.000834235463513662,0.0116037869513376,0.0236027323851799
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTKN2,Rhotekin-2,24111,-0.00827010871288912,0.00366154097142862,-0.0154467290168892,-0.00109348840888904,0.0239145899702558
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD58,Lymphocyte function-associated antigen 3,29409,-0.0028031121416774,0.00124502463709271,-0.00524336043037911,-0.000362863852975694,0.0243643313192851
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00421496692577053,0.00187521756267714,0.000539540502923336,0.00789039334861773,0.0246029923228775
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00996999008422896,0.00444045783825956,-0.0186732874472177,-0.00126669272124022,0.0247603676750039
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.00908822970740112,0.00405554956492184,0.00113935256015432,0.0170371068546479,0.0250375960863124
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00907332416820026,0.00405155876960603,-0.0170143793566281,-0.00113226897977244,0.025134762601381
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00802224851646206,0.00358427940304819,-0.0150474361464365,-0.000997060886487616,0.0252170790282897
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00669605188475421,0.00299534448831236,0.000825176687661995,0.0125669270818464,0.0253930762605896
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAU,Urokinase-type plasminogen activator,29443,-0.00458052093976566,0.00205296467427551,-0.00860433170134565,-0.000556710178185663,0.0256771234405618
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSPN,Claspin,28719,0.00546601024642167,0.0024538689244614,0.00065642715447733,0.010275593338366,0.0259211288298107
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.00900158379161365,0.0040520242624777,0.00105961623715737,0.0169435513460699,0.0263262076980815
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00618522466730465,0.00278516079442381,0.000726309510233974,0.0116441398243753,0.0263752425062503
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.00978844693837004,0.00441343040851334,0.00113812333768391,0.0184387705390562,0.0265724593862305
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEF,Thyrotroph embryonic factor,24111,0.00669653031088961,0.00303005673702125,0.000757619106327952,0.0126354415154513,0.027112122419276
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0119414771470499,0.0054076792836063,0.00134242575118158,0.0225405285429183,0.0272366292975808
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK15,Kallikrein-15,24754,0.00806094961953666,0.00365580336985368,0.000895575014623447,0.0152263242244499,0.0274651190990333
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00737006905991474,0.00334773977370369,-0.013931639016374,-0.000808499103455505,0.0277096359496831
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.004837992035342,0.00220667333796047,0.000512912292939476,0.00916307177774452,0.0283558021690863
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR4,Toll-like receptor 4,24229,0.00438708156023283,0.00200372362996182,0.000459783245507661,0.008314379874958,0.0285726127245513
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4C,Semaphorin-4C,29349,-0.00434640646515722,0.0019854614060106,-0.00823791082093801,-0.000454902109376436,0.0285962208284167
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0213232254381835,0.00974370943036215,-0.0404208959216933,-0.00222555495467371,0.0286490417850524
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00331088282433306,0.00151452431016386,0.000342415176411892,0.00627935047225423,0.0288185157709397
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUCL3,Mucin-like protein 3,24016,-0.00678508673720906,0.00310396464774807,-0.0128688574467953,-0.000701316027622846,0.0288294747939377
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00518134641429989,0.00237402726498035,-0.00983443985366137,-0.000528252974938409,0.0290796121554519
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL11,Interleukin-11,28931,0.00961083924219536,0.00441076405724258,0.000965741689999909,0.0182559367943908,0.029343345064482
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRC,Chymotrypsin-C,29456,0.00981375829192592,0.0045075671384949,0.000978926700475918,0.0186485898833759,0.0294754970674185
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0148987956628069,0.00686328878737588,0.00144674963955019,0.0283508416860637,0.0299561043278376
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00506320214683251,0.00234325802415469,0.000470416419489311,0.00965598787417571,0.0307241829907242
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0132531289124615,0.00613848090338585,-0.0252845514830978,-0.00122170634182525,0.0308578555925945
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0087437963894132,0.00405031474690118,0.000805179485486885,0.0166824132933395,0.0308759166067832
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD160,CD160 antigen,29786,0.00710751890649959,0.00330865434862172,0.000622556383201027,0.0135924814297982,0.031709090686072
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00343535753440388,0.00160459184049835,0.000290357527027107,0.00658035754178065,0.0322858238894915
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKLR,Pyruvate kinase PKLR,29491,0.00970791332434626,0.00455518665118656,0.00077974748802059,0.0186360791606719,0.0330827347184977
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00720991246191684,0.00339852680744891,-0.0138710250045167,-0.000548799919316977,0.03389140966014
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.00554531178539763,0.00261488104197593,0.000420144943124795,0.0106704786276705,0.0339575555421434
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00631650724640623,0.00298402233588059,-0.0121651910247322,-0.000467823468080268,0.034288761708473
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAC1,Cartilage acidic protein 1,29820,0.00449173622899329,0.00212238451398804,0.000331862581576727,0.00865160987640985,0.0343222051671115
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKAP12,A-kinase anchor protein 12,24381,-0.00321980478432405,0.00152185178134852,-0.00620263427576715,-0.000236975292880951,0.0343791624925399
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.00807741811977978,0.00382506463766827,-0.0155745448096096,-0.000580291429949979,0.0347201365225991
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF9,Fibroblast growth factor 9,23970,0.0060866152994697,0.00288546438774921,0.000431105099481252,0.0117421254994582,0.0349199161080405
NMR metabolomics,X23501.Triglycerides in Large VLDL,REST,RE1-silencing transcription factor,24016,-0.00522634994567192,0.00247945312852361,-0.0100860780775782,-0.000366621813765637,0.0350530967135284
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00558807542717635,0.00266600039481453,0.000362714653339861,0.0108134362010128,0.0360864417971055
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,0.0073786647773072,0.00353660207432531,0.000446924711629586,0.0143104048429848,0.0369552042511118
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.0110315609822948,0.00529688486943611,-0.0214134553263895,-0.000649666638199988,0.0372935986215281
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.00979792792630609,0.00471391593420571,-0.0190372031573493,-0.000558652695262906,0.0376709497673985
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.00754968535963109,0.00363242531109928,-0.0146692389693857,-0.000430131749876496,0.0376814663137437
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX33,Testis-expressed protein 33,24445,-0.00572285429909889,0.00275660957611602,-0.0111258090682863,-0.000319899529911489,0.0378999272998867
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00481009057880228,0.00231715915575814,-0.00935172252408823,-0.000268458633516325,0.0379177806280784
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1,Integrin beta-1,29474,0.00317588810557811,0.00153236883806558,0.000172445182969574,0.00617933102818665,0.0382242483912835
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.00994074898979185,0.00480688337830489,0.000519257568314261,0.0193622404112694,0.038646709392838
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB116,Beta-defensin 116,24101,-0.0112607648004276,0.00545653039535926,-0.0219555643753318,-0.000565965225523445,0.0390547170128155
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPLX2,Complexin-2,24016,-0.00447496313309206,0.00217637480106963,-0.00874065774318854,-0.000209268522995582,0.0397784021254536
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.0046088509653654,0.00224151825217379,0.000215475191104778,0.00900222673962602,0.0397788602531173
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0113595019022715,0.00554609768286522,0.000489150443855668,0.0222298533606873,0.0405497375447538
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO6,Coronin-6,24101,-0.00543305169394084,0.00265657262956173,-0.0106399340478818,-0.000226169339999851,0.0408523180260817
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.00724716748229903,0.00355006761290705,0.000289034961001217,0.0142053000035968,0.0412202524825541
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD4,Sushi domain-containing protein 4,24793,-0.00604219828514461,0.00295992633182598,-0.0118436538955235,-0.000240742674765687,0.0412282094938154
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00875464336354269,0.0043131793019751,-0.0172084747954139,-0.000300811931671493,0.0423936849124026
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00369105501436796,0.00182591966149136,0.0001122524778449,0.00726985755089101,0.043241482159586
NMR metabolomics,X23501.Triglycerides in Large VLDL,MERTK,Tyrosine-protein kinase Mer,29786,-0.00362793160229046,0.00179594949739994,-0.00714799261719434,-0.000107870587386576,0.0433857642728627
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.00501388649060434,0.00248217160382858,0.000148830147100321,0.00987894283410837,0.043398563375629
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNR,Tenascin-R,29218,-0.00600055549766443,0.00297940252601001,-0.0118401844486441,-0.000160926546684811,0.0440173182404244
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNLZ,DNL-type zinc finger protein,24101,-0.0128052910315391,0.00638478921298727,-0.0253194778889942,-0.000291104174084083,0.0449108115548998
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00449865300002902,0.00224693210548981,-0.00890263992678905,-9.4666073268997e-05,0.0452797652913995
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.00446111264284227,0.00223430449929269,8.18758242285911e-05,0.00884034946145595,0.045873131150745
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.00237257268272976,0.00118950795953313,4.11370820448276e-05,0.0047040082834147,0.0460992091318811
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00988092563727006,0.00495856155943779,-0.0195997062937681,-0.000162144980772,0.0463055716749508
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5A,Cytochrome b5,24016,0.010151336362661,0.0051092037460037,0.000137297020493782,0.0201653757048283,0.0469478787944583
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.00412710208748627,0.00207900751233598,5.22473633077433e-05,0.0082019568116648,0.0471392797471123
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00421186536598155,0.0021265731362312,-0.0083799487129947,-4.37820189684024e-05,0.047648846662889
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00904532704645373,0.0045950973017325,-0.0180517177578494,-3.89363350580298e-05,0.0490250370936511
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.00288056933408371,0.00148462486719048,-2.92954056096252e-05,0.00579043407377705,0.0523566875264587
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPA33,Cell surface A33 antigen,29349,0.0183833508959903,0.00951946415813657,-0.000274798853957325,0.037041500645938,0.0534762360792271
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOP56,Nucleolar protein 56,24111,0.0151550480708908,0.00784986662284256,-0.000230690509880675,0.0305407866516622,0.0535427494013941
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00739396359577571,0.00384167596762953,-0.0149236484923296,0.00013572130077816,0.0542822537426194
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.00505925812755686,0.00262978698174979,-9.51243566727255e-05,0.0102136406117865,0.0543875737684412
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.00478018580510503,0.00248511338383027,-9.06364272023046e-05,0.00965100803741236,0.0544235477324973
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36G,Interleukin-36 gamma,24149,0.00923912123750906,0.00480881084011108,-0.000186148009108662,0.0186643904841268,0.0547068935958111
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB118,Beta-defensin 118,24101,0.00781332684129453,0.00407168709721452,-0.000167179869245941,0.015793833551835,0.0550036193301623
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1,DNA topoisomerase 1,24805,0.0153425551462975,0.00800066333568284,-0.000338744991640896,0.0310238552842358,0.0551655647236514
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPE4,NXPE family member 4,24111,-0.00465638639524149,0.00243179096422209,-0.00942269668511679,0.000109923894633817,0.0555302056849257
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,0.00540061597324918,0.0028241799202111,-0.000134776670364564,0.0109360086168629,0.0558508189083206
NMR metabolomics,X23501.Triglycerides in Large VLDL,BEX3,Protein BEX3,24016,-0.00637108055840966,0.00333967359896766,-0.0129168408123863,0.000174679695566956,0.0564424951403163
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00880682012855556,0.00463716834727674,-0.000282029832106857,0.017895670089218,0.0575526082464819
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36A,Interleukin-36 alpha,24229,-0.0078097499694952,0.00411632511835193,-0.015877747201465,0.000258247262474571,0.0578051648409688
NMR metabolomics,X23501.Triglycerides in Large VLDL,WNT9A,Protein Wnt-9a,28931,-0.00386198567130636,0.00203893804849356,-0.00785830424635373,0.000134332903741012,0.0582195520611405
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD177,CD177 antigen,29413,-0.0171046059448619,0.00903830441499814,-0.0348196825982583,0.000610470708534417,0.058439881193453
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR1,Folate receptor alpha,29383,0.0038522181922824,0.00203842189368576,-0.000143088719341687,0.0078475251039065,0.0587939947139859
NMR metabolomics,X23501.Triglycerides in Large VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00684376968507625,0.00362282515171694,-0.0139445069824414,0.000256967612288952,0.0588945164098193
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN15,Tetraspanin-15,24111,-0.00674866510455637,0.00357764752901927,-0.0137608542614341,0.000263524052321401,0.0592609601492591
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC1,Syndecan-1,29478,0.00531831839607533,0.00283617130766141,-0.00024057736694103,0.0108772141590917,0.0607784928002587
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00936190023285186,0.00500654975159947,-0.0191747377459868,0.000450937280283113,0.0615055862176137
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.00589601371580805,0.00315865771046642,-0.0120869828283222,0.000294955396706127,0.0619644924785354
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.006495203698457,0.00348497842573475,-0.0133257614128971,0.000335354015983105,0.0623659011068994
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,0.00354569886573059,0.00190575665877081,-0.000189584185460196,0.00728098191692137,0.0628218758583669
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00389660782039539,0.00209496752204083,-0.00800274416359543,0.000209528522804637,0.0628994767940773
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00357276632011007,0.00192604285053703,-0.000202277666942506,0.00734781030716264,0.0636096031956776
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.0109818761705955,0.00593425659779268,-0.0226130191022691,0.000649266761078206,0.0642408324215761
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,0.00819333767704612,0.00443902042243905,-0.000507142350934421,0.0168938177050267,0.064940257300034
NMR metabolomics,X23501.Triglycerides in Large VLDL,NINJ1,Ninjurin-1,28797,0.00720733487394563,0.00390789253233762,-0.000452134489436099,0.0148668042373274,0.0651493778386215
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00472078223195358,0.00256049838002468,-0.00029779459289479,0.00973935905680195,0.0652392277099986
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELB,Transcription factor RelB,24229,0.00641708780333891,0.00349063745175389,-0.000424561602098724,0.0132587372087765,0.0660199476338175
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0153845278651342,0.00836912537900469,-0.00101895787771497,0.0317880136079834,0.0660381779837135
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD82,CD82 antigen,24445,-0.00539595261097766,0.00294014954669566,-0.0111586457225011,0.000366740500545831,0.0664786311937117
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRC1,Macrophage mannose receptor 1,24951,0.00366252787824021,0.00199915369315536,-0.000255813360344298,0.00758086911682471,0.0669575045021134
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR5,Proline-rich protein 5,24229,0.00614501619999242,0.00336826720358955,-0.000456787519043095,0.0127468199190279,0.0681062030117694
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.00894748599382029,0.00490577521409029,-0.0185628054134373,0.000667833425796675,0.0681843805732439
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00382351246503472,0.00211734514472817,-0.000326484018632485,0.00797350894870193,0.0709591974663162
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAV,Integrin alpha-V,29725,0.00211098761299728,0.00117147336146408,-0.000185100175472316,0.00440707540146688,0.0715565294652832
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLNS1A,Methylosome subunit pICln,24195,0.00424320668684577,0.00237075769081075,-0.000403478387143304,0.00888989176083485,0.0734969108459019
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.00428295804605534,0.00240209211919391,-0.000425142507564731,0.00899105859967541,0.0745947113515276
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFD,Complement factor D,24966,0.00245648300596488,0.0013810332117693,-0.000250342089102944,0.0051633081010327,0.0752964712915497
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM3,Paralemmin-3,24111,0.00928268859259826,0.00522156635740509,-0.000951581467915723,0.0195169586531122,0.0754559899310773
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.00480088600147408,0.00271048657641645,-0.0101134396912503,0.000511667688302157,0.0765336809241505
NMR metabolomics,X23501.Triglycerides in Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00916802707589894,0.00518254698906644,-0.0193258191744692,0.000989765022671294,0.0769032602412036
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS2,Podocin,24229,-0.0129084860216031,0.00730250350935,-0.0272213928999291,0.0014044208567229,0.0771270842144619
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00960966500776527,0.00544660645733537,-0.0202850136641426,0.00106568364861205,0.077687445507846
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00732538722537291,0.00417323126454776,-0.0155049205038865,0.000854146053140692,0.0792160314739745
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.00694414128310791,0.00398635510074207,-0.000869114714346544,0.0147573972805624,0.0815251233174696
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,0.00332042201474538,0.00191746910560171,-0.000437817432233978,0.00707866146172474,0.0833428902577619
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRING1,SREBP regulating gene protein,24016,0.00728190004519303,0.00421031997684819,-0.000970327109429415,0.0155341271998155,0.0837260626042583
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM2,Intercellular adhesion molecule 2,29820,-0.00387802120762786,0.0022469807536864,-0.00828210348485321,0.000526061069597496,0.0843792019041785
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00616041500035491,0.00359427548105309,-0.013205194943219,0.000884364942509148,0.0865504352159834
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBX2,Chromobox protein homolog 2,24111,-0.0048788583821138,0.00284954715087919,-0.010463970797837,0.000706254033609404,0.0868814926751807
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00565003930555907,0.00331074975952422,-0.0121391088342265,0.000839030223108401,0.0879142052983128
NMR metabolomics,X23501.Triglycerides in Large VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00334389882703805,0.00197446938718219,-0.000526061171839046,0.00721385882591515,0.0903602012943903
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRP15,RRP15-like protein,24101,-0.0108470913640882,0.00643566703086779,-0.0234609987445891,0.00176681601641264,0.0919118499664941
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00557250107357213,0.00331364838672052,-0.000922249764400083,0.0120672519115443,0.0926435819381007
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA3,Carbonic anhydrase 3,29761,0.00711821057568099,0.004234543302937,-0.00118149429807553,0.0154179154494375,0.092776014415309
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.00309372004994199,0.00184108334259779,-0.00670224340143366,0.000514803301549679,0.0928940129881243
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00863506836327244,0.00515328569791608,-0.018735508331188,0.00146537160464308,0.0938210668776917
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00486349286971545,0.00291556667848937,-0.0105780035595546,0.000851017820123705,0.0953064181803349
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH22,Cadherin-22,24445,-0.00335840305295949,0.00202007640547205,-0.00731775280768472,0.000600946701765738,0.096422810096258
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00633408273781474,0.00384205285556791,-0.0138645063347278,0.00119634085909835,0.0992385183957585
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0077412434347282,0.00469821944509485,-0.00146726667765771,0.0169497535471141,0.0994277793223924
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX1B,Syntaxin-1B,24195,0.00483427819129788,0.0029443018384287,-0.000936553412022371,0.0106051097946181,0.100621691912643
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00523541642199664,0.00320114344028158,-0.00103882472095527,0.0115096575649485,0.101958670585684
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00408441269723765,0.00249833269323671,-0.000812319381506309,0.00898114477598161,0.102092361922199
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00423262972406041,0.0026255951653439,-0.00937879624813446,0.000913536800013637,0.1069609206417
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.00381440838484572,0.00236682684935975,-0.000824572239899401,0.00845338900959084,0.107059325694475
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTN3,Myeloblastin,28671,-0.00539587469650622,0.00335320061463428,-0.0119681479011894,0.00117639850817697,0.107589872323897
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00365426007962702,0.00227168923003317,-0.000798250811237995,0.00810677097049203,0.107714534074609
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00423936844237015,0.00263681002613017,-0.00940751609358529,0.000928779208844994,0.107899959616596
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A3,Protein S100-A3,24793,0.00504097668872846,0.00313783149408938,-0.00110917303968672,0.0111911264171436,0.108173311126412
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.00733062414189363,0.0045668868083754,-0.0162817222863094,0.00162047400252215,0.108467361428131
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX2,Transcription factor SOX-2,24826,0.00270388464905574,0.00168448308835849,-0.000597702204126895,0.00600547150223837,0.10846874144614
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.00971932496168719,0.00605914860333494,-0.0215952562242237,0.0021566063008493,0.108708426474162
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17A,Interleukin-17A,28879,-0.00480619137422613,0.00301797756616352,-0.0107214274039066,0.00110904465545437,0.111278733245408
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESPL1,Separin,24016,-0.00623441450183147,0.00392164428006962,-0.0139208372907679,0.00145200828710499,0.111905459753864
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0165358343830168,0.0104044395007353,-0.00385686703842444,0.036928535804458,0.112004157707909
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.00471233780198843,0.00296723011014019,-0.0105281088178632,0.00110343321388634,0.112270708424229
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00431040961189783,0.00272107124011183,-0.00102289001872135,0.00964370924251701,0.113187342942232
NMR metabolomics,X23501.Triglycerides in Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.00930228342953763,0.00593735802337532,-0.00233493829627801,0.0209395051553533,0.117189069502445
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDNRB,Endothelin receptor type B,24229,0.00503096719543123,0.00323018753399278,-0.00130020037119463,0.0113621347620571,0.119368553165365
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAPPA,Pappalysin-1,28931,0.0051579586893306,0.00333217208571771,-0.00137309859867612,0.0116890159773373,0.121650849119237
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.0060732550394858,0.00393698751099898,-0.0016432404820722,0.0137897505610438,0.122937044841868
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0099099769054133,0.00645321552978474,-0.00273832553296479,0.0225582793437914,0.124633710090192
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6,Interleukin-6,29349,0.00798527134085728,0.00520076911789208,-0.0022082361302112,0.0181787788119258,0.124695895786919
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF7,Fibroblast growth factor 7,24016,-0.008611829053567,0.00561543728894429,-0.0196180861398978,0.00239442803276381,0.125141512803583
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRNN,Cornulin,28580,0.0072228288750426,0.00472095395348058,-0.00203024087377933,0.0164758986238645,0.126039896812814
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSV,Cathepsin L2,29618,0.00446951044653071,0.00292433233031577,-0.00126218092088821,0.0102012018139496,0.126427255428343
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEB,Nebulin,24111,-0.00405624667635299,0.00268094172335328,-0.00931089245412541,0.00119839910141943,0.13029449312955
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.00456293104636118,0.00301864097566091,-0.0013536052659342,0.0104794673586566,0.130650323119269
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00649122933360478,0.00431253836405373,-0.00196134585994054,0.0149438045271501,0.132285975416855
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00642767362142157,0.0042722885350272,-0.00194601190723175,0.0148013591500749,0.132462665909295
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPO,Lactoperoxidase,28452,-0.00636365216545595,0.0042571639184843,-0.0147076934456852,0.00198038911477328,0.134975072190423
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1A,Interleukin-1 alpha,28931,0.00587158797183848,0.003932584116437,-0.00183627689637804,0.013579452840055,0.13543213030424
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTR,Methionine synthase,24111,0.00688006048549761,0.00461408557081186,-0.00216354723329364,0.0159236682042889,0.135948474828501
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.0029493612902785,0.00198486826923249,-0.000940980517417182,0.00683970309797419,0.137312524147524
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBH,Dopamine beta-hydroxylase,24919,0.0114605565457887,0.00771611972273547,-0.00366303811077279,0.0265841512023502,0.137483757498976
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0130595806995677,0.0088327643565368,-0.00425263743924441,0.0303717988383798,0.1392746871658
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCLRE1C,Protein artemis,24016,-0.00325180776502561,0.00219986532199604,-0.00756354379613786,0.00105992826608663,0.139371408599716
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN2,Prorelaxin H2,24326,0.0118498864604043,0.0080198837102449,-0.00386908561167573,0.0275688585324843,0.13953763650065
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00778713307989358,0.00527146737161715,-0.0181192091282632,0.00254494296847604,0.139628932514484
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEFL,Neurofilament light polypeptide,28674,0.0046763891587642,0.00316631888288579,-0.00152959585169196,0.0108823741692204,0.139708961818047
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00372366816989345,0.00252292324752646,-0.0012212613952584,0.00866859773504531,0.139974635275885
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.0120308822714892,0.00815926144359772,-0.00396127015796229,0.0280230347009408,0.140357993596017
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.0028700976021111,0.00194819253809224,-0.00668855497677189,0.000948359772549692,0.14070490340354
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPE,Coatomer subunit epsilon,28774,0.00491392569453384,0.0033474672114784,-0.00164711003996384,0.0114749614290315,0.14212783198384
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTN,Neuroplastin,28797,0.00845623729119419,0.00576524323881404,-0.00284363945688132,0.0197561140392697,0.142451849427888
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00545791014186844,0.00376031348960272,-0.00191230429775289,0.0128281245814898,0.146667989503447
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.00384621104105287,0.00265518187362015,-0.00135794543124262,0.00905036751334837,0.147468965181467
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF8,SLAM family member 8,28797,0.00547170993055245,0.00378378913914242,-0.00194451678216669,0.0128879366432716,0.148162085650453
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00792673629393073,0.00549017968020667,-0.00283401587927434,0.0186874884671358,0.148807435090566
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL25,Interleukin-25,23913,0.00352320168700216,0.00244676316802258,-0.00127245412232209,0.00831885749632641,0.149896371451838
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00368575472787702,0.00256461606816406,-0.00134089276572454,0.00871240222147858,0.150686460571297
NMR metabolomics,X23501.Triglycerides in Large VLDL,MB,Myoglobin,29820,-0.0052999443497734,0.00370293818368221,-0.0125577031897905,0.00195781449024373,0.152360237133025
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMCH,Pro-MCH,24111,-0.0084651220399651,0.00591792041429213,-0.0200642460519777,0.00313400197204748,0.15260897748989
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.00800209960130463,0.00559609467846916,-0.00296624596849492,0.0189704451711042,0.152743787526875
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSTN,Osteocrin,24195,-0.00422853951987444,0.00295728096759939,-0.0100248102163692,0.00156773117662036,0.152766070928472
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFRC,Transferrin receptor protein 1,29565,-0.00388792366829488,0.00272059552234893,-0.00922029089209879,0.00144444355550902,0.152994450244581
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRND,Prion-like protein doppel,24845,-0.00519864961368006,0.00364206268103182,-0.0123370924685024,0.00193979324114232,0.153479630752008
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGN,Mimecan,29443,-0.0042411627674284,0.00297204645333954,-0.0100663738159739,0.0015840482811171,0.153585414540621
NMR metabolomics,X23501.Triglycerides in Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00494640790972434,0.00346707433262407,-0.0117418736016675,0.00184905778221883,0.153684969001786
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.00578385479911134,0.0040634760888868,-0.00218055833510679,0.0137482679333295,0.154638001026217
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL6,Fc receptor-like protein 6,29434,0.00679648406067536,0.00479557236855521,-0.00260283778169286,0.0161958059030436,0.156422929000437
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,0.00467244521591108,0.00332169542454693,-0.00183807781620091,0.0111829682480231,0.159543572140555
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.00629287587574677,0.0044824150863786,-0.00249265769355528,0.0150784094450488,0.160360681843513
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGN,Secretagogin,28931,-0.0043669541487058,0.00311598746270973,-0.0104742895756169,0.00174038127820527,0.161085149022828
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.00340531565064502,0.00243085790083197,-0.00816979713627569,0.00135916583498564,0.161263459746345
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.0036837451994718,0.00263111251266445,-0.00147323532535052,0.00884072572429412,0.161502687487986
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.00771186411454053,0.00551606953071772,-0.0030996321656662,0.0185233603947473,0.16210208018847
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR3,Folate receptor gamma,29461,-0.0184052198780382,0.0132362439980579,-0.0443482581142317,0.00753781835815521,0.164382504637528
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.0031438789398881,0.00226241704490329,-0.00129045846812234,0.00757821634789855,0.164657639805224
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD48,CD48 antigen,29536,0.00293481279456049,0.00211467426502858,-0.00120994876489552,0.0070795743540165,0.165198656184256
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00392877115376866,0.00283737965831014,-0.00949003528405653,0.00163249297651921,0.166172870388946
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00675966516244663,0.0049055757265732,-0.0163745935865301,0.00285526326163684,0.16822981619092
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.00338717917376688,0.00246074019469458,-0.00821022995536826,0.00143587160783449,0.168681050847071
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00460880349905063,0.00335143251075541,-0.00196000422202997,0.0111776112201312,0.169090231571241
NMR metabolomics,X23501.Triglycerides in Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00558092550778668,0.00405929528482001,-0.00237529325046054,0.0135371442660339,0.169190528472617
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.00671685036798649,0.00489885455954278,-0.0163186053046903,0.00288490456871736,0.170354526565707
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00341190463100099,0.00250238661284006,-0.00149277313016553,0.00831658239216751,0.172748173581323
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY6D,Lymphocyte antigen 6D,29283,0.00369192298354289,0.0027113398850743,-0.00162230319120273,0.00900614915828851,0.173315700927518
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAP1,Antigen peptide transporter 1,24445,-0.0057245128958543,0.00424536681268294,-0.0140454318487129,0.00259640605700425,0.177537699221661
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.00565885433183614,0.00420480206605616,-0.0139002663813062,0.00258255771763394,0.178375143771375
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0250595316464349,0.0186586039906931,-0.0616303954681933,0.0115113321753236,0.179266742542324
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00350620958252736,0.00261290946955894,-0.00862751214286289,0.00161509297780816,0.179647772239317
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMCN2,Hemicentin-2,24343,0.00545513712162015,0.00407331619762117,-0.00252856262571734,0.0134388368689576,0.180505933589143
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAN,Neurocan core protein,29694,0.00352338479113814,0.00263751637280363,-0.00164614729955697,0.00869291688183325,0.181601292819739
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.0047516238108749,0.00356131097048107,-0.0117317933130178,0.00222854569126799,0.182139638385224
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANK2,Ankyrin-2,24111,-0.00679860468783861,0.00510285275010895,-0.0168001960780522,0.00320298670237494,0.182769464975825
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.00565090102229091,0.00424538730932369,-0.0139718601485653,0.00267005810398353,0.183176709227177
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00380721818514225,0.00287435569200201,-0.00182651897118169,0.00944095534146618,0.185331772393263
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00458960263726166,0.00347442404671982,-0.00222026849430918,0.0113994737688325,0.186524616573508
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00222309869580206,0.00168306376791999,-0.00552190368092523,0.00107570628932111,0.186558806587953
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA2,Ephrin type-A receptor 2,28347,0.00292854035381833,0.00222063276803583,-0.0014238998715319,0.00728098057916855,0.187251182241294
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00580286924927386,0.0044303782656174,-0.00288067215133625,0.014486410649884,0.190278993928975
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB2,Integrin beta-2,29274,-0.00265670563495167,0.00202953550571501,-0.00663459522615309,0.00132118395624974,0.190537344198404
NMR metabolomics,X23501.Triglycerides in Large VLDL,JUN,Transcription factor AP-1,28931,0.0046348192685369,0.00354304845867241,-0.00230955571046101,0.0115791942475348,0.190834708715963
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,-0.00423309615023991,0.0032418316954931,-0.0105870862734064,0.00212089397292655,0.191640019719535
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3G,Semaphorin-3G,24381,0.00408018136177531,0.0031256832836589,-0.00204615787419613,0.0102065205977468,0.191778323858213
NMR metabolomics,X23501.Triglycerides in Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00308903523203804,0.00239026199227395,-0.00159587827281889,0.00777394873689498,0.196250854454191
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAL,Galanin peptides,29581,-0.00587033357251502,0.00455146026014579,-0.0147911956824008,0.00305052853737074,0.197140868959957
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00493086379066751,0.00382375957939198,-0.00256370498494078,0.0124254325662758,0.197225310863933
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00289926115798034,0.0022551362394353,-0.00731932818727354,0.00152080587131286,0.198586118551477
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.00295148479552715,0.00229888980391331,-0.00155433922014293,0.00745730881119724,0.199196396997922
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM25,RNA-binding protein 25,24016,-0.00420907894795759,0.00328541052248751,-0.0106484835720331,0.00223032567611792,0.200156006859884
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00754421506339675,0.00589377438185822,-0.0190960128518389,0.00400758272504536,0.200546319046092
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00393806886684799,0.00307770118667574,-0.00209422545903647,0.00997036319273244,0.200715840415717
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDAN1,Codanin-1,24845,0.0020316680917408,0.00159510651962569,-0.00109474068672555,0.00515807687020716,0.20278591982335
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.00248373118063409,0.00195353616381266,-0.00134519970043873,0.0063126620617069,0.203595465785783
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN1,Cerebellin-1,24101,-0.00858103435259513,0.00675439969398129,-0.0218196577527985,0.00465758904760819,0.203941541370769
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00497498401974386,0.00391649071791669,-0.00270133778737285,0.0126513058268606,0.204001911061367
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP7,Retinoid-binding protein 7,24805,0.00539173656504289,0.00425114938225425,-0.00294051622417544,0.0137239893542612,0.20470242760351
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00374482199819368,0.00296175261152665,-0.00206021312039854,0.00954985711678591,0.206100530825667
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00471984963866393,0.00373729616698759,-0.0120449501259596,0.00260525084863174,0.206635431884467
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22,Interleukin-22,24793,-0.00602732077675686,0.00477827428242638,-0.0153927383703126,0.00333809681679884,0.207176221281073
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK12,Kallikrein-12,28797,-0.0123280912959435,0.00978775861146687,-0.0315120981744186,0.00685591558253156,0.207844908090456
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00768404645388108,0.00610823053212545,-0.0042880853890848,0.019656178296847,0.208410147381614
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.00240333466552537,0.00191187435184662,-0.001343939064094,0.00615060839514474,0.208744890312879
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00364006917059778,0.00294398509701447,-0.00941027996074613,0.00213014161955057,0.216306008312313
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00447760823651354,0.00362740075957587,-0.0115873137252822,0.00263209725225516,0.21707160047136
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN4,Alpha-actinin-4,28931,0.00278941622155237,0.00226162034916046,-0.00164335966280213,0.00722219210590688,0.217447525204049
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.00263738646910057,0.00214866414268377,-0.00157399525055961,0.00684876818876075,0.219661730411189
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHH,Sonic hedgehog protein,24229,-0.00372498705489135,0.00303887909246193,-0.00968119007611673,0.00223121596633404,0.220294654778192
NMR metabolomics,X23501.Triglycerides in Large VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00691082822289642,0.0056419653256151,-0.017969080261102,0.00414742381530917,0.220625953050261
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00478048216788304,0.00393442036534567,-0.0124919460839606,0.00293098174819447,0.22436230708591
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN1,Tetraspanin-1,28916,0.00483517401463979,0.00400713601580551,-0.00301881257633901,0.0126891606056186,0.22758036320565
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00297136084543982,0.00248990131534435,-0.00190884573263511,0.00785156742351474,0.232736116614105
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL33,Interleukin-33,28931,0.0032856140460166,0.00275383496990996,-0.00211190249500693,0.00868313058704012,0.232838074609588
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP4,Caspase-4,24445,-0.0141030458766081,0.0119002019338473,-0.0374274416669488,0.00922134991373268,0.235985566216537
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00315358158092947,0.00266136106322284,-0.00836984926484623,0.00206268610298729,0.236046688972501
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00347082876655286,0.00293163277471656,-0.00921682900499732,0.00227517147189159,0.236455007276486
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00415647386955973,0.00351148952991494,-0.011038993348193,0.00272604560907355,0.23655211844233
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00308692540642848,0.00261335600964146,-0.00203525237246878,0.00820910318532575,0.237530143490529
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,0.00490149874238222,0.00415638953422778,-0.00324502474470423,0.0130480222294687,0.238300749653898
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBN2,Fibrillin-2,24195,0.00503151687697386,0.00427357710518362,-0.00334469424918604,0.0134077280031338,0.239065477204587
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB5,Serpin B5,28916,0.00403920345176201,0.00343708727581468,-0.00269748760883475,0.0107758945123588,0.239931550150586
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00264951436637499,0.00225873904529384,-0.00707664289515091,0.00177761416240093,0.240805014606268
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD10,Frizzled-10,24195,0.00498178686696389,0.00425940978328491,-0.00336665630827455,0.0133302300422023,0.242175284095217
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.003204153301507,0.0027409640902707,-0.00216813631542358,0.00857644291843758,0.242419993547641
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL12,Stromal cell-derived factor 1,28931,-0.00328613664532779,0.00282917274549874,-0.00883131522650532,0.00225904193584973,0.245440668287809
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00384510274001479,0.00331845744308735,-0.00265907384843641,0.010349279328466,0.246587063893022
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31,Interleukin-31,24229,-0.00463230896591337,0.00402330867120876,-0.0125179939614825,0.0032533760296558,0.249592229881499
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNNI3,"Troponin I, cardiac muscle",28916,0.00680411288532375,0.00594807291518986,-0.00485411002844838,0.0184623357990959,0.252666755948719
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN5,Contactin-5,29511,-0.00298521676531919,0.00261511394160105,-0.00811084009085724,0.00214040656021886,0.253660968577351
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB7,Integrin beta-7,29725,0.00367678556461862,0.00323518637045512,-0.00266417972147341,0.0100177508507106,0.255757016200189
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00498487088723806,0.00440531613526839,-0.00364954873788799,0.0136192905123641,0.257831240454414
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00724611181505697,0.00640658751109157,-0.0198030233367964,0.00531079970668251,0.258049123993245
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00498633204951746,0.00442610056533553,-0.0136614891575751,0.00368882505854019,0.259933642513775
NMR metabolomics,X23501.Triglycerides in Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00280994579372023,0.00249677322821132,-0.00770362132101441,0.00208372973357395,0.260417683363075
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGM2,Phosphoglucomutase-2,24195,0.0047878460559801,0.00425635976732718,-0.00355461908798117,0.0131303111999414,0.260655824815822
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00352229762280772,0.00313561409279597,-0.00966810124468782,0.00262350599907238,0.261312803345465
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.00634746190556693,0.00567397340483798,-0.0174684497790494,0.00477352596791551,0.263280254228095
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.0036626516142972,0.00327548934603222,-0.0100826107325204,0.00275730750392595,0.26349275194715
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00520630926245914,0.00466035865321581,-0.0143406122227621,0.00392799369784385,0.263942332001656
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00359610094253537,0.00322129803081502,-0.00990984508293281,0.00271764319786207,0.264282834071719
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00493168355734919,0.00442294615068729,-0.0136006580126963,0.00373729089799789,0.264851993463903
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.00205709395046491,0.00185119712451375,-0.00568544031451187,0.00157125241358204,0.266482861114591
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMI,N-myc-interactor,24706,0.00560072500522881,0.00509049554704894,-0.00437664626698711,0.0155780962774447,0.271241870758215
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.00714935468030265,0.00653894083001985,-0.00566696934653625,0.0199656787071415,0.274250784102643
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.00594223940764044,0.00546289532376706,-0.0166495142422239,0.00476503542694299,0.276716615514936
NMR metabolomics,X23501.Triglycerides in Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00371413851088068,0.00341698050006691,-0.0104114202910118,0.00298314326925045,0.277063058337262
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.00544850691097081,0.00502310730418206,-0.00439678340522603,0.0152937972271676,0.278068455700385
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.00829217003443103,0.00765004680712475,-0.00670192170753348,0.0232862617763955,0.278403510106448
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.00233115561942034,0.00216076391856695,-0.00656625289981156,0.00190394166097088,0.28066045070468
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00206605338672391,0.0019251172478632,-0.00170717641908796,0.00583928319253578,0.283187994525959
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC8,Histone deacetylase 8,24229,0.00465267825927126,0.00433654646428197,-0.00384695281072139,0.0131523093292639,0.283326930611094
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00223422666232199,0.0020885098146574,-0.0063277058990505,0.00185925257440651,0.284733184913568
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00252161232045347,0.00235787773291574,-0.00209982803606137,0.00714305267696831,0.284879703142467
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI2B,Protein EVI2B,24016,-0.00309206398304702,0.00290575031044378,-0.00878733459151684,0.0026032066254228,0.287285520260729
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF20,Fibroblast growth factor 20,24229,-0.00329970635262621,0.00310409977728017,-0.00938374191609533,0.00278432921084292,0.287785497249833
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP8,Neutrophil collagenase,29640,0.00542493997639471,0.00511024587660827,-0.0045911419417575,0.0154410218945469,0.288434592348734
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00268557153444235,0.00253646237643114,-0.00765703779224739,0.00228589472336268,0.289705818864907
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.00887565733659757,0.00838362725453556,-0.0253075667554873,0.00755625208229212,0.289749944759311
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCP11,T-complex protein 11 homolog,24445,-0.0044326388696638,0.00419663191002122,-0.0126580374133054,0.00379275967397779,0.290870289169824
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.00336136989003721,0.00319452393803232,-0.00289989702850613,0.00962263680858056,0.292703221374528
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBB,Inhibin beta B chain,24381,0.00383856725905117,0.00366324571207124,-0.00334139433660845,0.0110185288547108,0.294713682314805
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00583831714122819,0.00562373164195675,-0.0168608311594634,0.00518419687700703,0.299207178720515
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALLD,Palladin,24229,-0.00291465033287781,0.00282229487218614,-0.00844634828236264,0.00261704761660702,0.301743611047887
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPT,Microtubule-associated protein tau,28774,0.00384205577241272,0.00373872175684691,-0.00348583887100722,0.0111699504158327,0.304128379057798
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00211305992702848,0.00205776965649206,-0.00192016859969595,0.00614628845375292,0.304491019659804
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00184213186429053,0.00179822182075026,-0.00536664663296105,0.00168238290437999,0.305647928717384
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00410297027069414,0.00401743798359113,-0.0119771487185328,0.00377120817714448,0.307127234534332
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDSN,Corneodesmosin,29676,-0.00311382443508458,0.00306133166689719,-0.00911403450220306,0.0028863856320339,0.309091782953819
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00260518624387639,0.0025751243021383,-0.00244205738831468,0.00765242987606747,0.311703981069858
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,0.00428560639073879,0.0042382887554991,-0.00402143957003945,0.012592652351517,0.311947639911279
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.00365769335934994,0.00365561852365831,-0.0108227056657202,0.00350731894702035,0.317045654510768
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF12,Fibroblast growth factor 12,24229,0.00330675042276342,0.00330907690022029,-0.00317904030166834,0.00979254114719518,0.317660852493752
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00250232527951604,0.00250444035470721,-0.0024063778157101,0.00741102837474218,0.31772927933089
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUOX2,Dual oxidase 2,28916,0.00498840681271884,0.00504093326211392,-0.00489182238102445,0.0148686360064621,0.322387726654876
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00350546044147763,0.00356461134809482,-0.0104920986837435,0.00348117780078822,0.325417381430961
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTF,Ciliary neurotrophic factor,24101,-0.00236355755168829,0.00241233713644117,-0.00709173833911298,0.0023646232357364,0.32720500250522
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF2,Trefoil factor 2,29536,0.00397548173237862,0.00407038847991308,-0.00400247968825102,0.0119534431530083,0.3287338126108
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL2,Podocalyxin-like protein 2,29566,-0.00192159055462371,0.00196979894355825,-0.00578239648399788,0.00193921537475046,0.329307277905496
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00430535121954158,0.00445192857469185,-0.0130311312259376,0.00442042878685444,0.333515846318858
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00191990412703625,0.00198715640404298,-0.001974922424888,0.0058147306789605,0.333975272775774
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGB,Secretogranin-1,29590,-0.00279424612804788,0.00290490584512936,-0.00848786158450142,0.00289936932840567,0.336104728763646
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00427889688706737,0.00445876050769319,-0.00446027370801128,0.013018067482146,0.337235544311218
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00331273730247099,0.00345904457077032,-0.0100924646611808,0.00346699005623884,0.338220596319575
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN1,Neuroligin-1,24195,-0.00463504522405936,0.00483994745355102,-0.0141213422330194,0.00485125178490064,0.338241603807431
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAND5,DAN domain family member 5,24229,-0.00360948645037741,0.00384752160807228,-0.0111506288021991,0.00393165590144425,0.34818549342014
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB5,Integrin beta-5,29566,0.00249233397249607,0.00266029525512156,-0.00272184472754219,0.00770651267253432,0.348836345709224
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00258342798905504,0.00277045623753626,-0.00284666623651602,0.0080135222146261,0.351091715743714
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00523119701858243,0.00564065974153614,-0.0058244960748284,0.0162868901119933,0.35372369140828
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBQLN3,Ubiquilin-3,24111,-0.00330088567571869,0.00356036334290984,-0.010279197827822,0.00367742647638459,0.353873283434798
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH2,Growth hormone variant,28797,0.0108336954994809,0.0116876468654836,-0.0120740923568669,0.0337414833558287,0.353967764744991
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.00313818419599468,0.00339571493777261,-0.00351741708203963,0.009793785474029,0.355410728920172
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00354845381368426,0.00388683733902283,-0.00406974737080049,0.011166654998169,0.361281137869896
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM1,Neural cell adhesion molecule 1,29594,-0.00194283975836189,0.00213129721332576,-0.00612018229648038,0.00223450277975659,0.361999298399902
NMR metabolomics,X23501.Triglycerides in Large VLDL,L1CAM,Neural cell adhesion molecule L1,29566,0.00186189757247985,0.00204382492126415,-0.00214399927319788,0.00586779441815758,0.362309746955385
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00265476658710212,0.00295117401765626,-0.00312953448750415,0.00843906766170838,0.36836187877686
NMR metabolomics,X23501.Triglycerides in Large VLDL,GJA8,Gap junction alpha-8 protein,24016,0.00394098968948455,0.00439929737049084,-0.00468163315667749,0.0125636125356466,0.370356540177517
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00160730366035365,0.00179573574830476,-0.00512694572703098,0.00191233840632368,0.370759961147316
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00448341224319199,0.00505389322801609,-0.0143890429701035,0.00542221848371955,0.375022765568672
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN15,Lipocalin-15,24867,-0.00387443354626737,0.00440025767404495,-0.0124989385873955,0.00475007149486073,0.378596199290006
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00308705687901086,0.00353421623004574,-0.00384000693187879,0.0100141206899005,0.382412025752791
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,-0.00194399974550984,0.00224537016934147,-0.00634492527741913,0.00245692578639945,0.386617233564295
NMR metabolomics,X23501.Triglycerides in Large VLDL,POF1B,Protein POF1B,24229,0.00280687347282244,0.00324238952910743,-0.00354821000422812,0.00916195694987301,0.386673958735689
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXOSC10,Exosome component 10,24111,-0.00371380507284159,0.00429108932904325,-0.0121243401577663,0.00469673001208317,0.386790003632124
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00165440781863783,0.00193637625887065,-0.00214088964874865,0.0054497052860243,0.392899432490844
NMR metabolomics,X23501.Triglycerides in Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00262774489454348,0.00308496109852699,-0.00341877885856942,0.00867426864765637,0.394337948631973
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME3,Nucleoside diphosphate kinase 3,29497,-0.00143493595523589,0.00168722336007748,-0.00474189374098774,0.00187202183051596,0.395069716761341
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEBP1,Heme-binding protein 1,28916,-0.00315698117758223,0.00376272978409432,-0.0105319315544071,0.00421796919924265,0.401468659572993
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLON5,IgLON family member 5,24016,-0.00550714560712308,0.00659979418065954,-0.0184427422012158,0.00742845098696963,0.404040249972435
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.0013226825403616,0.00158599649704877,-0.00178587059385398,0.00443123567457718,0.404301481626984
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBR1,T-box brain protein 1,24195,0.00283847273466151,0.00341767945553928,-0.00386017899819547,0.0095371244675185,0.406249473976031
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVPL,Envoplakin,24445,-0.00198676262222718,0.00239916254201823,-0.0066891212045829,0.00271559596012855,0.407618153623092
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00330457562712168,0.00399315769156558,-0.0111311647025902,0.00452201344834686,0.40792820481182
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN7,Septin-7,24445,0.00307785478267139,0.00372585539900848,-0.00422482179938522,0.010380531364728,0.408766755467727
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRAS,GTPase Hras,24421,0.00564764693799115,0.00696611279910025,-0.00800593414824535,0.0193012280242276,0.417527796342725
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTH3,Cytohesin-3,24016,0.00420168411934546,0.00518664825234317,-0.00596414645524715,0.0143675146939381,0.417892910677757
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00216207519471786,0.00267304466050777,-0.0074012427293131,0.00307709233987737,0.418613043977532
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,-0.00264721245674345,0.00328991964615277,-0.00909545496320289,0.00380103004971598,0.421033148868582
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH17,Protocadherin-17,29478,0.0020441762209358,0.00254287561475527,-0.00293985998398453,0.00702821242585614,0.421470638445196
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4,Interleukin-4,28931,0.00520873120350856,0.00648804203954331,-0.00750783119399633,0.0179252936010134,0.422085263545957
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYAL1,Hyaluronidase-1,29265,0.00130352745505542,0.00162373145531914,-0.00187898619737009,0.00448604110748094,0.422098344908378
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL9,Interleukin-9,24445,-0.00321776753877334,0.00401389910929108,-0.0110850097929839,0.00464947471543718,0.422759593345312
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2,T-cell surface antigen CD2,24111,0.00217492489013839,0.00271767322979593,-0.00315171464026164,0.00750156442053842,0.423551072793593
NMR metabolomics,X23501.Triglycerides in Large VLDL,NENF,Neudesin,24793,0.00618525017278032,0.00776595655723948,-0.00903602467940906,0.0214065250249697,0.425774111225099
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.00221058639960179,0.00280546961608697,-0.00770930684713225,0.00328813404792868,0.430730239278394
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLHL41,Kelch-like protein 41,24867,0.0027604824215839,0.00351356181546132,-0.0041260987367203,0.00964706357988809,0.43207128347209
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM2,Isthmin-2,24938,-0.00243829098533255,0.00310756684795239,-0.00852912200731923,0.00365254003665413,0.432677839980043
NMR metabolomics,X23501.Triglycerides in Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00370871009284459,0.00473877926310219,-0.0129967174485249,0.00557929726283571,0.433852199442373
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00356715514811555,0.0045621690152992,-0.012509006418102,0.00537469612187087,0.434281541497541
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.00565054710178633,0.00729460448052783,-0.00864687768004821,0.0199479718836209,0.438571762751131
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN7,Tetraspanin-7,24101,-0.00515082522286276,0.00665917006110677,-0.018202798542632,0.00790114809690651,0.439237923588255
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,0.00259413554571477,0.0033703158909255,-0.00401168360049922,0.00919995469192876,0.441483450529248
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.00285583414613938,0.00371290647172834,-0.0101331308307269,0.00442146253844817,0.441803473099108
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSMB,Beta-microseminoprotein,29313,0.00377582133975945,0.00491218484163207,-0.0058520609498394,0.0134037036293583,0.442098792707495
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.0031028057447106,0.00404673346275289,-0.0110344033317063,0.00482879184228506,0.443240290440184
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF1,Trefoil factor 1,29319,0.00424260889120509,0.00557168576997743,-0.00667789521795067,0.0151631130003608,0.446389234598588
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSND,Barttin,24016,-0.00181899461592074,0.00239652961378906,-0.00651619265894731,0.00287820342710582,0.447852861754674
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00294489503519904,0.00389277418555445,-0.0105747324388858,0.00468494236848769,0.44935514791412
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC9,Histone deacetylase 9,24101,-0.0034565823734127,0.00458380509682594,-0.0124408403631915,0.00552767561636614,0.450805069764674
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC5D,Netrin receptor UNC5D,24229,-0.00139516379486575,0.00186610358290033,-0.0050527268173504,0.00226239922761889,0.454687787719673
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00375926592827804,0.00504260700798635,-0.0061242438073752,0.0136427756639313,0.455976469296572
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.00148372902996264,0.00199033694893929,-0.00241733138995837,0.00538478944988365,0.455997094670734
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00363879282145234,0.00491682044573637,-0.00599817525219095,0.0132757608950956,0.459264519142707
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.00443712729977491,0.00600113669128929,-0.00732510061515209,0.0161993552147019,0.45968148931189
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2B,Alpha-amylase 2B,27585,-0.0025541400328315,0.00346487716500634,-0.00934529927624393,0.00423701921058093,0.461036385323311
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00174340906570094,0.00236548134282865,-0.00289293436624321,0.00637975249764509,0.461116875211513
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.00164843846047875,0.00225227431298242,-0.00276601919296679,0.00606289611392428,0.464235865776035
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00250289094130159,0.00343751476844868,-0.00423463800485783,0.00924041988746101,0.466552960424205
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENG,Endoglin,29820,-0.000882596833698542,0.00121482367873584,-0.00326365124402078,0.00149845757662369,0.467524175397607
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP15,Matrix metalloproteinase-15,24922,0.00252080641402453,0.00347726360527815,-0.00429463025232065,0.0093362430803697,0.468495837832727
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17F,Interleukin-17F,28931,-0.00392634334158767,0.00541664018716045,-0.0145429581084222,0.00669027142524682,0.468539535804802
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.00372532900673643,0.00517764795349483,-0.00642286098211345,0.0138735189955863,0.47183853811352
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.00245952855660228,0.00344484079056773,-0.00921141650611502,0.00429235939291047,0.475249849438181
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00327795378347873,0.00465479904861371,-0.0124013599187616,0.00584545235180413,0.481309111071703
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF75D,Zinc finger protein 75D,24445,0.00291704572341601,0.0042513074381806,-0.00541551685541795,0.01124960830225,0.492623385310014
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSCA,Prostate stem cell antigen,24805,0.0125324320922896,0.0183241982676046,-0.0233829965122155,0.0484478606967947,0.494027030880715
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00135455994707435,0.00198387970514903,-0.00253384427501774,0.00524296416916644,0.494750124963443
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAGLN3,Transgelin-3,24016,-0.00290455185129788,0.00427422671374904,-0.011282036210246,0.00547293250765024,0.496795830180964
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH17,Cadherin-17,29478,-0.00324793433048332,0.00479388681275233,-0.0126439524834779,0.00614808382251124,0.498084032652818
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00447987183027796,0.00661420721435574,-0.0174437179704152,0.00848397430985929,0.498215514147089
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD1,Glutamate decarboxylase 1,24016,-0.00124632130958181,0.00184031484008773,-0.00485333839615376,0.00236069577699014,0.498264877613755
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00211585866581562,0.00312959911555701,-0.00824987293230736,0.00401815560067613,0.498996511006115
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00241253409690667,0.00362818420411539,-0.00952377513697284,0.0046987069431595,0.506093573396036
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL1,Interferon lambda-1,28774,0.00212530896144266,0.00320210298536352,-0.00415081288986984,0.00840143081275515,0.506873023795984
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00138638878124516,0.0021060725912114,-0.0055142910600195,0.00274151349752917,0.510363295752682
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00275237012963111,0.00420718900028462,-0.00549372031092673,0.010998460570189,0.51298505774573
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.00357711281276671,0.00552224267950368,-0.0072464828390605,0.0144007084645939,0.517143361244182
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00263587206128911,0.00407985365258,-0.00536064109776769,0.0106323852203459,0.518240039144402
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNB2,Ephrin-B2,24195,-0.00262838907708211,0.00408534741013425,-0.0106356700009452,0.00537889184678102,0.519990286656849
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.00191601038217029,0.00300100835847737,-0.00396596600044535,0.00779798676478594,0.523183239730679
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.00310085460423815,0.00486122445478697,-0.0126288545356206,0.00642714532714432,0.523560889797281
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRX,Cone-rod homeobox protein,28916,-0.00480402386903514,0.00757948833256069,-0.0196598210008541,0.0100517732627838,0.526203954656657
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13,Interleukin-13,28931,-0.00215620681293205,0.00340458905151901,-0.00882920135390931,0.0045167877280452,0.526527311684486
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.00203267580438839,0.00320959015467979,-0.00425812089878401,0.00832347250756078,0.526534981430643
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAGE2A,G antigen 2A,24016,0.00284065306830509,0.00449466560543042,-0.00596889151833853,0.0116501976549487,0.527389348681728
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.00169621869878302,0.00268869906160186,-0.00357363146195662,0.00696606885952266,0.528131693844722
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00241829141276155,0.00383891175420565,-0.00510597562548153,0.00994255845100462,0.528738564938228
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR1B,Cornifin-B,24445,0.00380326685621148,0.00605007221513146,-0.00805487468544618,0.0156614083978691,0.529596114176439
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.00159079622112883,0.00258115677467482,-0.00664986349949147,0.00346827105723381,0.537694692851814
NMR metabolomics,X23501.Triglycerides in Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00424559181026232,0.0069412647264284,-0.00935928705353734,0.017850470674062,0.540778243010496
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN4,Prefoldin subunit 4,24016,0.00231470173647149,0.00378578667242623,-0.00510544014148391,0.0097348436144269,0.540928046795792
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00331952230454004,0.00546216085336776,-0.0140253575771409,0.00738631296806078,0.54337189253453
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00240374375322776,0.00401096945525134,-0.0102652438855204,0.00545775637906486,0.548983508998198
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.00251899849666691,0.00421094306967049,-0.00573444991988726,0.0107724469132211,0.549710158927656
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHC1,SHC-transforming protein 1,24016,-0.00493378074593979,0.00825097155513337,-0.0211056849940012,0.0112381235021216,0.549869855622915
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.00329330168828626,0.00553045996544544,-0.0141330032205593,0.00754639984398679,0.551525411002995
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00211208965889643,0.00355036524819312,-0.00484662622756209,0.00907080554535495,0.551920165885329
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.00272740291107652,0.00462410687007541,-0.00633584655427128,0.0117906523764243,0.555314197730588
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171A2,Protein FAM171A2,24867,0.00658559425314023,0.0111953020107084,-0.0153571976878483,0.0285283861941288,0.556372373337926
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAX,Integrin alpha-X,24445,0.00219154574429637,0.00378491020091421,-0.00522687824949547,0.00960996973808821,0.56257976146692
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5L,CD5 antigen-like,24833,-0.0019326187664829,0.00333849611662617,-0.0084760711550702,0.0046108336221044,0.562669308488628
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00212549886199186,0.00367889769979826,-0.00508514062961273,0.00933613835359646,0.563435281988969
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC4A1,Band 3 anion transport protein,24938,0.00190843795051375,0.00330505008272669,-0.00456946021163057,0.00838633611265808,0.563653640220763
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00138346893317876,0.00240606200821443,-0.00609935046927903,0.00333241260292152,0.565301386745598
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABO,Histo-blood group ABO system transferase,24951,-0.00581118338792281,0.0101878124018629,-0.0257792956955741,0.0141569289197285,0.568407895161523
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCLN,Nicalin,28931,-0.00210520321326336,0.00369741485353641,-0.00935213632619473,0.00514172989966801,0.569108371281549
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00350889584274768,0.00617220549671928,-0.0085886269308221,0.0156064186163175,0.569701152342452
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.0010397734827272,0.00183039506671003,-0.00462734781347886,0.00254780084802446,0.569999794381863
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20,Interleukin-20,28931,-0.0019627245145023,0.00346149808444838,-0.00874726076002114,0.00482181173101653,0.570707768013708
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00125270777637042,0.0022117737613875,-0.00308236879594908,0.00558778434868991,0.571138854917908
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNPO1,Transportin-1,24445,0.00140184075887958,0.00250286122579411,-0.00350376724367688,0.00630744876143604,0.575419585213085
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN1,Transcobalamin-1,24546,0.00135030188245504,0.00241402045531736,-0.00338117820996699,0.00608178197487707,0.575922461010549
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGN,Cingulin,24195,0.00156477240061463,0.00282275830559418,-0.00396783387834997,0.00709737867957922,0.579350201007696
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00378685164069047,0.00683387655848412,-0.00960754641393841,0.0171812496953194,0.57949546273382
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTNL10,Butyrophilin-like protein 10,24016,-0.00158955858359492,0.0028922441618794,-0.00725835714087853,0.0040792399736887,0.582603333437755
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOS,Proto-oncogene c-Fos,23970,-0.00137769242580903,0.0025099723285148,-0.00629723818969805,0.00354185333807998,0.583087775479898
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,-0.00229322497912176,0.00419860673977767,-0.010522494189086,0.00593604423084248,0.584941500817576
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.00213117683021225,0.00393923752035089,-0.00985208237009999,0.0055897287096755,0.588503971811239
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2A,Pancreatic alpha-amylase,28334,-0.00182881689560641,0.00338324955266083,-0.00845998601882165,0.00480235222760882,0.588821764966177
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00280092477962309,0.00521004014030151,-0.00741075389536787,0.0130126034546141,0.59085724247491
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.00185331276202476,0.00360838328720782,-0.00521911848090257,0.0089257440049521,0.607526496322353
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,-0.00152584687199197,0.0029849180754952,-0.00737628629996256,0.00432459255597863,0.60922498219374
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00176150333758505,0.00345871657434146,-0.00501758114812421,0.00854058782329431,0.610550856732321
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL2,Interferon lambda-2,24101,0.00222534069866459,0.00437746373955744,-0.006354488230868,0.0108051696281972,0.611203435457965
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00130096497957652,0.00256489803204801,-0.00372623516323757,0.00632816512239062,0.612005800225763
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.00193693909902965,0.00384898334279399,-0.00948094645090588,0.00560706825284658,0.614804373948033
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00259171019689277,0.00519297083163489,-0.0127699330268971,0.0075865126331116,0.617727206401139
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.00141675480585395,0.00286239540608878,-0.00702704980178796,0.00419354019008005,0.6206369372434
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.00203684876636908,0.00411918283506985,-0.00603674959036783,0.010110447123106,0.62097176361411
NMR metabolomics,X23501.Triglycerides in Large VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00292687962017738,0.00593627261827563,-0.00870821471164285,0.0145619739519976,0.62198170510102
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP9,Matrix metalloproteinase-9,29411,0.00209550384426294,0.00427046987054637,-0.00627461710200796,0.0104656247905338,0.623644913311859
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFL4,Insulin growth factor-like family member 4,24229,0.0025969061795996,0.00532570793671831,-0.00784148137636828,0.0130352937355675,0.625825506163585
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLLT1,Protein ENL,24016,-0.00235781196888983,0.00489200898375464,-0.0119461495770489,0.00723052563926926,0.629830142431573
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00169804749796233,0.00352759750124927,-0.00521604360448624,0.0086121386004109,0.630264393892366
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00158692332566249,0.00331033005297277,-0.00490132357816414,0.00807517022948912,0.631668164050572
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00154496434914211,0.00333278170506227,-0.00498728779277995,0.00807721649106416,0.642962871097317
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKIV2L,Helicase SKI2W,24111,-0.00130595376415783,0.00283172856300818,-0.00685614174765387,0.00424423421933821,0.644669278189661
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXK,Tyrosine-protein kinase TXK,24445,-0.00242947179812346,0.00526905939857538,-0.0127568282193312,0.00789788462308427,0.644743423394623
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,0.00220177747781352,0.00478705773624765,-0.00718085568523188,0.0115844106408589,0.64555997294309
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3A,Uroplakin-3a,24101,-0.00159753637790795,0.00348236059533452,-0.00842296314476361,0.00522789038894771,0.646417130724662
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB2,Beta-crystallin B2,24845,0.00220995689042203,0.00488900429789037,-0.0073724915334431,0.0117924053142872,0.651254224969493
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,-0.00182999962292674,0.0040646940588219,-0.00979679997821766,0.00613680073236418,0.652556331813948
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX101,Testis-expressed protein 101,24195,0.00160764516352125,0.00358178810027929,-0.00541265951302617,0.00862794984006865,0.653552031418699
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGR,Progesterone receptor,24229,-0.00322667493372374,0.00719709322899655,-0.017332977662557,0.0108796277951095,0.653918850774369
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA3,GDNF family receptor alpha-3,29157,-0.000867542632489221,0.00198911678267047,-0.00476621152652334,0.00303112626154489,0.662735018072728
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,0.00154584797159385,0.00355381926939945,-0.00541963779642906,0.00851133373961677,0.663579260813537
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.0012955585332415,0.0029911290067709,-0.00456705432002947,0.00715817138651246,0.664920849640744
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORN4,MORN repeat-containing protein 4,24016,0.00232773682146822,0.00554893959029892,-0.00854818477551766,0.0132036584184541,0.674860215635128
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCL2,Phosducin-like protein 2,24016,0.00155633731003821,0.00375193494804992,-0.00579745518813963,0.00891012980821605,0.678285257235388
NMR metabolomics,X23501.Triglycerides in Large VLDL,THY1,Thy-1 membrane glycoprotein,29694,-0.000827716230279696,0.00201564175147526,-0.0047783740631712,0.00312294160261181,0.681334726249006
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00119042052891659,0.00290168517247385,-0.00449688240913216,0.00687772346696534,0.681625105206006
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00142868908744523,0.00349492428811295,-0.00827874069214661,0.00542136251725614,0.68269763889338
NMR metabolomics,X23501.Triglycerides in Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00322138459820343,0.0080149536748675,-0.0189306938009437,0.0124879246045369,0.687745143960395
NMR metabolomics,X23501.Triglycerides in Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,-0.000973332687784405,0.00243401597215474,-0.0057440039932077,0.00379733861763889,0.689242893527022
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2,Interleukin-2,28931,0.000890878350983696,0.00223150408848271,-0.00348286966244241,0.00526462636440981,0.689728347828291
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.000606089140293991,0.00153302680813245,-0.00239864340364561,0.00361082168423359,0.692584721163395
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPGN,Epigen,24793,-0.00133991657277332,0.00339110974496415,-0.00798649167290305,0.00530665852735642,0.692753097418053
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.00182910080003762,0.00468160494440601,-0.0110050464910734,0.00734684489099816,0.696022761082243
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.000749017914461925,0.00194820740017706,-0.00306946858988512,0.00456750441880897,0.70063646047372
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.0017053920257676,0.00449709521185511,-0.0105196986410036,0.00710891458946842,0.704526625752195
NMR metabolomics,X23501.Triglycerides in Large VLDL,TET2,Methylcytosine dioxygenase TET2,24421,-0.00269052193658926,0.00709640765727181,-0.016599480944842,0.0112184370716635,0.704588255190791
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPEP,Glutamyl aminopeptidase,24111,-0.00118185013566542,0.00315024287710231,-0.00735632617478595,0.00499262590345511,0.707543593906066
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR1,Toll-like receptor 1,24229,0.000695161535465913,0.00186475306041596,-0.00295975446294936,0.00435007753388119,0.709307912281578
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL3A1,Collagen alpha-1(III) chain,24938,0.000606524098702189,0.00164654695013125,-0.00262070792355507,0.00383375612095945,0.712607012966518
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.000948436876241932,0.00259139966182338,-0.00602758021341576,0.0041307064609319,0.714372711736052
NMR metabolomics,X23501.Triglycerides in Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.00170111295995118,0.0047370111115809,-0.0109856547386498,0.00758342881874739,0.719515130659986
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.00100816180357891,0.00285041213823752,-0.00659496959452444,0.00457864598736663,0.723574354327807
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.000766121339728048,0.00226949153567761,-0.00521432474965617,0.00368208207020007,0.735687078129749
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,-0.000766246317526893,0.00228861842420372,-0.00525193842896618,0.00371944579391239,0.737773299901603
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL5A1,Collagen alpha-1(V) chain,24381,0.000952345335443373,0.00285344414068514,-0.0046404051802995,0.00654509585118625,0.738568878874686
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.000959315929388299,0.00290235136927632,-0.00472929275439329,0.00664792461316989,0.741001401019461
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10,Interleukin-10,28931,-0.00186986853761389,0.00578220622345682,-0.0132029927355893,0.00946325566036148,0.746407365174893
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00111221541729291,0.00345362085146573,-0.00788131228616573,0.00565688145157991,0.747422704901378
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASN,Vasorin,29065,0.000623914883089391,0.00194099375113388,-0.00318043286913301,0.0044282626353118,0.74787856413628
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF6,Fibroblast growth factor 6,24229,-0.000933003324000277,0.00291098271598212,-0.00663852944732523,0.00477252279932468,0.748583409091258
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA2,Protein disulfide-isomerase A2,24016,-0.000910271153065183,0.00288426739309005,-0.00656343524352169,0.00474289293739132,0.752309838635067
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00072756206991168,0.0023089639757725,-0.00379800732260242,0.00525313146242578,0.752685983860875
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,0.000329028478299263,0.00104638038854895,-0.00172187708325667,0.0023799340398552,0.753186158394278
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHDC3L,KH domain-containing protein 3,24016,-0.00149452432895694,0.00477980376078495,-0.0108629397000954,0.00787389104218156,0.754530436514226
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROK1,Prokineticin-1,29434,0.00134456183769127,0.00433438777108495,-0.00715083819363523,0.00983996186901777,0.756404971282926
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00164011766928797,0.00541616941654383,-0.0122558097257139,0.00897557438713794,0.762030533071003
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRV1,Acrosomal protein SP-10,24229,0.00164206580081255,0.00542688039198667,-0.00899461976748131,0.0122787513691064,0.76221251043148
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00135857370721192,0.0045126435038576,-0.00748620756034898,0.0102033549747728,0.763371814010387
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSG1,Tryptase gamma,24229,0.000567980899238744,0.00189020867330886,-0.00313682810044663,0.00427278989892412,0.763809192174809
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.00129830442559718,0.00446273114363275,-0.0100452574671174,0.007448648615923,0.771113457561886
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,-0.000661942175314452,0.00230184661979108,-0.00517356155010496,0.00384967719947606,0.773678337158168
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.000956990276461167,0.00336057625372371,-0.00754371973375963,0.00562973918083729,0.775822641219106
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A14,Zinc transporter ZIP14,28774,-0.000669188976626526,0.00236831162135704,-0.00531107975448632,0.00397270180123327,0.777516553888526
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53BP1,TP53-binding protein 1,24229,-0.00173874874869696,0.00617813613880767,-0.01384789558076,0.0103703980833661,0.778378559936902
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELL,L-selectin,24966,0.000460571315766447,0.00163851673980693,-0.00275092149425513,0.00367206412578803,0.778643399548129
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKZF2,Zinc finger protein Helios,28797,-0.00178303811288223,0.00645280494392459,-0.0144305358029744,0.01086445957721,0.782304392823124
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMMR,Hyaluronan mediated motility receptor,23975,0.000939247113577709,0.00342650630363712,-0.00577670524155105,0.00765519946870647,0.784000776632646
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.000719578797336036,0.00265909925283728,-0.00449225573822502,0.0059314133328971,0.786693310698441
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMA1,Proteasome subunit alpha type-1,28797,0.000873257704247776,0.00327423956346147,-0.00554425184013671,0.00729076724863226,0.789697828462813
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBZ,Hemoglobin subunit zeta,24922,0.00198756746338637,0.00748112660726433,-0.0126754406868517,0.0166505756136245,0.79048974576572
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF830,Zinc finger protein 830,24793,-0.00147696492062807,0.00559955778195424,-0.0124520981732584,0.00949816833200223,0.791963534531686
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.00116417059411614,0.00447589039832113,-0.00760857458659328,0.00993691577482556,0.794790333537246
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC1A4,Neutral amino acid transporter A,24195,0.000948867515312405,0.00365368777964876,-0.00621236053279917,0.00811009556342398,0.7950963903521
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00115627579429313,0.0044811275481453,-0.00762673420007165,0.00993928578865791,0.796384166331849
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,-0.000808733417264028,0.00315286780449969,-0.00698835431408342,0.00537088747955537,0.797561320543347
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA10,Annexin A10,28774,0.00148646693918072,0.00579975847831781,-0.00988105967832219,0.0128539935566836,0.797722515953714
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.000674156309857188,0.00265323395567288,-0.00452618224326165,0.00587449486297603,0.799429334002845
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.000825777378098644,0.00329269571485567,-0.00562790622301848,0.00727946097921577,0.801978025368379
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.000859128988898602,0.00344746197532977,-0.00589789648274774,0.00761615446054495,0.803203034394105
NMR metabolomics,X23501.Triglycerides in Large VLDL,HK2,Hexokinase-2,28916,-0.000482512069323112,0.00193864555508161,-0.00428225735728307,0.00331723321863685,0.803446611005288
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR2,Toll-like receptor 2,24445,-0.000380993121736809,0.00162669559154933,-0.0035693164811735,0.00280733023769988,0.814821649116294
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI16,Peptidase inhibitor 16,24951,0.000400592792451313,0.00173272539085299,-0.00299554897362055,0.00379673455852318,0.817167297670402
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHIT1,Chitotriosidase-1,29579,0.00246151282647937,0.010760617266328,-0.0186292970155236,0.0235523226684823,0.819063250552306
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,-0.000907145454354827,0.00408389716568027,-0.00891158389908816,0.0070972929903785,0.824216582699174
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,-0.000924582945791715,0.0041673288294868,-0.00909254745158584,0.00724338156000241,0.824421132010984
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.000397808117638197,0.00183147398793242,-0.00398749713398574,0.00319188089870935,0.828049169564813
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00249569555981063,0.0121850958180863,-0.0263784833632598,0.0213870922436385,0.837718017736586
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5,Interleukin-5,28931,0.00205093053947505,0.0100456098662284,-0.0176384647983327,0.0217403258772828,0.838228440429226
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD2,Bromodomain-containing protein 2,24101,-0.000488550015955258,0.0024533952335155,-0.00529720467364564,0.00432010464173512,0.842161006257441
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.000602821768893529,0.00315824882374541,-0.00679298946343453,0.00558734592564747,0.84862733973585
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL24,Interleukin-24,28931,-0.00065738783129035,0.00344458454185152,-0.00740877353331932,0.00609399787073862,0.848646985263765
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00039216796634346,0.00208575429788551,-0.00369591045751214,0.00448024639019906,0.850860598971171
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.00111746882027093,0.00610436393579986,-0.0130820221344387,0.0108470844938968,0.854751972069275
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHD,SH2 domain-containing adapter protein D,24059,0.00109449559428387,0.00602886346587929,-0.0107220767988395,0.0129110679874073,0.855943222954984
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP73,Tumor protein p73,24195,0.000443115668337547,0.00244591882330601,-0.00435088522534223,0.00523711656201733,0.856239332489575
NMR metabolomics,X23501.Triglycerides in Large VLDL,RUVBL1,RuvB-like 1,28797,0.00131572793225504,0.00730736808080443,-0.0130067135061216,0.0156381693706317,0.857110681939335
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.000500729537687308,0.00281384937972643,-0.00601587432195112,0.0050144152465765,0.858762332109918
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.000740744527694241,0.00419640971645026,-0.00748421851654827,0.00896570757193675,0.859887725151757
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSD1,Tryptase delta,24867,-0.000465584087940736,0.00264279371494849,-0.00564545976923978,0.00471429159335831,0.860160896859234
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.000680979452909754,0.00387156470465672,-0.00690728736821742,0.00826924627403693,0.860379781883102
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL19,Interleukin-19,28654,-0.000871830838874204,0.00497187242226398,-0.0106167007865116,0.00887303910876319,0.860803809709569
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,0.000512969313128269,0.00298560139483334,-0.00533880942074507,0.00636474804700161,0.863584879839544
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP350,Centrosome-associated protein 350,24016,0.000440481005257788,0.00261610804888908,-0.00468709077056482,0.00556805278108039,0.86629155365797
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL6B,Myosin light chain 6B,24195,0.00109163379139065,0.00649049970562995,-0.011629745631644,0.0138130132144253,0.866435620870893
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGEA3,Melanoma-associated antigen 3,24445,0.000997491064811474,0.00601616505635712,-0.0107941924456485,0.0127891745752714,0.868314292398008
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCIN,Adseverin,24101,0.000860777581750541,0.00519420347537922,-0.00931986122999272,0.0110414163934938,0.868379578327425
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPN3,Calpain-3,24793,0.000443319895141582,0.00268092458357934,-0.00481129228867393,0.00569793207895709,0.868661336930253
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH4,Cadherin-4,24101,0.000519703348509848,0.00340132652883548,-0.00614689664800769,0.00718630334502738,0.878561762888037
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,-0.00183344334893449,0.0121344422231751,-0.0256169501063577,0.0219500634084887,0.879902489698989
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L,Seizure 6-like protein,29566,-0.000289167434268826,0.00194092145144349,-0.00409337347909806,0.00351503861056041,0.881566789889531
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRN1,Neuritin,24867,0.000375248498924713,0.00252477482758902,-0.00457331016314977,0.00532380716099919,0.881849550541777
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD2,Leiomodin-2,24101,0.000648675921091042,0.00447812253443754,-0.00812844424640654,0.00942579608858863,0.884827012432984
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF3,Fibroblast growth factor 3,24229,0.000299149316169701,0.0021223062449113,-0.00386057092385645,0.00445886955619585,0.887906798811986
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.000277464767806442,0.00203720672708843,-0.00427038995289977,0.00371546041728689,0.891665177005888
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.000286903969509223,0.00214230378785986,-0.00448581939371455,0.0039120114546961,0.893464285970496
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A16,Protein S100-A16,28722,0.000567704736326386,0.00434666620215043,-0.00795176101988845,0.00908717049254122,0.896087174032043
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG2,"Arginase-2, mitochondrial",24793,0.000394168738022751,0.00306282607957616,-0.00560897037794653,0.00639730785399203,0.897600466371751
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,0.000669375897115595,0.00540485832397,-0.0099241464178656,0.0112628982120968,0.901437359348214
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.000461629358186606,0.00381748965535265,-0.00702065036630458,0.00794390908267779,0.903751554790758
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL21R,Interleukin-21 receptor,24229,0.000468904537853486,0.00389062400429725,-0.00715671851056913,0.0080945275862761,0.904070907278162
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.000238050998762019,0.0019917448737963,-0.00366576895387873,0.00414187095140277,0.904865142040851
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,0.000474122421176304,0.00424434108044826,-0.00784478609650228,0.00879303093885489,0.911056694767852
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSP90B1,Endoplasmin,28626,-0.000519274347379975,0.00474163193065778,-0.00981287293146923,0.00877432423670928,0.912795708599293
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2BP,LRP2-binding protein,24195,-0.000634176498446697,0.00584836597863055,-0.0120969738165626,0.0108286208196692,0.913650326883357
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,-0.000423989569122715,0.00396688622832699,-0.00819908657664361,0.00735110743839818,0.9148833163842
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESR1,Estrogen receptor,24229,0.000432136344467935,0.00407118063101489,-0.00754737769232125,0.00841165038125712,0.91546801641101
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.000257632245883508,0.00244041742739456,-0.00452558591180984,0.00504085040357685,0.91592509462291
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAG,Myelin-associated glycoprotein,24195,-0.000340488494169167,0.00335599039801272,-0.00691822967427411,0.00623725268593577,0.919188584489388
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.000241494723649915,0.00239816349697794,-0.00494189517772668,0.00445890573042685,0.91978940881074
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.000474414652079702,0.00486983586983458,-0.0100192929569555,0.00907046365279608,0.922394304042412
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPB41L5,Band 4.1-like protein 5,24195,0.000420327915742808,0.00444839276022768,-0.00829852189430345,0.00913917772578906,0.924720836539456
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN6,Prefoldin subunit 6,24195,-0.000390746612542069,0.00462771753757043,-0.00946107298618011,0.00867957976109598,0.932710372146664
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA5,Annexin A5,28650,-0.000180917900173536,0.00215138815511892,-0.00439763868420662,0.00403580288385955,0.932982628552266
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF174,Zinc finger protein 174,24229,-0.00019954154960774,0.00267329896290292,-0.00543920751689746,0.00504012441768198,0.940499824952138
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.000206802255805556,0.00288583724437365,-0.00586304325477792,0.0054494387431668,0.942872210341358
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,-0.000243004042903978,0.00347231447993902,-0.00704874042358445,0.00656273233777649,0.94420752878796
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.000702974030376067,0.0101549424289652,-0.0206066611911478,0.0192007131303957,0.944811246120862
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLINT1,Clathrin interactor 1,24016,-0.000225564506406352,0.00337321096543786,-0.00683705799866456,0.00638592898585186,0.946686251232606
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,-0.000179133971787939,0.00283920174894963,-0.00574396939972921,0.00538570145615333,0.949692911375254
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,-0.000270198969817894,0.00463374603996736,-0.00935234120815392,0.00881194326851813,0.95350119895623
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.000271059057720128,0.00465446429157261,-0.00939380906920245,0.00885169095376219,0.95356084003444
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3B,Sodium channel subunit beta-3,24101,0.000186329067751055,0.00326150594593765,-0.00620622258628673,0.00657888072178884,0.95444230008941
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,-0.000303429713762595,0.00549790550191862,-0.0110793244975231,0.0104724650699979,0.955987506803662
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.000248516040270234,0.00460740963155143,-0.00878200683757058,0.00927903891811105,0.956984660561813
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.000151722857675864,0.00291248270811437,-0.00586018896558003,0.00555674325022831,0.958454228610177
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3,Interleukin-3,24016,-0.000220533935768813,0.00428283752077888,-0.00861489547649542,0.0081738276049578,0.95893352055963
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP1,Retinol-binding protein 1,24195,-0.000247641912033472,0.00490751643590119,-0.00986637412639979,0.00937109030233285,0.959754839189782
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,-0.000302147966068408,0.00641278240427778,-0.0128712014784529,0.012266905546316,0.962420752479151
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC51B,Organic solute transporter subunit beta,24111,-0.000244298666774521,0.00540211957499195,-0.0108324530337587,0.0103438557002097,0.96393014099384
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCARE,Photoreceptor cilium actin regulator,24101,0.000270153794517607,0.00598835598491615,-0.0114670239359181,0.0120073315249533,0.964017468231473
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.000142574351492365,0.00348603119710295,-0.00697519549781415,0.00669004679482942,0.967376940610276
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-8.06988919904917e-05,0.00209959532411565,-0.00419590572725716,0.00403450794327618,0.969340804532005
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD8,Frizzled-8,24101,-0.00010852841525088,0.00311126257744359,-0.00620660306704032,0.00598954623653856,0.972173775813572
NMR metabolomics,X23501.Triglycerides in Large VLDL,STEAP4,Metalloreductase STEAP4,24101,-0.000179839774809095,0.00523773619297065,-0.0104458027130316,0.0100861231634134,0.972609979745519
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPT1,Translationally-controlled tumor protein,28931,-0.000144347334875471,0.00461446900862352,-0.00918870659177757,0.00890001192202662,0.975045290597177
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1B,Lithostathine-1-beta,29820,0.00012127814321579,0.00397732290834431,-0.00767427475713907,0.00791683104357065,0.975674554200102
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,-5.84472114503267e-05,0.00217683895489705,-0.00432505156304855,0.00420815714014789,0.978579924175289
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXDNL,Peroxidasin-like protein,24793,-0.000106878510249323,0.00408889137068967,-0.00812110559680108,0.00790734857630243,0.979146879887403
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_A,,24867,-5.61468663567219e-05,0.00230997442738242,-0.00458369674402627,0.00447140301131283,0.980608505551528
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL4,Myosin light chain 4,24240,-8.04114069047438e-05,0.00367849677683155,-0.00729026508949458,0.00712944227568509,0.982559928054688
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC2,Stanniocalcin-2,29396,-3.685038760844e-05,0.00183141803757103,-0.00362642974124766,0.00355272896603079,0.983946799346462
NMR metabolomics,X23501.Triglycerides in Large VLDL,RETN,Resistin,29362,-3.5759005794647e-05,0.0029801338949856,-0.00587682143996642,0.00580530342837713,0.990426392929336
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC1,Sialoadhesin,29581,3.2656698323823e-05,0.00299674997821848,-0.0058409732589844,0.00590628665563205,0.991305400997282
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAN,Brevican core protein,29218,2.36639140673464e-05,0.00240061313057346,-0.00468153782185664,0.00472886564999133,0.992135090809966
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASQ2,Calsequestrin-2,24111,-2.79683274726629e-05,0.00345760275383134,-0.0068048697249821,0.00674893307003677,0.993546100175318
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-1.41699832479072e-05,0.00200117094686766,-0.00393646503910852,0.00390812507261271,0.994350406502906
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMP,Olfactory marker protein,24101,2.16150880581628e-05,0.00349005815855823,-0.00681889890271598,0.0068621290788323,0.995058519084201
